<SEC-DOCUMENT>0000950170-23-016017.txt : 20230501
<SEC-HEADER>0000950170-23-016017.hdr.sgml : 20230501
<ACCEPTANCE-DATETIME>20230501072754
ACCESSION NUMBER:		0000950170-23-016017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20230426
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230501
DATE AS OF CHANGE:		20230501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eledon Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36620
		FILM NUMBER:		23870003

	BUSINESS ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612
		BUSINESS PHONE:		949-238-8090

	MAIL ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Novus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070622
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eldn-20230426.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-05-01T06:13:06.5108+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:eldn="http://www.eledon.com/20230426" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_c3d98b99-4c6d-4180-85a5-22485eeb6d4c" name="dei:EntityCentralIndexKey" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a">0001404281</ix:nonNumeric><ix:nonNumeric id="F_14222ccc-4b59-4d6d-bca3-2237a06d498a" name="dei:AmendmentFlag" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="eldn-20230426.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_48c1f781-f488-4629-9efd-dada7ef92a5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_985d01b5-0e17-430f-a8bb-89af571b2bf7" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9cb388a8-980b-4cb9-baad-df0e37f66f02" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">April 26, 2023</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_52dba78f-6695-4df4-aecf-49b5f9a03b81" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eledon Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_13ae3907-20c6-4e2d-ab2e-0e0d537beb1a" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4f43e3de-57eb-4a0a-b3f0-261a1bc02066" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-36620</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_262126fc-7ed8-4859-8f05-77ea69ac2485" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20-1000967</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c9ab9090-9363-4113-a3ff-e71ffeb2ab90" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19900 MacArthur Blvd.</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b6719140-4a8b-4848-993f-6ba05ac7e05a" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 550</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e45863ee-617f-4b83-ba91-32accd4e6b4e" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Irvine</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_332f937d-8380-4028-a20e-ffe51bee6587" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e0b053b4-9b9e-4ecc-a829-e1cf8bf2dcb9" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92612</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8aaa76e6-a0dd-45d2-b42b-aabfc90c206b" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">949</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fe3c26c3-3f36-4b0e-afa9-815f1c11ee1b" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">238-8090</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e7bf27af-73d3-4fdd-b821-ad253da1d3ae" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b9ff66e4-4d8a-4d36-a801-ee86d87cb65d" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_60c04ceb-545e-47ab-bd0e-da3487134096" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_580e676e-c4d0-4abe-a07b-ffcc72bf7bf6" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a4fba383-3bb7-4160-884e-43c6471043a9" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, $0.001 par value</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7456d117-5dda-48d9-9290-88a304938875" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELDN</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_59842e74-253f-4345-b787-c6af976bb194" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_a0db72f0-f574-4199-8199-eb0fe490448b" contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.01 Entry into a Material Definitive Agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 28, 2023, Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) entered into a Securities Purchase Agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with certain institutional and accredited investors (the &#x201c;Purchasers&#x201d;), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the &#x201c;Private Placement&#x201d;) (i) in an initial closing, (a) an aggregate of 15,151,518 shares (the &#x201c;Shares&#x201d;) of the Company&#x2019;s common stock, $0.001 par value per share (the &#x201c;Common Stock&#x201d;), or pre-funded warrants in lieu thereof (the &#x201c;Pre-Funded Warrants&#x201d;), and (b) common stock warrants exercisable into an aggregate of 15,151,518 shares of Common Stock (or Pre-Funded Warrants in lieu thereof) (the &#x201c;Common Warrants&#x201d; and, together with the Pre-Funded Warrants, the &#x201c;Warrants&#x201d;); (ii) in a second closing, upon the satisfaction of specified conditions set forth in the Securities Purchase Agreement, an aggregate of 20,202,024 shares of Common Stock (or Pre-Funded Warrants); and (iii) in a third closing, upon the satisfaction of specified conditions set forth in the Securities Purchase Agreement, an aggregate of 25,252,530 shares of Common Stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $3.00 per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The second and third closings under the Securities Purchase Agreement have mandatory funding conditions whereby the Purchasers committed to purchase shares in the second and third closings upon the satisfaction of specified clinical trial milestones and volume weighted average share price levels and trading volume conditions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A holder (together with its affiliates) may not exercise any portion of a Warrant to the extent that the holder would own more than 4.99% (or, at the holder&#x2019;s option upon issuance, 9.99% and, for one Purchaser, 19.99%) of the Company&#x2019;s outstanding Common Stock immediately after exercise. However, upon at least 61 days&#x2019; prior notice from the holder to the Company, a holder with a 4.99% ownership blocker may increase the amount of ownership of outstanding Common Stock after exercising the holder&#x2019;s Warrant up to 9.99% of the number of the Company&#x2019;s Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Securities Purchase Agreement contains customary representations and warranties and agreements of the Company and the Purchasers and customary indemnification rights and obligations of the parties. The initial closing of the Private Placement is expected to occur the week of May 1, 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Private Placement is expected to result in gross proceeds to the Company of approximately $35 million in the initial closing, an additional $105 million upon sale of the shares to be issued in the second and third closings, and an additional $45 million assuming the exercise of all Common Warrants. The Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes, including the clinical development of its lead asset, tegoprubart.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Shares, the Warrants, and the shares of Common Stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Private Placement, the Company entered into a registration rights agreement, dated April 28, 2023 (the &#x201c;Registration Rights Agreement&#x201d;), with the Purchasers, pursuant to which, among other things, the Company will (i) prepare and file with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) a registration statement on Form S-3 to register for resale the Shares and the shares of Common Stock issuable upon the exercise of the Warrants within 20 calendar days, and (ii) use its reasonable best efforts to have the registration statement declared effective promptly after filing, and in any event no later than 60 days after the date of the Securities Purchase Agreement (or 90 days after the date of the Securities Purchase Agreement if the registration statement is reviewed by the SEC). The Registration Rights Agreement contains customary terms and conditions for a transaction of this type, including certain customary cash penalties on the Company for its failure to satisfy specified filing and effectiveness time periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SVB Securities LLC is acting as lead placement agent and Cantor Fitzgerald, LifeSci Capital and Noble Capital Markets, Inc. are acting as co-placement agents in connection with the Private Placement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The foregoing description of the material terms of the Securities Purchase Agreement, the Warrants and the Registration Rights Agreement is not complete and is qualified in its entirety by reference to the full text of the Securities Purchase Agreement, the form of Pre-Funded Warrant, the form of Common Warrant and the Registration Rights Agreement, which are filed as Exhibits 10.1, 4.1, 4.2 and 10.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.02 Unregistered Sales of Equity Securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information contained in Item 1.01 of this Current Report on Form 8-K related to the Shares, the Warrants, and the shares of Common Stock issuable upon the exercise of the Warrants is incorporated herein by reference.</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 26, 2023, Gary A. Lyons notified the Company that he is retiring from the Board of Directors of the Company at the end of his term and will not be standing for election at the Company&#x2019;s 2023 annual meeting of stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 27, 2023, the Company entered into a letter agreement with David-Alexandre Gros, its CEO (the &#x201c;Gros Agreement&#x201d;), amending his employment agreement, dated as of September 9, 2020. Pursuant to the Gros Agreement, Dr. Gros&#x2019; employment agreement was amended to provide for (i) a modification of his Performance Bonus (as defined in his employment agreement), (ii) a retention bonus, (iii) potential equity acceleration of certain outstanding equity awards, and (iv) a new potential equity award that replaces his rights under his current employment agreement to receive a similar potential equity award.  Pursuant to his Performance Bonus, Dr. Gros remains entitled to a $10 million bonus in the event that, during the Measurement Period (as defined in his employment agreement), the market value of the Company exceeds $1 billion. The amendment to his Performance Bonus entitles Dr. Gros to a pro-rata portion of his Performance Bonus in the event that his employment is terminated for any reason other than by the Company for Cause and the market value of the Company at the time of termination of employment is equal to or greater than $600 million, but less than $1 billion. The threshold Performance Bonus payment is $6 million at a $600 million market value and increases up to the maximum $10 million bonus payable at a $1 billion market value using linear interpolation. The amendment also provides that market value is calculated by taking into account the total value of all securities treated as equity securities in the Company&#x2019;s financial statements (&#x201c;Market Value&#x201d;).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the amendment provides for a retention bonus (the &#x201c;Gros Retention Bonus&#x201d;) upon the earlier to occur of (i) a termination of his employment other than for cause, (ii) a change in control during the term of his employment, and (iii) July 31, 2026 (the earliest date to be the &#x201c;Retention Bonus Date&#x201d;).  The Gros Retention bonus will be paid in cash or stock in an amount equal to the product of 761,589 multiplied by the difference between the fair market value of the Company&#x2019;s common stock on the Retention Bonus Date over the fair market value of the Company&#x2019;s common stock at the time of the initial closing of the Private Placement. The common stock price used to calculate the Gros Retention Bonus, however, will be limited to a maximum of $9.00.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amendment also provides for vesting acceleration of Dr. Gros&#x2019; outstanding equity awards. If Dr. Gros&#x2019; employment is terminated by the Company without cause or by him for good reason, subject to his execution of the release contemplated by his employment agreement, any then-unvested and outstanding performance-based equity awards will now (1) remain outstanding and eligible to vest if the applicable performance conditions are satisfied during the 12 months following such termination of employment, and (2) the term of such performance-based options will be extended until the earlier of (A) 90 days after the performance conditions are achieved and (B) the normal expiration date of such performance-based options.  If his employment is terminated without cause or for good reason in connection with a change of control, subject to his execution of the release contemplated by his employment agreement, any then-unvested and outstanding performance-based equity awards will become fully vested at the target performance level.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finally, the Gros Agreement modifies Dr. Gros&#x2019; employment agreement to provide that instead of the Incentive Shares provided in Section 4(c) of his employment agreement, Dr. Gros will be eligible to receive a proportionate grant of common stock that will be equal to one percent of the fully diluted shares of Company common stock, upon the first occurrence of (i) the exercise of a majority of the Common Warrants or Pre-Funded Warrants held by the largest holder of such warrants on the initial closing of the Private Placement and (ii) the first date that is six months after the date on which topline data for the Company&#x2019;s kidney transplantation phase 2 trial (K207) is available to the Company and where the Company&#x2019;s Market Value is equal to or greater than $900 million for a period of 20 consecutive calendar days.  Dr. Gros will be entitled to such new incentive shares if either of the above conditions are satisfied at any time during the term of his employment agreement or within 12 months following a termination of his employment without cause or for good reason.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The foregoing description of the Gros Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Gros Agreement, a copy of which is filed herewith as Exhibit 10.3.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Steven Perrin, Ph.D. Letter Agreement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 27, 2023, the Company entered into a letter agreement with Steven Perrin, Ph.D. (the &#x201c;Perrin Agreement&#x201d;), amending his employment agreement, dated as of September 14, 2020. Pursuant to the Perrin Agreement, Dr. Perrin&#x2019;s employment agreement was amended to provide for a retention bonus providing for substantially similar terms as those provided pursuant to the Gros Retention Bonus. The only difference is that instead of using 761,589 in the calculation, the applicable number for the calculation will be 327,350.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The foregoing description of the Perrin Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Perrin Agreement, a copy of which is filed herewith as Exhibit 10.4.</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 1, 2023, the Company issued a press release announcing the Private Placement. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.0%;"></td>
    <td style="width:89.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex4_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex4_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Tranche A Warrant to Purchase Common Stock or Pre-Funded Warrants</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Purchase Agreement, dated April 28, 2023</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex10_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Rights Agreement, dated April 28, 2023</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex10_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">David-Alexandre Gros, M.D. Letter Agreement, dated April 27, 2023</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex10_4.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Perrin, Ph.D. Letter Agreement, dated April 27, 2023</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eldn-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Press Release dated May 1, 2023</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eledon Pharmaceuticals, Inc.</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: David-Alexandre C. Gros, M.D.<br />Title: Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>2
<FILENAME>eldn-ex4_1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<html>
 <head>
  <title>EX-4</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 4.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Shares:  _______ Issue Date:______, 20__<br>Initial Exercise Date:  _______, 20__</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">THIS PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) certifies that, for value received, _____________ or its assigns (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Exercise Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and until this Warrant is exercised in full (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) but not thereafter, to subscribe for and purchase from Eledon Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), up to ______ shares (as subject to adjustment hereunder, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.001 per share (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), dated April 28, 2023, among the Company and the purchasers signatory thereto. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Within five (5) Trading Days following the date of exercise as </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#x2019;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.  No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.  Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.  The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.  The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cashless Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Warrant may also be exercised, in whole or in part, at such time by means of a &#x201c;cashless exercise&#x201d; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</font></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;">(A)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">= as applicable:  (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#x201c;regular trading hours&#x201d; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#x2019;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#x201c;regular trading hours&#x201d; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#x201c;regular trading hours&#x201d; on a Trading Day) pursuant </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#x201c;regular trading hours&#x201d; on such Trading Day;</font></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;">(B)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">= the Exercise Price of this Warrant, as adjusted hereunder; and </font></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;">(C)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bid Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies:  (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">VWAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on the Nasdaq Capital Market or any other national securities exchange, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Nasdaq Capital Market or other national securities exchange, as applicable, on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The Company agrees not to take any position contrary to this Section 2(c).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mechanics of Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of Warrant Shares Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following delivery of the Notice of Exercise, the Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#x2019;s or its designee&#x2019;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DWAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#x2019;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the latest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (ii) one (1) Trading Day after delivery of the aggregate Exercise Price and Notice of Exercise to the Company (such date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Share Delivery Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date.  If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the third Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the eighth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.  The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of New Warrants Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rescission Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#x2019;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Buy-In</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.  The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#x2019;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Fractional Shares or Scrip</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">vi.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">vii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing of Books</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder&#x2019;s Exercise Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#x2019;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#x2019;s Affiliates (such Persons, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attribution Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.  To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#x2019;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.  In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#x2019;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Limitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall be [4.99%/9.99%/19.99%] of the number of shares of the Common </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that to the extent required under Nasdaq Marketplace Rules, the Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.  The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.  The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Adjustments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock Dividends and Splits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the Company, at any time while this Warrant is outstanding:  (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re classification.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsequent Rights Offerings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all of the record holders of any class of shares of Common Stock (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (such date, the &#x201c;Rights Determination Date&#x201d;) (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that to the extent that the Holder&#x2019;s right to participate </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation, but not later than three months after the Rights Determination Date.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pro Rata Distributions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that to the extent that the Holder&#x2019;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fundamental Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fundamental Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alternate Consideration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  In the context of a Fundamental Transaction that is an exchange offer (i.e., a stock-for-stock transaction), the Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successor Entity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (reflecting a ratable adjustment to the exercise price and the number of shares issuable hereunder accounting for the exchange ratio in such Fundamental Transaction).  Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &#x201c;Company&#x201d; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calculations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.  For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice to Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustment to Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice to Allow Exercise by Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer of Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transferability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.  The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.  All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Register</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Register</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Restrictions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representation by the Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Rights as Stockholder Until Exercise; No Settlement in Cash</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting the rights of a Holder to receive Warrant Shares on a &#x201c;cashless exercise,&#x201d; and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle an exercise of this Warrant. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorized Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonwaiver and Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder or the Company shall operate as a waiver of such right or otherwise prejudice such party&#x2019;s rights, powers or remedies, notwithstanding the fact that the right to exercise this Warrant terminates on the Termination Date.  Without limiting any other provision of this Warrant or the Purchase Agreement, if either the Holder or the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the other party, the party who failed to comply with the Warrant shall pay to the materially damaged party such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#x2019; fees, including those of appellate proceedings, incurred by the materially damaged party in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Limitation of Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Warrant Shares or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">k)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">l)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder; provided, however, that this </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant may not be amended to cause the Beneficial Ownership Limitation to exceed 19.99% if the issuance of shares of Common Stock upon exercise of this Warrant would require shareholder approval under Rule 5635(b) of the Listing Rules of The Nasdaq Stock Market LLC, unless such issuance has first been approved by stockholders of the Company in accordance with such Nasdaq listing rule.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">m)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">n)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Headings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">********************</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Signature Page Follows)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">						</font></p>
  <p style="margin-left:33.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: David-Alexandre C. Gros, M.D.</font></p>
  <p style="margin-left:33.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title: Chief Executive Officer</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">[Signature Page to Pre-Funded Warrant]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acknowledged and Agreed</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	 </font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	 </font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">						</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:	</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:  	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">[Signature Page to Pre-Funded Warrant]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTICE OF EXERCISE</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TO:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2) Payment shall take the form of (check applicable box):</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[ ] in lawful money of the United States; or</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Warrant Shares shall be delivered to the following DWAC Account Number:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(4) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accredited Investor</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The undersigned is an &#x201c;accredited investor&#x201d; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE OF HOLDER]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Investing Entity:  _______________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Investing Entity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  _________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  ___________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  ____________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:  ________________________________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASSIGNMENT FORM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to exercise the Warrant to purchase shares.)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                        (Please Print)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                        (Please Print)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phone Number:________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address:________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dated:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">				</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder&#x2019;s Signature: _______________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder&#x2019;s Address: ________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>3
<FILENAME>eldn-ex4_2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<html>
 <head>
  <title>EX-4</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 4.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRANCHE A WARRANT TO PURCHASE COMMON STOCK<br>OR PRE-FUNDED WARRANTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Shares:  _______ Issue Date:______, 2023<br>Initial Exercise Date:  _______, 2023</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">THIS TRANCHE A WARRANT TO PURCHASE COMMON STOCK OR PRE-FUNDED WARRANTS (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) certifies that, for value received, _____________ or its assigns (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Exercise Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and on or prior to 5:00 p.m.  (New York City time) on [_________], 2028 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) but not thereafter, to subscribe for and purchase from Eledon Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), up to ______ shares (as subject to adjustment hereunder, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.001 per share (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) or Pre-Funded Warrants (as defined below) to purchase the same number of Warrant Shares (as subject to adjustment hereunder).  The purchase price of one Warrant Share or Pre-Funded Warrant under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), dated April 28, 2023, among the Company and the purchasers signatory thereto. In addition to the other terms defined herein, the following terms are defined as follows:</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;Pre-Funded Warrant Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; equals $0.001 per Warrant Share, subject to adjustment hereunder.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">VWAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on the Nasdaq Capital Market or any other national securities exchange, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Nasdaq Capital Market or other national securities exchange, as applicable, on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the terms and conditions hereof, this Warrant may be exercised for, at the Holder&#x2019;s discretion, either (i) Warrant Shares or (ii) in the event that the limitations set forth in Section 2(e) restrict the exercise of this Warrant into Warrant Shares, a Pre-Funded Warrant to purchase a number of shares of Common Stock equal to the number of Warrant Shares as to which this Warrant is being exercised in the form of a Pre-Funded Warrant attached as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereto (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Funded Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Within five (5) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the following by wire transfer or cashier&#x2019;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise: (i) if this Warrant is being exercised for Warrant Shares, the aggregate Exercise Price for the Warrant Shares as to which this Warrant is being exercised, as specified in the applicable Notice of Exercise or (ii) if this Warrant is being exercised for Pre-Funded Warrants, the aggregate Exercise Price for the Warrant Shares covered by a Pre-Funded Warrant as to which this Warrant is being exercised, as specified in the applicable Notice of Exercise, minus the aggregate Pre-Funded Warrant Exercise Price for such Warrant Shares covered by the Pre-Funded Warrant.  No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares or Pre-Funded Warrants available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.  Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares or Pre-Funded Warrants available hereunder shall have the effect of lowering the outstanding number of Warrant Shares or Pre-Funded Warrants purchasable </font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hereunder in an amount equal to the applicable number of Warrant Shares or Pre-Funded Warrants purchased.  The Holder and the Company shall maintain records showing the number of Warrant Shares and Pre-Funded Warrants purchased hereunder and the date of such purchases.  The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares or Pre-Funded Warrants hereunder, the number of Warrant Shares or Pre-Funded Warrants available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price.  The exercise price per share of Common Stock under this Warrant shall be $3.00, subject to adjustment hereunder (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cashless Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If at the time of exercise hereof there is no effective registration statement registering, or prospectus available for, the resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#x201c;cashless exercise&#x201d; in which the Holder shall be entitled to receive a number of Warrant Shares or Pre-Funded Warrants equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</font></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;">(A)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">= as applicable:  (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#x201c;regular trading hours&#x201d; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#x2019;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#x201c;regular trading hours&#x201d; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#x201c;regular trading hours&#x201d; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#x201c;regular trading hours&#x201d; on such Trading Day;</font></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;">(B)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">= the Exercise Price of this Warrant, as adjusted hereunder; and </font></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.14323979728499%;">(C)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bid Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies:  (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The Company agrees not to take any position contrary to this Section 2(c).</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mechanics of Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of Warrant Shares Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following delivery of the Notice of Exercise, the Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#x2019;s or its designee&#x2019;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DWAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#x2019;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the latest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (ii) one (1) Trading Day after delivery of the aggregate Exercise Price and Notice of Exercise to the Company (such date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Share Delivery Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date.  If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the third Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the eighth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.  The Company </font></div></div>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of Pre-Funded Warrants Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If this Warrant is being exercised for Pre-Funded Warrants, the Company shall issue and dispatch by overnight courier to the address as specified in the Notice of Exercise, Pre-Funded Warrants to purchase a number of shares of Common Stock with respect to which this Warrant is being exercised by the date that is the latest of (i) five (5) Business Days after the delivery to the Company of the Notice of Exercise or (ii) five (5) Business Days after delivery of the aggregate Exercise Price less the aggregate Pre-Funded Warrant Exercise Price to the Company.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of New Warrants Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares or Pre-Funded Warrants, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares or Pre-Funded Warrants called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rescission Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#x2019;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Buy-In</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.  The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#x2019;s right to pursue </font></div></div>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">vi.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Fractional Shares or Scrip</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">vii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Issuance of Warrant Shares or Pre-Funded Warrants shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares or Pre-Funded Warrants, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares or Pre-Funded Warrants shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that in the event that Warrant Shares or Pre-Funded Warrants are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares or Pre-Funded Warrants.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">viii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing of Books</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder&#x2019;s Exercise Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall not effect any exercise of this Warrant (other than for Pre-Funded Warrants), and a Holder shall not have the right to exercise any portion of this Warrant (other than for Pre-Funded Warrants), pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#x2019;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#x2019;s Affiliates (such Persons, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attribution Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, </font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.  To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#x2019;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.  In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#x2019;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Limitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall be [4.99%/9.99%/19.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that to the extent required under Nasdaq Marketplace Rules, the Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.  The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.  The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Adjustments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock Dividends and Splits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the Company, at any time while this Warrant is outstanding:  (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of </font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re classification.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsequent Rights Offerings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all of the record holders of any class of shares of Common Stock (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (such date, the &#x201c;Rights Determination Date&#x201d;) (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that to the extent that the Holder&#x2019;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation, but not later than three months after the Rights Determination Date. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pro Rata Distributions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that to the extent that the Holder&#x2019;s right to </font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fundamental Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fundamental Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alternate Consideration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  In the context of a Fundamental Transaction that is an exchange offer (i.e., a stock-for-stock transaction), the Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successor Entity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this </font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (reflecting a ratable adjustment to the exercise price and the number of shares issuable hereunder accounting for the exchange ratio in such Fundamental Transaction).  Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &#x201c;Company&#x201d; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calculations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.  For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice to Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustment to Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares or Pre-Funded Warrants and setting forth a brief statement of the facts requiring such adjustment. </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice to Allow Exercise by Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such </font></div></div>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer of Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transferability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.  The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares or Pre-Funded Warrants without having a new Warrant issued. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.  All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares or Pre-Funded Warrants issuable pursuant thereto. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Register</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Register</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Restrictions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representation by the Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">Section 5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Rights as Stockholder Until Exercise; No Settlement in Cash</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting the rights of a Holder to receive Warrant Shares on a &#x201c;cashless exercise,&#x201d; and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(v), in no event will the Company be required to net cash settle an exercise of this Warrant. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorized Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.  The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></p>
  <p style="margin-left:6.667%;text-indent:14.286%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before taking any action which would result in an adjustment in the number of Warrant Shares or Pre-Funded Warrants for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonwaiver and Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder or the Company shall operate as a waiver of such right or otherwise prejudice such party&#x2019;s rights, powers or remedies, notwithstanding the fact that the right to exercise this Warrant terminates on the Termination Date.  Without limiting any other provision of this Warrant or the Purchase Agreement, if either the Holder or the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the other party, the party who failed to comply with the Warrant shall pay to the materially damaged party such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#x2019; fees, including those of appellate proceedings, </font></div></div>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incurred by the materially damaged party in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Limitation of Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares or Pre-Funded Warrants, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Warrant Shares or Pre-Funded Warrants or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">k)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares or Pre-Funded Warrants.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">l)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder; provided, however, that this Warrant may not be amended to cause the Beneficial Ownership Limitation to exceed 19.99% if the issuance of shares of Common Stock upon exercise of this Warrant would require shareholder approval under Rule 5635(b) of the Listing Rules of The Nasdaq Stock Market LLC, unless such issuance has first been approved by stockholders of the Company in accordance with such Nasdaq listing rule.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">m)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">n)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Headings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">********************</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Signature Page Follows)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">						</font></p>
  <p style="margin-left:33.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: David-Alexandre C. Gros, M.D.</font></p>
  <p style="margin-left:33.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title: Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">[Signature Page to Tranche A Warrant]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acknowledged and Agreed</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	 </font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	 </font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">						</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:	</font></p>
  <p style="text-indent:37.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">[Signature Page to Tranche A Warrant]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTICE OF EXERCISE</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TO:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1) The undersigned hereby elects to purchase ________ Warrant Shares and/or ________ Pre-Funded Warrants of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the aggregate Exercise Price in full, minus the aggregate Pre-Funded Warrant Exercise Price for such Warrant Shares covered by the Pre-Funded Warrant, together with all applicable transfer taxes, if any.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2) Payment shall take the form of (check applicable box):</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[ ] in lawful money of the United States; or</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3) Please issue said Warrant Shares or Pre-Funded Warrants in the name of the undersigned or in such other name as is specified below:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Warrant Shares (if applicable) shall be delivered to the following DWAC Account Number:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Pre-Funded Warrants (if applicable) shall be delivered to:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:18.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            _______________________________</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(4) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accredited Investor</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The undersigned is an &#x201c;accredited investor&#x201d; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE OF HOLDER]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Investing Entity:  _______________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Investing Entity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  _________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  ___________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  ____________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:  ________________________________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASSIGNMENT FORM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to exercise the Warrant to purchase Warrant Shares or Pre-Funded Warrants.)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                        (Please Print)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                        (Please Print)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phone Number:________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address:________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dated:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">				</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder&#x2019;s Signature: _______________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder&#x2019;s Address: ________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>4
<FILENAME>eldn-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES PURCHASE AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Securities Purchase Agreement (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is dated as of April 28, 2023, between Eledon Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and collectively the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchasers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and/or Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">Article I.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br>DEFINITIONS</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.1</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</font></div></div>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquiring Person</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 4.5.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(j).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Pre-Funded Warrant Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the shares of Common Stock issuable upon exercise of the Additional Pre-Funded Warrants.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Pre-Funded Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the applicable Closings in accordance with Sections 2.1(b) and (c) hereof, which Additional Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Additional Shares, the Additional Pre-Funded Warrants and the Additional Pre-Funded Warrant Shares.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the shares of Common Stock issued or issuable to each Purchaser in connection with the applicable Closings pursuant to Sections 2.1(b) and (c) of this Agreement, but excluding the Additional Pre-Funded Warrant Shares.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Subscription Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to each Purchaser, the Second Closing Subscription Amount and/or the Third Closing Subscription Amount, as applicable.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Affiliate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Limitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means 4.99% (or, at the election of the Purchaser at the Closing, such other beneficial ownership limitation as set forth on the signature page hereto and including such Purchaser&#x2019;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&#x2019;s Affiliates) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. Any increase in the Beneficial Ownership Limitation will not be effective until the 61</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">st</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> day after such notice is delivered to the Company.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Board of Directors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the board of directors of the Company.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#x201c;stay at home&#x201d;, &#x201c;shelter-in-place&#x201d;, &#x201c;non-essential employee&#x201d; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Initial Closing, the Second Closing and/or the Third Closing, as applicable.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Initial Closing Date, the Second Closing Date and/or the Third Closing Date, as applicable.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the United States Securities and Exchange Commission.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock Equivalents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock Warrant Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the shares of Common Stock issuable upon exercise of the Common Stock Warrants.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively, the Tranche A Warrants to Purchase Common Stock or Pre-Funded Warrants delivered to the Purchasers at the Initial Closing in accordance with Section 2.2(a) hereof, in the form of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto, which shall be exercisable immediately and have a term of exercise equal to five (5) years.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Counsel</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means O&#x2019;Melveny &amp; Myers LLP, with offices located at 610 Newport Center Drive, 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Floor, Newport Beach, CA 92660.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Disclosure Schedules of the Company delivered concurrently herewith.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Time</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the earliest of the date that (a) the initial Registration Statement filed pursuant to this Agreement has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions, or (c) all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluation Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(s).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exchange Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exempt Issuance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">securities (other than in connection with stock splits or combinations or as otherwise required by the terms of such securities in effect as of the date of this Agreement) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &#x201c;restricted securities&#x201d; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FCPA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Foreign Corrupt Practices Act of 1977, as amended.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(jj).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDCA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(jj).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GAAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(h).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indebtedness</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(bb).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the initial closing of the purchase and sale of the Initial Securities pursuant to Section 2.1(a).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Closing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#x2019; obligations to pay the Initial Subscription Amount and (ii) the Company&#x2019;s obligations to deliver the Initial Securities, in each case, have been satisfied or waived.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Pre-Funded Warrant Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the shares of Common Stock issuable upon exercise of the Initial Pre-Funded Warrants.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Pre-Funded Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Initial Closing in accordance with Section 2.2(a) hereof, which Initial Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Initial Shares, the Initial Pre-Funded Warrants, the Initial Pre-Funded Warrant Shares, the Common Stock Warrants and the Common Stock Warrant Shares.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the shares of Common Stock issued or issuable to each Purchaser on the Initial Closing pursuant to Section 2.1(a) of this Agreement, but excluding the Initial Pre-Funded Warrant Shares and Common Stock Warrant Shares.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Subscription Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to each Purchaser, the aggregate amount to be paid for the Initial Securities purchased hereunder as specified opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto under the heading &#x201c;Aggregate Purchase Price at Initial Closing,&#x201d; in United States dollars and in immediately available funds.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(p).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legend Removal Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 4.1(c).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liens</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a material lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lock-Up Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and its directors and executive officers, in the form of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit D</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Adverse Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning assigned to such term in Section 3.1(b).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Permits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(n).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Share Purchase Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; equals $2.31 (less $0.001 for each Pre-Funded Warrant, as applicable), in each case subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the applicable Closing Date.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Person</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pharmaceutical Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(jj).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placement Agent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means SVB Securities LLC and Noble Capital Markets, Inc.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Funded Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively, the Initial Pre-Funded Warrants and the Additional Pre-Funded Warrants.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchaser Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 4.8.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Rights Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers, in the form of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the Purchasers of the Shares and the Warrant Shares.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Required Approvals</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(e).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 144</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 424</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEC Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 3.1(h).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 2.1(b).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Trading Day on which all conditions precedent to (i) the Purchasers&#x2019; obligations to pay the Second Closing Subscription Amount and (ii) the Company&#x2019;s obligations to deliver Additional Securities in connection with the Second Closing, in each case, have been satisfied or waived; provided, that the Second Closing Date shall be a date that is not more than five (5) Trading Days following the date on which all such conditions have been satisfied or waived.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 4.18(a).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing Subscription Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to each Purchaser, the aggregate amount to be paid for Additional Shares and/or Additional Pre-Funded Warrants purchased hereunder in connection with the Second Closing, as specified opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto under the heading &#x201c;Second Closing Subscription Amount,&#x201d; in United States dollars and in immediately available funds.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing Trigger Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 2.4(b)(i).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Initial Securities and the Additional Securities.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively, the Initial Shares and the Additional Shares.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all &#x201c;short sales&#x201d; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subscription Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to each Purchaser, the Initial Subscription Amount, the Second Closing Subscription Amount and/or the Third Closing Subscription Amount, as applicable.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiary</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 2.1(c).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Trading Day on which all conditions precedent to (i) the Purchasers&#x2019; obligations to pay the Third Closing Subscription Amount and (ii) the Company&#x2019;s obligations to deliver Additional Securities in connection with the Third Closing, in each case, have been satisfied or waived; provided, that the Third Closing Date shall be a date that is not more than five (5) Trading Days following the date on which all such conditions have been satisfied or waived.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 4.18(b).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing Subscription Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to each Purchaser, the aggregate amount to be paid for Additional Shares and/or Additional Pre-Funded Warrants purchased hereunder in connection with the Third Closing as specified opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto under the heading &#x201c;Third Closing Subscription Amount,&#x201d; in United States dollars and in immediately available funds.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing Trigger Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 2.4(b)(ii).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a day on which the principal Trading Market is open for trading.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading Market</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:  the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means this Agreement, the Warrants, the Registration Rights Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Agent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address of 1 State Street, 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Floor, New York, New York, 10004, and any successor transfer agent of the Company.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable Rate Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to such term in Section 4.12(b).</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">VWAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed or quoted on the Nasdaq Capital Market or any other national securities exchange, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the Nasdaq Capital Market or other national securities exchange, as applicable, on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Shares so reported, or (d) in all other cases, the fair market value of a share of Common Shares as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the shares of Common Stock issuable upon exercise of the Warrants.</font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively, the Pre-Funded Warrants and the Common Stock Warrants.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">Article II.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br>PURCHASE AND SALE</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.1</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On the Initial Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, (i) an aggregate of approximately $35 million of Initial Shares and (ii) Common Stock Warrants to purchase up to an aggregate of approximately $45 million of Shares or Pre-Funded Warrants; provided, however, that such Purchaser may elect to purchase Initial Pre-Funded Warrants in lieu of Initial Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company (it being understood that such Purchaser shall be under no obligation to elect to purchase Initial Pre-Funded Warrants in lieu of any or all Initial Shares, except to the extent that the purchase of Initial Shares would cause such Purchaser (together with such Purchaser&#x2019;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&#x2019;s </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Affiliates) to beneficially own in excess of 19.99% of the outstanding Common Stock immediately after giving effect to the issuance of the Initial Shares on the Initial Closing Date, in which case such Purchaser must elect to purchase sufficient Initial Pre-Funded Warrants in lieu of Initial Shares in order to ensure such 19.99% is not exceeded).  For the avoidance of doubt, the number of Securities that the Company agrees to sell, and each Purchaser agrees to purchase on the Initial Closing Date, shall equal (i) the number of Initial Shares set forth opposite such Purchaser&#x2019;s name under the heading &#x201c;Number of Shares to be Purchased at Initial Closing,&#x201d; (ii) the number of Pre-Funded Warrants set forth opposite such Purchaser&#x2019;s name under the heading &#x201c;Number of Pre-Funded Warrants to be Purchased at Initial Closing,&#x201d; and (iii) the number of Common Stock Warrants set forth opposite such Purchaser&#x2019;s name under the heading &#x201c;Number of Common Stock Warrants to be Purchased at Initial Closing,&#x201d; in each case as set forth opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereto.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or before the date that is the later of (i) February 29, 2024 or (ii) 95 days after the 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Company&#x2019;s Phase 1b trial evaluating the safety, pharmacokinetics, and efficacy of tegoprubart in patients undergoing kidney transplantation (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 1b Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and the 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Company&#x2019;s planned BESTOW Phase 2 trial evaluating the safety and efficacy of tegoprubart in patients undergoing kidney transplantation (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), upon the terms and subject to Section 2.4, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of approximately $47 million of Additional Shares in a second closing (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); provided, however, that such Purchaser may elect to purchase Additional Pre-Funded Warrants in lieu of Additional Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company (it being understood that such Purchaser shall be under no obligation to elect to purchase Additional Pre-Funded Warrants in lieu of any or all Additional Shares, except to the extent that the purchase of Additional Shares would cause such Purchaser (together with such Purchaser&#x2019;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&#x2019;s Affiliates) to beneficially own in excess of 19.99% of the outstanding Common Stock immediately after giving effect to the issuance of the Additional Shares on the Second Closing Date, in which case such Purchaser must elect to purchase sufficient Additional Pre-Funded Warrants in lieu of Additional Shares in order to ensure such 19.99% is not exceeded); provided, at the written election of Purchaser prior to the Second Closing, Purchaser may elect to delay the Second Closing with respect to such Purchaser&#x2019;s Additional Shares for 61 days following the Second Closing; and provided, further, if the Company ceases all development programs in kidney transplant, that the rights and obligations of the Company and the Purchasers to consummate the Second Closing shall expire five (5) days after the Company publicly announces that it is ceasing all tegoprubart development programs in kidney transplant.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or before the date that is the later of (i) September 30, 2024 or (ii) 65 days after the 78</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Phase 2 Trial, upon the terms and subject to Section 2.4, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of approximately $58 million of Additional Shares in a third closing (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); provided, however, that such Purchaser may elect to purchase Additional Pre-Funded Warrants in lieu of Additional Shares in such manner to result in </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the same aggregate purchase price being paid by such Purchaser to the Company (it being understood that such Purchaser shall be under no obligation to elect to purchase Additional Pre-Funded Warrants in lieu of any or all Additional Shares, except to the extent that the purchase of Additional Shares would cause such Purchaser (together with such Purchaser&#x2019;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&#x2019;s Affiliates) to beneficially own in excess of 19.99% of the outstanding Common Stock immediately after giving effect to the issuance of the Additional Shares on the Third Closing Date, in which case such Purchaser must elect to purchase sufficient Additional Pre-Funded Warrants in lieu of Additional Shares in order to ensure such 19.99% is not exceeded); provided, at the written election of Purchaser prior to the Third Closing, Purchaser may elect to delay the Third Closing with respect to such Purchaser&#x2019;s Additional Shares for 61 days following the Third Closing; and provided, further, if the Company ceases all development programs in kidney transplant, that the rights and obligations of the Company and the Purchasers to consummate the Third Closing shall expire five (5) days after the Company publicly announces that it is ceasing all tegoprubart development programs in kidney transplant.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Purchaser&#x2019;s Subscription Amount shall be made available for &#x201c;Delivery Versus Payment&#x201d; settlement with the Company or its designee.  At each applicable Closing, the Company shall deliver to each Purchaser its respective Shares and Warrants, as determined pursuant to Section 2.2, and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at such Closing.  Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Placement Agent or such other location as the parties shall mutually agree.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.2</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deliveries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or prior to the Initial Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">this Agreement duly executed by the Company;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent and Purchasers; </font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate or book entry statement evidencing a number of Initial Shares as set forth opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto under the heading &#x201c;Number of Shares to be Purchased at Initial Closing,&#x201d; registered in the name of such Purchaser;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for each Purchaser of Initial Pre-Funded Warrants pursuant to Section 2.1(a), a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock as set forth opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto under the heading &#x201c;Number of Pre-Funded Warrants to be Purchased at Initial Closing&#x201d; (such Pre-Funded Warrant certificate may be delivered within three Business Days of the Initial Closing Date);</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a Common Stock Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock (or Pre-Funded Warrants) set forth opposite such Purchaser&#x2019;s name on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto under the heading &#x201c;Number of Common Stock Warrants to be Purchased at Initial Closing&#x201d; (such Common Stock Warrant certificates may be delivered within three Business Days of the Closing Date);</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(vi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">on the date hereof, the duly executed Lock-Up Agreements;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(vii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall have provided each Purchaser with the Company&#x2019;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer; and</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(viii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Registration Rights Agreement duly executed by the Company.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or prior to the Initial Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">this Agreement duly executed by such Purchaser;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such Purchaser&#x2019;s Initial Subscription Amount, which shall be made available for &#x201c;Delivery Versus Payment&#x201d; settlement with the Company or its designee, by wire transfer pursuant to the wire instructions provided by the Company; and</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Registration Rights Agreement duly executed by such Purchaser.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or prior to each of the Second Closing Date and the Third Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent and Purchasers; </font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate or book entry statement evidencing a number of Additional Shares equal to such Purchaser&#x2019;s applicable Additional Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for each Purchaser of Additional Pre-Funded Warrants pursuant to Section 2.1(b) or (c), as applicable, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&#x2019;s applicable Additional Subscription Amount applicable to Pre-Funded Warrants divided by the Per Share Purchase Price, with an exercise price equal to $0.001, subject to adjustment therein (such Pre-Funded Warrant certificate may be delivered within three Business Days of the applicable Closing Date); and </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall have provided each Purchaser with the Company&#x2019;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or prior to each of the Second Closing Date and the Third Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Such Purchaser&#x2019;s applicable Additional Subscription Amount, which shall be made available for &#x201c;Delivery Versus Payment&#x201d; settlement with the Company or its designee, by wire transfer pursuant to the wire instructions provided by the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.3</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Conditions for the Initial Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The obligations of the Company hereunder in connection with the Initial Closing are subject to the following conditions being met (or being waived in the sole discretion of the Company):</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Initial Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); </font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Initial Closing Date shall have been performed; and</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The respective obligations of the Purchasers hereunder in connection with the Initial Closing are subject to the following conditions being met (or being waived in the sole discretion of the Purchasers):</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Initial Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all obligations, covenants and agreements of the Company required to be performed at or prior to the Initial Closing Date shall have been performed;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">from the date hereof to the Initial Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#x2019;s principal Trading Market, and, at any time prior to the Initial Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Initial Securities at the Initial Closing.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.4</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Conditions for the Second and Third Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The obligations of the Company hereunder in connection with each of the Second Closing and the Third Closing are subject to the following conditions being met (or being waived in the sole discretion of the Company):</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the applicable Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the applicable Closing Date shall have been performed; and</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the delivery by each Purchaser of the items set forth in Section 2.2(d) of this Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The respective obligations of the Purchasers hereunder in connection with each of the Second Closing and the Third Closing are subject to the following conditions being met (or being waived in the sole discretion of the Purchasers): </font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with respect to the Second Closing only, (1) the occurrence of the date that is 90 days after the 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> patient dosed in the Phase 1b Trial and the 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Phase 2 Trial (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing Trigger Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); (2) a VWAP of not less than $23.10 on the Trading Day immediately following the Second Closing Trigger Date; and (3) a daily trading volume of not less than 25,000,000 shares of Common Stock on the Trading Day immediately following the Second Closing Trigger Date;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with respect to the Third Closing only, (1) the occurrence of the date that is 60 days after the 78</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Phase 2 Trial (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing Trigger Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); (2) a VWAP of not less than $23.10 on the Trading Day immediately following the Third Closing Trigger Date; and (3) a daily trading volume of not less than 25,000,000 shares of Common Stock on the Trading Day immediately following the Third Closing Trigger Date;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the applicable Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have been performed;</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the delivery by the Company of the items set forth in Section 2.2(c) of this Agreement and the timely delivery of the notice as set forth in Section 4.18(a) or (b), as applicable; and</font></div></div>
  <div style="margin-left:13.333%;text-indent:15.385%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.8465159749385585%;">(vi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">there shall have been no Material Adverse Effect with respect to the Company since the date hereof.</font></div></div>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">Article III.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br>REPRESENTATIONS AND WARRANTIES</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.1</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representations and Warranties of the Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as set forth in the SEC Reports or the Disclosure Schedules, which applicable disclosures in the SEC Reports and the Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the SEC Reports or the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiaries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All of the direct and indirect subsidiaries of the Company are set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.  If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Organization and Qualification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">currently conducted.  Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.  Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in:  (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#x2019;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Adverse Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforcement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.  The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#x2019;s stockholders in connection herewith or therewith other than in connection with the Required Approvals.  This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#x2019; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Conflicts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&#x2019;s or any Subsidiary&#x2019;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filings, Consents and Approvals</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than:  (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission required pursuant to the Registration Rights Agreement, (iii) application(s) or notification(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iv) the filing of Form D with the Commission and (v) such filings as are required to be made under applicable state securities laws (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Required Approvals</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of the Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents or any applicable beneficial ownership limitation applicable to the Purchaser.  The Warrant Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents or any applicable beneficial ownership limitation applicable to the Purchaser.  The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The capitalization of the Company as of the date hereof is as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#x2019;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#x2019;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.  No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.  Except as a result of the purchase and sale of the Securities and except as disclosed in the SEC Reports or pursuant to employee stock options awarded under the Company&#x2019;s stock option plans, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary.  The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers).  Except as disclosed in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary.  Except as disclosed in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.  The Company does not have any stock appreciation rights or &#x201c;phantom stock&#x201d; plans or agreements or any similar plan or agreement.  All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.  Except for approval by the Board of Directors and/or a committee thereof occurring on or prior to the date hereof, no further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.  Except as disclosed in the SEC Reports, there are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#x2019;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#x2019;s stockholders.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEC Reports; Financial Statements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEC Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and the Company&#x2019;s filing of the SEC Reports has been on a timely basis to the extent required to be eligible to register the issuance or resale of securities under the Securities Act or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.  As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.  The Company has never been an issuer subject to Rule 144(i) under the Securities Act.  The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.  Such financial statements have been prepared in accordance with United States generally </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">accepted accounting principles applied on a consistent basis during the periods involved (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GAAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Changes; Undisclosed Events, Liabilities or Developments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Since the date of the latest audited financial statements included within the SEC Reports, except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or as disclosed in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#x2019;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity compensation plans.  The Company does not have pending before the Commission any request for confidential treatment of information.  Except for the issuance of the Securities contemplated by this Agreement or as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Litigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect.  Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws.  There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company.  The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(k)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Labor Relations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect.  None of the Company&#x2019;s or its Subsidiaries&#x2019; employees is a member of a union that relates to such employee&#x2019;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.  To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters.  The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(l)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any Subsidiary:  (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as would not have or reasonably be expected to result in a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(m)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Environmental Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hazardous Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Environmental Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(n)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Permits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Permits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(o)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title to Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties.  Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(p)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  To the Company&#x2019;s knowledge, the Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have would have a Material Adverse Effect (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, except as would not have a Material Adverse Effect.  Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect.  To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.  The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  The Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights.  The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(q)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage.  Neither the Company nor any Subsidiary has been advised that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(r)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transactions With Affiliates and Employees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  None of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(s)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sarbanes-Oxley; Internal Accounting Controls</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and the Subsidiaries are in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date.  Except as disclosed in the SEC Reports, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that:  (i) transactions are executed in accordance with management&#x2019;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#x2019;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.  The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#x2019;s rules and forms.  The Company&#x2019;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluation Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.  Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(t)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Fees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except for the fees and expenses of the Placement Agent or as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(t)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, no brokerage or finder&#x2019;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.  The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(u)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Private Placement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Assuming the accuracy of the Purchasers&#x2019; representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.  The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investment Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#x201c;investment company&#x201d; within the meaning of the Investment Company Act of 1940, as amended.  The Company has no reason to believe that the conduct of its business in the manner currently conducted and expected to be conducted in the foreseeable future would cause the Company to become an &#x201c;investment company&#x201d; subject to registration under the Investment Company Act of 1940, as amended.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(w)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Other than to each of the Purchasers pursuant to the Registration Rights Agreement and other than as disclosed in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(x)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listing and Maintenance Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.  The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market.  The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.  The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(y)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Application of Takeover Protections</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#x2019;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&#x2019;s issuance of the Securities and the Purchasers&#x2019; ownership of the Securities.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(z)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information.  The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company.  All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in all material respects as of the date made and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.  The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading.  The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(aa)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Integrated Offering</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Assuming the accuracy of the Purchasers&#x2019; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(bb)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Solvency</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#x2019;s assets </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exceeds the amount that will be required to be paid on or in respect of the Company&#x2019;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#x2019;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.  The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).  The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date.  All outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments, as of the date hereof is disclosed in the SEC Reports.  For the purposes of this Agreement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indebtedness</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (x) any liabilities for borrowed money or amounts owed in excess of $500,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#x2019;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $500,000 due under leases required to be capitalized in accordance with GAAP.  Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(cc)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax Status</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.  There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(dd)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No General Solicitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising.  The Company has offered the Securities for sale only to the Purchasers and certain other &#x201c;accredited investors&#x201d; within the meaning of Rule 501 under the Securities Act.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(ee)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign Corrupt Practices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(ff)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accountants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company&#x2019;s independent registered public accounting firm is KMJ Corbin &amp; Company LLP.  To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#x2019;s Annual Report for the fiscal year ended December 31, 2022.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(gg)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acknowledgment Regarding Purchasers&#x2019; Purchase of Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#x2019;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.  The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#x2019; purchase of the Securities.  The Company further represents to each Purchaser that the Company&#x2019;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(hh)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acknowledgment Regarding Purchaser&#x2019;s Trading Activity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(e) and 4.14 hereof), it is understood and acknowledged by the Company that:  (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#x201c;derivative&#x201d; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#x201c;derivative&#x201d; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#x2019;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &#x201c;derivative&#x201d; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#x201c;short&#x201d; position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#x2019;s length counter-party in any &#x201c;derivative&#x201d; transaction.  The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&#x2019; equity interests in </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company at and after the time that the hedging activities are being conducted.  The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulation M Compliance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(jj)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As to each product or product candidate subject to the jurisdiction of the U.S. Food and Drug Administration (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDCA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pharmaceutical Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect.  There is no pending, completed or, to the Company&#x2019;s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect.  The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA.  The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(kk)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form S-3 Eligibility</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is eligible to register the resale of the Securities for resale by the Purchaser on Form S-3 promulgated under the Securities Act.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(ll)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office of Foreign Assets Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any Subsidiary nor, to the Company&#x2019;s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OFAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(mm)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Real Property Holding Corporation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#x2019;s request.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(nn)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bank Holding Company Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">BHCA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and to regulation by the Board of Governors of the Federal Reserve System (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal Reserve</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.  Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(oo)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money Laundering</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money Laundering Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(pp)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Disqualification Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  With respect to the Securities to be offered and sold hereunder in reliance on Section 4(a)(2) of and/or Rule 506 under the Securities Act, none of the Company, any of its predecessors, or, to the knowledge of the Company, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#x2019;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuer Covered Person</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and, together, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuer Covered Persons</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is subject to any of the &#x201c;Bad Actor&#x201d; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disqualification Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).  The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.  The Company has complied, to the extent applicable, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(qq)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Covered Persons</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(rr)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Disqualification Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will notify the Purchasers and the Placement Agent in writing, prior to each Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.2</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representations and Warranties of the Purchasers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of each applicable Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Organization; Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.  The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.  Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:  (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#x2019; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Understandings or Arrangements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#x2019;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws).  Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.  Such Purchaser understands that the Warrants and the Warrant Shares are &#x201c;restricted securities&#x201d; and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#x2019;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchaser Status</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be either:  (i) an &#x201c;accredited investor&#x201d; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &#x201c;qualified institutional buyer&#x201d; as defined in Rule 144A(a) under the Securities Act.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Experience of Such Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment.  Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placement Agent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Such Purchaser hereby acknowledges and agrees that (i) the Placement Agent is acting solely as a placement agent in connection with the execution, delivery and performance of the Transaction Documents and is not acting as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary for such Purchaser, the Company or any other person or entity in connection with the execution, delivery and performance of the Transaction Documents, (ii) the Placement Agent has not made and will not make any representation or warranty, whether express or implied, of any kind or character, and has not provided any advice or recommendation in connection with the execution, delivery and performance of the Transaction Documents, (iii) each Placement Agent will not have any responsibility with respect to (y) any representations, warranties or agreements made by any person or entity under or in connection with the execution, delivery and performance of the Transaction Documents, or the execution, legality, validity or enforceability (with respect to any person) thereof, or (z) the business, affairs, financial condition, operations, properties or prospects of, or any other matter concerning the Company, and (iv) each Placement Agent will not have any liability or obligation (including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by such Purchaser, the Company or any other person or entity), whether in contract, tort or otherwise, to such Purchaser, or to any person claiming through it, in respect of the execution, delivery and performance of the Transaction Documents.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Solicitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Access to Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired.  Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it.  In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Transactions and Confidentiality</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof.  Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#x2019;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#x2019;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.  Other than to other Persons party to this Agreement or to such Purchaser&#x2019;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).  Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#x2019;s right to rely on the Company&#x2019;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby.  Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">Article IV.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br>OTHER AGREEMENTS OF THE PARTIES</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.1</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Restrictions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Securities may only be disposed of in compliance with state and federal securities laws.  In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act.  As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement. </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[NEITHER] THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] [HAS NOT BEEN] REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#x201c;ACCREDITED INVESTOR&#x201d; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &#x201c;accredited investor&#x201d; as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties.  Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith.  Further, no notice shall be required of such pledge.  At the appropriate Purchaser&#x2019;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including, if </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance with the current public information required under Rule 144 (assuming cashless exercise of the Warrants), or (iii) if the Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares or Warrant Shares, or (iv) if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission).  In such event, any Warrant Shares issued upon exercise of Warrants shall be issued free of all legends and, upon the written request of a Purchaser, any legend (including the legend set forth in Section 4.1(b) hereof) on the Shares or Warrant Shares held by such Purchaser shall be removed, subject in the case of clauses (ii), (iii) or (iv) to receipt from the Purchaser by the Company and the Transfer Agent of customary representations reasonably acceptable to the Company and the Transfer Agent in connection with such request.  The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(d), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legend Removal Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends.  The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.  Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#x2019;s prime broker with the Depository Trust Company System as directed by such Purchaser.  As used herein, &#x201c;Standard Settlement Period&#x201d; means the standard settlement period, expressed in a number of Trading Days, on the Company&#x2019;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to such Purchaser&#x2019;s other available remedies, if the Company fails to (a) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate (or book-entry notation) representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then the Company shall pay in cash to such Purchaser an amount equal to the excess of such Purchaser&#x2019;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Buy-In Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the date of such delivery and payment.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&#x2019;s reliance upon this understanding.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.2</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furnishing of Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Until the earliest of the time that (i) no Purchaser owns Securities or Pre-Funded Warrants or (ii) the Common Stock Warrants have expired, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to comply with the current public information requirement set forth in Rule 144(c) under the Securities Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.3</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Integration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.4</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Laws Disclosure; Publicity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act.  From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents.  In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other hand, shall terminate.  The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.  Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with (i) the Registration Statement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.5</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shareholder Rights Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#x201c;Acquiring Person&#x201d; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.6</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Public Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, which shall be disclosed prior to or concurrent with the information disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential.  The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.  To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser&#x2019;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law.  To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.7</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Proceeds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall use the net proceeds from the sale of the Securities hereunder to advance the Company&#x2019;s pipeline and for working capital and general corporate purposes and shall not use such proceeds:  (a) for the satisfaction of any portion of the Company&#x2019;s debt (other than payment of trade payables in the ordinary course of the Company&#x2019;s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.8</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification of Purchasers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchaser Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#x2019; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&#x2019;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).  If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party.  Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.  The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company&#x2019;s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#x2019;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents.  The indemnification required by this Section 4.8 shall be made by periodic payments of the amount </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">thereof during the course of the investigation or defense, as and when bills are received or are incurred, provided that the Indemnified Party executes an undertaking to reimburse amounts paid if indemnification is unavailable hereunder.  The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.9</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reservation of Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.10</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listing of Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company hereby agrees to use reasonable best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with each Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market.  The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.  The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#x2019;s reporting, filing and other obligations under the bylaws or rules of the Trading Market.  The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.11</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[RESERVED] </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.12</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsequent Equity Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From the date hereof until ninety (90) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, other than pursuant to the exercise of employee stock options under the Company&#x2019;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#x2019;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the date hereof, or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From the date hereof until the one (1) year anniversary after the Initial Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable Rate Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the Company may establish and/or use an at-the-market program or facility commencing on the later of (i) four (4) months following the date hereof and (ii) ninety days (90) days after the Effective Date.  Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.13</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equal Treatment of Purchasers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No consideration (including any modification of the Transaction Documents) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.  For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.14</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Transactions and Confidentiality</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&#x2019;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4.  Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.  Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.4.  Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#x2019;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#x2019;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.15</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The form of Notice of Exercise included in the Warrants sets forth the totality of the procedures required of the Purchasers in order to exercise the Warrants.  No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants.  Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants.  The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.16</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form D; Blue Sky Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser.  The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at each Closing under applicable securities or &#x201c;Blue Sky&#x201d; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.17</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lock-Up Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms.  If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.18</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices of Trial Achievement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Phase 1b Trial and the 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Phase 2 Trial (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Closing Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Company shall cause to be delivered by email to each Purchaser at the email address appearing on such Purchaser&#x2019;s signature page hereto (a) within fifteen (15) days after the occurrence of the Second Closing Milestone, a notice stating (1) the date on which the Second Closing Milestone occurred and (2) the expected Second Closing Date; and (b) at least fifteen (15) days prior to the Second Closing Date, milestone patients data for the Phase 1b Trial and the Phase 2 Trial.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the 78</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> subject is dosed in the Phase 2 Trial (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Closing Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Company shall cause to be delivered by email to each Purchaser at the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">email address appearing on such Purchaser&#x2019;s signature page hereto (a) within fifteen (15) days after the occurrence of the Third Closing Milestone, a notice stating (1) the date on which the Third Closing Milestone occurred and (2) the expected Third Closing Date; and (b) at least fifteen (15) days prior to the Third Closing Date, milestone patients data for the Phase 2 Trial.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that the delivery of any notice required by Section 4.18(a) or (b) would constitute the delivery of material non-public information to the Purchasers, then the Company shall make simultaneous public disclosure of substantially the same information in a manner permitted under Regulation FD.</font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">Article V.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br>MISCELLANEOUS</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.1</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement may be terminated by any Purchaser or the Company, as to such Purchaser&#x2019;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Initial Closing has not been consummated on or before the fifth (5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.2</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fees and Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.  The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.3</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Entire Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.4</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of:  (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given.  The address for such notices and </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">communications shall be as set forth on the signature pages attached hereto.  To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.5</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendments; Waivers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers holding at least 50.1% in interest of the Shares based on the Initial Subscription Amounts hereunder (or, prior to the Initial Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required.  No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.  Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser.  Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.6</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Headings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.7</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.  The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).  Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#x201c;Purchasers.&#x201d;</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.8</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Third-Party Beneficiaries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2.  This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.9</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.  Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.  Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.  If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#x2019; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.10</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Survival</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.11</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Execution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#x201c;.pdf&#x201d; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#x201c;.pdf&#x201d; signature page were an original thereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.12</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.  It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.13</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rescission and Withdrawal Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&#x2019;s right to acquire such shares pursuant to such Purchaser&#x2019;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.14</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Replacement of Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.  The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.15</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents.  The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.16</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payment Set Aside</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.17</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Independent Nature of Purchasers&#x2019; Obligations and Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document.  Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.  Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.  Each Purchaser has been </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.  The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.  It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.18</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidated Damages</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company&#x2019;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.19</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.20</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto.  In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.21</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further Assurances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In connection with this Agreement and all transactions contemplated by this Agreement, each signatory party hereto agrees to execute and deliver such additional documents and instruments and to perform such additional acts as may be necessary or appropriate to effectuate, carry out and perform all of the terms, provisions and conditions of this Agreement and all such transactions.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.22</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WAIVER OF JURY TRIAL.  IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.23</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exculpation of the Placement Agent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each party hereto agrees for the express benefit of the Placements Agent and its affiliates and representatives that:</font></div></div>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None of the Placement Agent, its affiliates or representatives (i) has any duties or obligations other than those specifically set forth herein or in its engagement letter with the Company; (ii) shall be liable for any improper payment made in accordance with the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">information provided by the Company; (iii) makes any representation or warranty, or has any responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company pursuant to this Agreement or the Transaction Documents or in connection with any of the transactions contemplated hereby and thereby; or (iv) shall be liable (A) for any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred upon it by this Agreement or any Transaction Document, or (B) for anything which any of them may do or refrain from doing in connection with this Agreement or any Transaction Document, except in each case for such party&#x2019;s own gross negligence, willful misconduct or bad faith.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.14287551026968%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Placement Agent, its affiliates and representatives shall be entitled to (i) rely on, and shall be protected in acting upon, any certificate, instrument, notice, letter or any other document or security delivered to any of them by or on behalf of the Company, (ii) with respect to SVB Securities LLC, be indemnified by the Company for acting as a Placement Agent hereunder pursuant to the indemnification provisions set forth in their engagement letter dated as of March 16, 2023 and (iii) with respect to Noble Capital Markets, Inc., be indemnified by the Company for acting as a Placement Agent hereunder pursuant to the indemnification provisions set forth in their engagement letter dated as of March 17, 2023.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Signature Pages Follow)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.         </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		Fax:</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: David-Alexandre C. Gros, M.D.		Email:</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title: Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:   </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biotechnology Value Fund, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer of BVF I GP LLC, General Partner of Biotechnology Value Fund, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biotechnology Value Fund II, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer of BVF II GP LLC, General Partner of Biotechnology Value Fund II, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biotechnology Value Trading Fund OS LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President of BVF Inc., General Partner of BVF Partners L.P., Sole Member of BVF Partners OS Ltd., General Partner of Biotechnology Value Trading Fund OS LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MSI BVF SPV, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President of BVF Inc., General Partner of BVF Partners L.P., Attorney in Fact MSI BVF SPV, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Armistice Capital Master Fund Ltd. 	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Boyd	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Steven Boyd	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CIO of Armistice Capital, LLC, the Investment Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JDRF T1D Fund LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven St. Peter	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Steven St. Peter	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Managing Director	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Research Invest LLC 	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jamie Haney	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jamie Haney	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vice President	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Zakharyayev	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Zakharyayev	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Zakharyayev	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adam J. Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Adam J. Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adam J. Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JMAG 2602 LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Andres Garcia	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Andres Garcia	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deschutes I, LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Robert J. Levitt	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Robert J. Levitt	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Cornelis F. Wit Revocable Living Trust, Cornelis F Wit, Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Cornelis Frans Wit	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cornelis Frans Wit	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chris Warren	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Chris Warren	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chris Warren	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diana Fernandez	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Diana Fernandez	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Diana Fernandez	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Erica Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Erica Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Erica Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Rohlinger Family Living Trust 2/14/2008	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ George Rohlinger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">George Rohlinger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hans J.J. Bos	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Hans J.J. Bos	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hans J.J. Bos	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marcia Kent Spousal Lifetime Access TR DTD 12/24/12	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Howard Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Howard Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ivonne Maria Letschert Declaration of Revocable Living Trust of Ivonne Letschert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ivonne Letschert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ivonne Letschert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shaf QIC, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jonathan Shafmaster	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jonathan Shafmaster	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">District 2 Capital Fund LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Managing Member of the GP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Snyder	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nathan Snyder	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Snyder	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Cali	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nathan Cali	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Cali	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">m[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nico P. Pronk	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nico P. Pronk	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nico P. Pronk	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Richard Friedman 2008 Revocable Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Richard Friedman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Richard Friedman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Riverside investments group LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Presidey	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Newco DE 22 Inc.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PASE Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PEAS Trust, dtd 12/27/2012	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEAS Trust, dtd 12/27/2012	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tomsat Investment &amp; Trading	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas A. Satterfield Rev Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AG Family LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President of General Partner	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TJ Brown Living Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ T.J. Brown	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T.J. Brown	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sole Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Surfside Angels LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Zalmi Ducman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Zalmi Ducman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  President</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Blu-B Nevada Par Equity LLC aka BBN Investing 1	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Shlomo Boehm	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shlomo Boehm	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auth. Rep.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Blu-G Nevada Par Equity LLC dba BGN Investing 1	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Charles-Edward Gros	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Charles-Edward Gros	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auth. Rep.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [PURCHASER SIGNATURE PAGES TO ELDN SECURITIES PURCHASE AGREEMENT]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bigger Capital Fund, LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Managing Member of the GP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email Address of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notice to Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership Blocker </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 9.99% or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 19.99%</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Omitted Exhibits and Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Exhibit A: Registration Rights Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Exhibit B: Pre-Funded Warrant</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Exhibit C: Common Stock Warrant</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Exhibit D: Lock-Up Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Schedule 1: Purchaser Allocations</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(a): Subsidiaries</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(g): Capitalization</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(i): Material Changes; Undisclosed Events, Liabilities or Developments</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(t): Certain Fees</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757319</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>5
<FILENAME>eldn-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">REGISTRATION RIGHTS AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Registration Rights Agreement (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is made and entered into as of April 28, 2023, by and between Eledon Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), and each of the several purchasers signatory hereto (each such purchaser, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and, collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchasers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company and each Purchaser hereby agrees as follows:</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  As used in this Agreement, the following terms shall have the following meanings:</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Advice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 6(d).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effectiveness Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to the Initial Registration Statement required to be filed hereunder, the 60</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> calendar day following the date hereof (or, in the event of a &#x201c;full review&#x201d; by the Commission, the 90</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> calendar day following the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 60</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a &#x201c;full review&#x201d; by the Commission, the 90</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> calendar day following the date such additional Registration Statement is required to be filed hereunder); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">further</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effectiveness Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 2(a).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 2(d).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Event Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 2(d).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to the Initial Registration Statement required hereunder, the 20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> calendar day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which the Company is permitted by SEC</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Guidance to file such additional Registration Statement related to the Registrable Securities.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the holder or holders, as the case may be, from time to time of Registrable Securities.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 5(c).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifying Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 5(c).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Registration Statement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the initial Registration Statement filed pursuant to this Agreement.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 5(a).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan of Distribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 2(a).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrable Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein) and (c) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company, and all Warrants are exercised by &#x201c;cashless exercise&#x201d; as provided in Section 2(c) of each of the Warrants), as reasonably determined by the Company, upon the advice of counsel to the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 415</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 424</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholder Questionnaire</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning set forth in Section 3(a).</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEC Guidance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission staff and (ii) the Securities Act.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shelf Registration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415.  Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85% in interest of the Holders) substantially the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan of Distribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and substantially the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; section attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that no Holder shall be required to be named as an &#x201c;underwriter&#x201d; without such Holder&#x2019;s express prior written consent.  Subject to the terms of this Agreement, the Company shall use its reasonable best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its reasonable best efforts to keep such Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effectiveness Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day.  The Company shall promptly notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement.  The Company shall, by 9:30 a.m. (New York City time) on the second Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows: </font></div></div>
  <div style="margin-left:16.667%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.7604070416281665%;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities; </font></div></div>
  <div style="margin-left:16.667%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.7604070416281665%;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second, the Company shall reduce Registrable Securities represented by Warrant Shares underlying the Common Stock Warrants (applied, in the case that some Warrant Shares underlying the Common Stock Warrants may be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares underlying the Common Stock Warrants held by such Holders); and</font></div></div>
  <div style="margin-left:16.667%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.7604070416281665%;">c.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third, the Company shall reduce Registrable Securities represented by Shares and the Pre-Funded Warrants (applied, in the case that some Shares and Pre-Funded Warrants may be registered, to the Holders on a pro rata basis based </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:16.667%;text-indent:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.7604070416281665%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">on the total number of unregistered Shares and the Pre-Funded Warrants held by such Holders).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&#x2019;s allotment.  In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its reasonable best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.</font></p>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If:  (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &#x201c;reviewed&#x201d; or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement (subject to any reductions to such Registrable Securities being registered pursuant to Sections 2(b) or 2(c)), or (v) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Event Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the earlier of (1) the applicable Event is cured or (2) the Registrable Securities are eligible for resale pursuant to Rule 144 without manner of sale or volume restrictions, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate Subscription Amount paid by such </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holder pursuant to the Purchase Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the Company shall not be required to make any payments pursuant to this Section 2(d) with respect to any Registrable Securities the Company is unable to register due to limits imposed by the Commission&#x2019;s interpretation of Rule 415 under the Securities Act. The parties agree that the maximum aggregate liquidated damages payable to a Holder under this Agreement shall be 10.0% of the aggregate Subscription Amount paid by such holder pursuant to the Purchase Agreement for the Registrable Securities then held by such Holder.  If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 10% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full.  The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form if permitted by applicable Commission rules and regulations and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any Underwriter without the prior written consent of such Holder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Company&#x2019;s registration obligations hereunder, the Company shall:</font></p>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not less than three (3) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related Prospectus or any amendment or supplement thereto, the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act.  Notwithstanding the foregoing, the Company shall not be required to furnish to the Holders any prospectus supplement being prepared and filed solely to name new or additional selling stockholders unless such Holders are named in such filing.  The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company is notified of such objection in writing no later than two (2) Trading Days after the Holders have been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto.  Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholder Questionnaire</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the second (2nd) Trading Day following the date on which such Holder receives draft materials in accordance with this Section.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &#x201c;review&#x201d; of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that in no event shall any such notice contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use its reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or successor thereto) need not be furnished in physical form.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&#x2019;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.  If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus.  The Company will use its reasonable best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.  The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(k)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(l)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company shall use its reasonable best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(m)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares.  During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&#x2019;s request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement.  The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company&#x2019;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement.  In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder.  In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification by the Company.  The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of such title or any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&#x2019; fees) and expenses (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&#x2019;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d).  The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware.  Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(h).</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification by Holders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon:  any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing by such Holder to the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&#x2019;s information provided in the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereto for this purpose), such Prospectus or in any amendment or supplement thereto.  In no event shall the liability of a selling Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conduct of Indemnification Proceedings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifying Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.</font></div></div>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless:  (1) the Indemnifying Party has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).  The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed.  No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.</font></p>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.  The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&#x2019; relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission.  The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&#x2019; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</font></div></div>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.  In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</font></p>
  <p style="margin-left:6.667%;text-indent:10.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement.  Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 6(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities.  The Company shall not file any other registration statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall not prohibit the Company from filing amendments or prospectus supplements to registration statements filed prior to the date of this Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[RESERVED]</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discontinued Disposition</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Advice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed.  The Company will use its reasonable best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.  The Company agrees and acknowledges that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions of Section 2(d).</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Piggy-Back Registrations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&#x2019;s stock option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities such Holder requests to be registered; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(e) that are eligible for resale pursuant to Rule 144 (without volume restrictions or current public information requirements) promulgated by the Commission pursuant to the Securities Act or that are the subject of a </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">then effective Registration Statement that is available for resales or other dispositions by such Holder.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendments and Waivers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall be required.  If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement.  Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6(f).  No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement. </font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder.  The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities.  Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Inconsistent Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.  Except as set forth in SEC Reports, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Execution and Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#x201c;.pdf&#x201d; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#x201c;.pdf&#x201d; signature page were an original thereof.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(k)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Purchase Agreement.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(l)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cumulative Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(m)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.  It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(n)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Headings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or affect any of the provisions hereof.</font></div></div>
  <div style="margin-left:6.667%;text-indent:10.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.285365304876089%;">(o)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Independent Nature of Holders&#x2019; Obligations and Rig</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hts.  The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder.  Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.  Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose.  The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:9.333%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">was done solely for the convenience of the Company and not because it was required or requested to do so by any Holder.  It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">********************</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Signature Pages Follow)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</font></p>
  <p style="margin-left:37.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="margin-left:37.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:37.333%;text-indent:0.277%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ David-Alexandre C. Gros. M.D.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">     </font></p>
  <p style="margin-left:37.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: David-Alexandre C. Gros, M.D.</font></p>
  <p style="margin-left:37.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title: Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:   </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biotechnology Value Fund, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer of BVF I GP LLC, General Partner of Biotechnology Value Fund, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biotechnology Value Fund II, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer of BVF II GP LLC, General Partner of Biotechnology Value Fund II, L.P.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biotechnology Value Trading Fund OS LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President of BVF Inc., General Partner of BVF Partners L.P., Sole Member of BVF Partners OS Ltd., General Partner of Biotechnology Value Trading Fund OS LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MSI BVF SPV, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Lampert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President of BVF Inc., General Partner of BVF Partners L.P., Attorney in Fact MSI BVF SPV, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Armistice Capital Master Fund Ltd. 	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Boyd	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Boyd	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CIO of Armistice Capital, LLC, the Investment Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JDRF T1D Fund, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven St. Peter	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven St. Peter	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Managing Director	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Research Invest LLC 	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jamie Haney	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jamie Haney	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vice President	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Zakharyayev	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Zakharyayev	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Zakharyayev	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adam J. Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Adam J. Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adam J. Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JMAG 2602 LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Andres Garcia	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Andres Garcia	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deschutes I, LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Robert J. Levitt	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Robert J. Levitt	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Cornelis F. Wit Revocable Living Trust, Cornelis F Wit, Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Cornelis Frans Wit	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cornelis Frans Wit	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chris Warren	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Chris Warren	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chris Warren	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diana Fernandez	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Diana Fernandez	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diana Fernandez	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Erica Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Erica Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Erica Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Rohlinger Family Living Trust 2/14/2008	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ George Rohlinger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">George Rohlinger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hans J.J. Bos	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Hans J.J. Bos	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hans J.J. Bos	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marcia Kent Spousal Lifetime Access TR DTD 12/24/12	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Howard Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Howard Kent	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ivonne Maria Letschert Declaration of Revocable Living Trust of Ivonne Letschert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ivonne Letschert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ivonne Letschert	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shaf QIC, LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Jonathan Shafmaster	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jonathan Shafmaster	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manager	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">District 2 Capital Fund LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Managing Member of the GP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Snyder	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nathan Snyder	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Snyder	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Cali	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nathan Cali	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nathan Cali	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nico P. Pronk	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nico P. Pronk	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nico P. Pronk	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Richard Friedman 2008 Revocable Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Richard Friedman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Richard Friedman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Riverside investment group LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Presidey	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Newco DE 22 Inc.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shalom Auerbach	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PASE Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PEAS Trust, dtd 12/27/2012	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEAS Trust, dtd 12/27/2012	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Berger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tomsat Investment &amp; Trading	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas A. Satterfield Rev Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AG Family LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas Satterfield	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President of General Partner	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TJ Brown Living Trust	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ T.J. Brown	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T.J. Brown	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sole Trustee	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Surfside Angels LLC	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Zalmi Ducman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Zalmi Ducman	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Blu-B Nevada Par Equity LLC aka BBN Investing 1	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Shlomo Boehm	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shlomo Boehm	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auth. Rep.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Blu-G Nevada Par Equity LLC dba BGN Investing 1	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Charles-Edward Gros	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Charles-Edward Gros	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auth. Rep.	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGES CONTINUE]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[SIGNATURE PAGE OF HOLDERS TO ELDN RRA]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Purchaser:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bigger Capital Fund, LP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael Bigger	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of Authorized Signatory:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Managing Member of the GP	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan of Distribution</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Selling Stockholder (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions.  These sales may be at fixed or negotiated prices.  A Selling Stockholder may use any one or more of the following methods when selling securities:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ordinary brokerage transactions and transactions in which the broker dealer solicits purchasers;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">block trades in which the broker dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">purchases by a broker dealer as principal and resale by the broker dealer for its account;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an exchange distribution in accordance with the rules of the applicable exchange;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">privately negotiated transactions;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">settlement of short sales; </font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in transactions through broker dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a combination of any such methods of sale; or</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&middot;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any other method permitted pursuant to applicable law.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), if available, rather than under this prospectus.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Broker dealers engaged by the Selling Stockholders may arrange for other brokers dealers to participate in sales.  Broker dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume.  The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities.  The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#x201c;underwriters&#x201d; within the meaning of the Securities Act in connection with such sales.  In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.  Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities.  The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect.  The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws.  In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.  In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling Stockholders or any other person.  We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SELLING STOCKHOLDERS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The common stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to the selling stockholders, upon exercise of the warrants.  For additional information regarding the issuances of those shares of common stock and warrants, see &#x201c;Private Placement of Shares of Common Stock and Warrants&#x201d; above.  We are registering the shares of common stock in order to permit the selling stockholders to offer the shares for resale from time to time.  Except for the ownership of the shares of common stock and the warrants [and as otherwise described under &#x201c;Certain Relationships with the Selling Stockholders,&#x201d; the selling stockholders have not had any material relationship with us within the past three years.]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling stockholders.  The second column lists the number of shares of common stock beneficially owned by each selling stockholder, based on its ownership of the shares of common stock and warrants, as of ________, 2023, assuming exercise of the warrants held by the selling stockholders on that date, without regard to any limitations on exercises.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The third column lists the shares of common stock being offered by this prospectus by the selling stockholders.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale of the sum of (i) the number of shares of common stock issued to the selling stockholders in the &#x201c;Private Placement of Shares of Common Stock and Warrants&#x201d; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants.  The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the warrants, a selling stockholder may not exercise the warrants to the extent such exercise would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed [4.99%/9.99%][or, in limited circumstances, 19.99%] of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of the warrants which have not been exercised.  The number of shares in the second column does not reflect this limitation.  The selling stockholders may sell all, some or none of their shares in this offering.  See &#x201c;Plan of Distribution.&#x201d;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:28.04%;"></td>
    <td style="width:21.06%;"></td>
    <td style="width:21.06%;"></td>
    <td style="width:29.84%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Selling Stockholder</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of shares of Common Stock Owned Prior to Offering</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of shares of Common Stock Owned After Offering</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annex C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholder Notice and Questionnaire</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undersigned beneficial owner of common stock (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrable Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of Eledon Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) a registration statement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Rights Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to which this document is annexed.  A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.  All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus.  Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTICE</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undersigned beneficial owner (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration Statement.  The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">QUESTIONNAIRE</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name.</font></div></div>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Full Legal Name of Selling Stockholder</font></div></div>
  <p style="margin-left:6.667%;text-indent:9.829%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_____________________________________________</font></p>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</font></div></div>
  <p style="margin-left:6.667%;text-indent:9.829%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_____________________________________________</font></p>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</font></div></div>
  <p style="margin-left:6.667%;text-indent:9.829%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_____________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Address for Notices to Selling Stockholder:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Telephone:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fax:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contact Person:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Broker-Dealer Status:</font></div></div>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Are you a broker-dealer?</font></div></div>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Yes		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> No</font></p>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If &#x201c;yes&#x201d; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</font></div></div>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Yes		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> No</font></p>
  <p style="margin-left:9.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note:  If &#x201c;no&#x201d; to Section 3(b), the Commission&#x2019;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</font></p>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Are you an affiliate of a broker-dealer?</font></div></div>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Yes		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> No</font></p>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</font></div></div>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Yes		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf0a8;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> No</font></p>
  <p style="margin-left:9.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note:  If &#x201c;no&#x201d; to Section 3(d), the Commission&#x2019;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable pursuant to the Purchase Agreement.</font></p>
  <div style="margin-left:6.667%;text-indent:2.857%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:6.0pt;min-width:2.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.571802042150151%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Type and Amount of other securities beneficially owned by the Selling<br>Stockholder:</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____________________________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____________________________________________________</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Relationships with the Company:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State any exceptions here:</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____________________________________________________</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____________________________________________________</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.  The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beneficial Owner: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">					</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">							</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 6(b)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Piggyback on Registrations</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OMM_US:80757331</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>6
<FILENAME>eldn-ex10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img103607317_0.jpg" alt="img103607317_0.jpg" style="width:259px;height:65px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">April 27, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dear David-Alexandre:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eledon Pharmaceuticals, Inc. (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eledon</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and you are parties to the executive employment agreement dated September 9, 2020 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The Company desires to provide certain additional benefits to you as described below.  The Employment Agreement continues in effect, as amended and supplemented by this letter agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Letter Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) pursuant to section 11(c) of the Employment Agreement.  Capitalized terms not otherwise defined herein shall have the meanings attributed to them in the Employment Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Performance Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Employment Agreement provides for your eligibility to receive the Performance Bonus upon the occurrence of, at any time during the Measurement Period, the market value of the Company&#x2019;s Common Stock exceeding $1 billion either (i) for a period of 30 consecutive calendar days or (ii) upon a Change of Control of the Company. Notwithstanding anything to the contrary in the Employment Agreement, the market value of the Company&#x2019;s Common Stock shall be determined by taking into account the total equity value of the Company, which shall mean the total value of all outstanding securities of the Company treated as equity securities under GAAP for purposes of the Company&#x2019;s financial reporting (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Value</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The Compensation Committee shall be responsible for determining Market Value consistent with the Company&#x2019;s financial reporting.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, you will be eligible to receive a pro rata Performance Bonus, if upon the date of your termination of employment for any reason other than a termination by the Company for Cause (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Qualifying Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Market Value is equal to or greater than $600 million, but less than $1 billion. If the Company achieves a Market Value equal to $600 million, the amount of the Performance Bonus will equal $6,000,000.  If the Company achieves a Market Value between $600 million and $1 billion, the amount of the Performance Bonus will be pro-rated between the $6,000,000 threshold bonus and $10,000,000 maximum bonus using linear interpolation.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding anything to the contrary in the Employment Agreement, the Performance Bonus will be payable within 30 days following the earlier of your Qualifying Termination or the achievement of the Capitalization Milestone (including the achievement of the Capitalization Milestone in connection with a Change of Control, and as the Capitalization Milestone has been modified above to include a threshold payout at a $600 million Market Value).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 3(c) of the Employment Agreement, the Performance Bonus may be paid in cash, Common Stock or a combination of cash and Common Stock in the Company&#x2019;s discretion. If the Performance Bonus is paid in Common Stock, the Company shall have the right at its</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(79,129,189,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img103607317_0.jpg" alt="img103607317_0.jpg" style="width:259px;height:65px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">discretion to satisfy any applicable withholding taxes due upon payment of the Performance Bonus by withholding an appropriate number of shares of Common Stock otherwise issuable upon payment of the Performance Bonus.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Pursuant to this Letter Agreement, you will also be eligible for a retention bonus (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) upon the earlier of (1) the date of your Qualifying Termination, (2) the date of a Change of Control during the Employment Term, and (3) July 31, 2026 (such earliest qualifying date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).   The Retention Bonus will be an amount paid in cash or shares of Common Stock equal to the product of 761,589 multiplied by the difference between the fair market value of the Common Stock on the Retention Bonus Date (which fair market value will be determined using the 90-day volume weighted average trading price for the 90 trading days preceding the Retention Bonus Date) over the fair market value of the Common Stock at the time of the closing of the Company&#x2019;s PIPE transaction on April 28, 2023.  The Retention Bonus will, however, be limited to a maximum of a $9.00 valuation of the Common Stock on the Retention Bonus Date (i.e., if the price of the Common Stock on the Retention Bonus Date exceeds $9.00, the Retention Bonus will be calculated using the $9.00 maximum price).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Retention Bonus will be payable within 30 days following the Retention Bonus Date.  The Company shall have the right (in the Company&#x2019;s sole and absolute discretion) to pay the Retention Bonus in Common Stock and shall have the right at its discretion to satisfy any applicable withholding taxes due upon payment of the Retention Bonus by withholding an appropriate number of shares of Common Stock otherwise issuable upon payment of the Retention Bonus.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Acceleration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Pursuant to Section 7(c) of your Employment Agreement, if your employment is terminated by the Company without Cause or by you for Good Reason, you are entitled to 12 months of accelerated vesting of all outstanding equity awards subject to time-based vesting, subject to your execution of the release contemplated by the Employment Agreement.  In addition, subject to your execution of the release contemplated by the Employment Agreement, any then-unvested and outstanding performance-based equity awards will (1) remain outstanding and eligible to vest</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the applicable performance conditions are satisfied for 12 months following your termination of employment without Cause or for Good Reason, and (2) the term of such performance-based options will be extended until the earlier of (A) 90 days after the performance conditions are achieved and (B) the normal expiration date of such performance-based options.  If the Board (or its Compensation Committee) determines that the performance conditions have not been satisfied, any performance-based options will immediately terminate.  If your employment is terminated by the Company without Cause or by you for Good Reason in connection with a Change of Control pursuant to Section 7(c)(ii) of the Employment Agreement,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to your execution of the release contemplated by the Employment Agreement, any then-unvested and outstanding performance-based equity awards will become fully vested at the target performance level.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(79,129,189,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img103607317_0.jpg" alt="img103607317_0.jpg" style="width:259px;height:65px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">[1]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You agree to file a 10b5-1 plan that will allow you to sell the Company&#x2019;s Common Stock to cover any tax due upon receipt of the Common Stock upon vesting of the Performance Bonus, the Retention Bonus, or the New Incentive Shares, to the extent the Company determines not to allow you to receive a net settlement for such benefits.  The Company shall notify you no later than 10 business days prior to the delivery of shares underlying such benefits to you as to whether or not the Company will allow a net settlement of such benefits with the Company paying any tax amounts due pursuant thereto.  Any such decision by the Company will be made by the Board.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancellation of Incentive Shares &amp; New Award</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  You are currently entitled to receive an award of Incentive Shares pursuant to Section 4(c) of the Employment Agreement. In lieu of the Incentive Share award, you will be entitled to receive a proportionate grant of Common Stock that in the aggregate shall be equal to one percent of the total number of shares of Common Stock on a fully diluted basis (calculated in a manner consistent with Section 4(c) of the Employment Agreement) upon the first occurrence of (1) a majority of the Tranche C Warrants to Purchase Common Stock or Pre-Funded Warrants, held by the largest holder of such Warrants on the PIPE closing date, are exercised (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) following the PIPE Transaction and (2) the first date (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Study and Hurdle Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) that is six months after the date on which the topline data for the K207 kidney transplantation trial is available to the Company and where the Company&#x2019;s Market Value is equal to or greater than $900 million for a period of 20 trading days (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New Incentive Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  You will be entitled to receive the New Incentive Shares if the Warrant Exercise or Study and Hurdle Date either occurs at any time during the Employment Term or within the 12-month period following your termination of employment by the Company without Cause or by you for Good Reason.  The New Incentive Shares shall be payable within 30 days following the first to occur of the Warrant Exercise and the Study and Hurdle Date, and the Company shall have the right (in the Company&#x2019;s sole and absolute discretion) to pay the New Incentive Shares in cash, Common Stock or a combination of cash and Common Stock.  Any shares of Common Stock issued as payment will be valued in the same manner as set forth in Section 4(c) of the Employment Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company hereby agrees that if the New Incentive Shares are paid in Common Stock, the Company shall have the right at its discretion to satisfy any applicable withholding taxes due upon payment of the New Incentive Shares by withholding an appropriate number of shares of Common Stock otherwise issuable upon payment of the New Incentive Shares.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as amended and supplemented by this Letter Agreement, the Employment Agreement shall continue in effect and the terms of the Employment Agreement are incorporated into this Letter Agreement. This Letter Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(79,129,189,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img103607317_0.jpg" alt="img103607317_0.jpg" style="width:259px;height:65px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thank you for your continuing contributions to the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sincerely,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Keith A. Katkin</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXECUTIVE ACKNOWLEDGEMENT</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I agree to the terms and conditions set forth above and agree that this Letter Agreement amends and supplements the Employment Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ David-Alexandre Gros</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	   _______________________		</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">David-Alexandre Gros	   April 27, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(79,129,189,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>7
<FILENAME>eldn-ex10_4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img104530838_0.jpg" alt="img104530838_0.jpg" style="width:259px;height:65px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">April 27, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dear Steven:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eledon Pharmaceuticals, Inc. (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eledon</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and you are parties to the executive employment agreement dated September 14, 2020 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The Company desires to provide certain additional benefits to you as described below.  The Employment Agreement continues in effect, as amended and supplemented by this letter agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Letter Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) pursuant to section 11(c) of the Employment Agreement.  Capitalized terms not otherwise defined herein shall have the meanings attributed to them in the Employment Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Pursuant to this Letter Agreement, you will also be eligible for a retention bonus (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) upon the earlier of (1) the date of your termination of employment for any reason other than a termination by the Company for Cause, (2) the date of a Change of Control during the Employment Term, and (3) July 31, 2026 (such earliest qualifying date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).   The Retention Bonus will be an amount paid in cash or shares of Common Stock equal to the product of 327,350 multiplied by the difference between the fair market value of the Common Stock on the Retention Bonus Date (which fair market value will be determined using the 90-day volume weighted average trading price for the 90 trading days preceding the Retention Bonus Date) over the fair market value of the Common Stock at the time of the closing of the Company&#x2019;s PIPE transaction on April 28, 2023.  The Retention Bonus will, however, be limited to a maximum of a $9.00 valuation of the Common Stock on the Retention Bonus Date (i.e., if the price of the Common Stock on the Retention Bonus Date exceeds $9.00, the Retention Bonus will be calculated using the $9.00 maximum price).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Retention Bonus will be payable within 30 days following the Retention Bonus Date.  The Retention Bonus may be paid in cash, Common Stock or a combination of cash and Common Stock in the Company&#x2019;s discretion. If the Retention Bonus is paid in Common Stock, the Company shall have the right at its discretion to satisfy any applicable withholding taxes due upon payment of the Retention Bonus by withholding an appropriate number of shares of Common Stock otherwise issuable upon payment of the Retention Bonus.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as amended and supplemented by this Letter Agreement, the Employment Agreement shall continue in effect and the terms of the Employment Agreement are incorporated into this Letter Agreement. This Letter Agreement may be executed in one or more counterparts, each of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(79,129,189,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img104530838_0.jpg" alt="img104530838_0.jpg" style="width:259px;height:65px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thank you for your continuing contributions to the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sincerely,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">David-Alexandre C. Gros, MD<br>Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXECUTIVE ACKNOWLEDGEMENT</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I agree to the terms and conditions set forth above and agree that this letter agreement amends and supplements the Employment Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steve Perrin, Ph.D__________</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	_______________________		</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Perrin, Ph.D.			April 27, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(79,129,189,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>8
<FILENAME>eldn-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><img src="img20068692_0.jpg" alt="img20068692_0.jpg" style="width:318px;height:81px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">$35 million in upfront financing with the potential to receive additional aggregate financing up to $105 million, subject to achieving clinical development milestones, plus up to $45 million upon exercise of warrants</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Led by BVF Partners LP and Armistice Capital, with participation from new investor Sanofi (via Sanofi Ventures)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Aggregate financing (subject to milestones) expected to be sufficient to fund Company through the completion of the Phase 2 BESTOW trial evaluating tegoprubart for the prevention of rejection in patients receiving a kidney transplant</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">IRVINE, Calif., May 1, 2023 (GLOBE NEWSWIRE) &#x2013; Eledon Pharmaceuticals, Inc. (&#x201c;Eledon&#x201d;) (NASDAQ: ELDN), a clinical stage transplant and immunology-focused biopharmaceutical company, today announced that it has entered into a definitive securities purchase agreement with certain healthcare investors that will provide up to $185 million in gross proceeds to Eledon through a private placement. The purchase is comprised of an initial upfront financing of $35 million in exchange for 15.2 million common shares (or pre-funded warrants), representing a purchase price of $2.31 for each share of common stock and associated warrant sold at the initial closing, and up to an additional $105 million in mandatory tranche financing, subject to achieving specified milestones, including clinical development milestones. In addition, Eledon will have the potential to receive $45 million upon the full exercise of warrants being issued in connection with the agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The financing is being led by BVF Partners LP and Armistice Capital, and includes participation from new and existing investors including Sanofi (via Sanofi Ventures).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#x201c;This financing represents a significant commitment by our shareholders to advance the development of tegoprubart in kidney transplantation,&#x201d; said David-Alexandre C. Gros, M.D., Chief Executive Officer. &#x201c;Eledon is now financially positioned to complete and report data from our planned Phase 2 BESTOW study, as well as to continue accumulating and reporting data from our ongoing Phase 1b kidney transplantation trial. We look forward to progressing the development of tegoprubart as a much-needed potential treatment option to better protect and extend the functional life of transplanted kidneys that patients often wait years to receive.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">In addition to the $35 million in upfront financing, the transaction includes a second and third closing, each having mandatory funding conditions whereby the holders have committed to exercise the warrants subject to the satisfaction of certain clinical trial milestones and volume weighted average</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">share price levels, and trading volume conditions. The private placement also includes a 5-year term warrant with an exercise price of $3.00 that is exercisable at investors&#x2019; election.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">SVB Securities is acting as lead placement agent. Cantor, LifeSci Capital and Noble Capital Markets are acting as co-placement agents in connection with the financing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The Company intends to use the net proceeds from the private placement to fund the clinical development of its lead asset tegoprubart, working capital and general corporate purposes.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The securities sold in the private placement, including the common shares underlying the warrants, are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended, or applicable state securities laws and may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. Concurrently with the execution of the securities purchase agreement, Eledon and the investors entered into a registration rights agreement pursuant to which the Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the securities issued in the private placement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">About Eledon Pharmaceuticals and tegoprubart</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Eledon Pharmaceuticals is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS. The company&#x2019;s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, CA. For more information, please visit the company&#x2019;s website at www.eledon.com.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">This press release contains forward-looking statements that involve substantial risks and uncertainties. Any statements about the completion of the private placement, the satisfaction of the mandatory funding conditions, exercise of the warrants, other customary closing conditions related to the private placement, the intended use of net proceeds from the private placement, statements about planned clinical trials, the Company&#x2019;s expectation that the aggregate financing (subject to milestones) is expected to be sufficient to fund the Company through the completion of the Phase 2 kidney transplant trial, and the Company&#x2019;s other future expectations, plans and prospects, as well as other statements containing the words &#x201c;believes,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;plans,&#x201d; &#x201c;expects,&#x201d; &#x201c;estimates,&#x201d; &#x201c;intends,&#x201d; &#x201c;predicts,&#x201d; &#x201c;projects,&#x201d; &#x201c;targets,&#x201d; &#x201c;looks forward,&#x201d; &#x201c;could,&#x201d; &#x201c;may,&#x201d; and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently uncertain and are subject to numerous risks and uncertainties,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">including: risks related to the private placement, risks relating to the safety and efficacy of our drug candidates; risks relating to clinical development timelines, including interactions with regulators and clinical sites, as well as patient enrollment; risks relating to costs of clinical trials and the sufficiency of the company&#x2019;s capital resources to fund planned clinical trials; and risks associated with the impact of the ongoing coronavirus pandemic. Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors. These risks and uncertainties, as well as other risks and uncertainties that could cause the company&#x2019;s actual results to differ significantly from the forward-looking statements contained herein, are discussed in our quarterly 10-Q, annual 10-K, and other filings with the U.S. Securities and Exchange Commission, which can be found at www.sec.gov. Any forward-looking statements contained in this press release speak only as of the date hereof and not of any future date, and the company expressly disclaims any intent to update any forward-looking statements, whether as a result of new information, future events or otherwise.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Investor Contact:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"><br>Stephen Jasper<br>Gilmartin Group<br>(858) 525 2047<br>stephen@gilmartinir.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Source: Eledon Pharmaceuticals</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img20068692_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img20068692_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 3X# 2(  A$! Q$!_\0
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M6_Y\-8_[\Q?_ !RO-_AW\-H?'-A>W,FIO9FVE6,*L(?=D9SU%=G_ ,,^VO\
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MI% 'R[>>/]>?PEJOA/Q"L\TKB,127 (FA99%8J^>2" >O.?;II? O_D?Y/\
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M>]U6/Q-?PE+*VS]E#C_6R=-P]E]?7'H:]/\ BG_R336_^N2?^C%H \8^"?\
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M\BWIW_7NG\JTZS/#G_(MZ=_U[I_*M.O&J_'+U9];AOX,/1?D%%%%9FX4444
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M14&G7YU"*:0V=U:^7,\06Y3:7"G&]1G[I['O0!:CCCAB6*)%2- %5%& H'0
M51US1[;Q!HEWI5YO%O<IL8H<,.X(]P0#6A10!P?@SX5Z7X-U=]3AO+FZN#&8
MT\T!0@.,G ZGC%=Y163KFN)HDFE*\#2C4+]+($-C865B&]_NXQ[T 7-2T^#5
M=,NM/NE+6]S$T4@!P=K#!P?6O-;#X$>'K:=WN[V]NXR,*A*IMYZY YKU2B@
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M'35**?9?D%%%%0;!1110 5Q_Q3_Y)IK?_7)/_1BUV%<?\4_^2::W_P!<D_\
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M  /:LQ?^2/\ A#_K^LO_ $;0!U:VWBC1]*U74M2\0Q7K+8R21VZ621K!*%+
MJP.648QANM9>B1^.O$^AV>KR>(;?1Q/ CQ6\-BDV\%1\[ENF[K@= 176^)O^
M14UC_KQG_P#0#4/@S_D1?#__ &#;;_T4M '+Z-JGC#Q9)<6RW=MHBZ9,UI>7
M$, G:XG4\^6'X5=NT\@GYJU?#VJ:S:>*+OPSKMS%?2I:K>6MZD0B,L6[:P=1
MP"&QTIO@+_7>+/\ L8+C_P! CILQ9?C C(NYAX=D(7U/VA>* 'KI_C+599[F
M?7$T2(NRP6EM:Q3L%!P&D=\Y)'.%P.:F\.Z[?*NLV'B"2$W6C,#-=Q+M2:)D
MWJ^W^$X!R/:N5\-_\(_XBT(ZMXKULW&H%G-U;7%\T$=H0Q&P1!@%  '7)/7-
M2>%K&QUF7QU8:5;M96-[!%#;EU(RKPNHDP><'.X>Q% &_;1^*O$=NNI)K']A
M6DZ[[:UBM(Y9=A^ZTK/D!B.=H''3)I\>O:KX=T?6)_$\:3)IJJ\5[;IL6[5N
M@VY.U]W!'3D5-HGB_2Y;".VU*[@TW4[91'=6EU*L;(X&#C)^93U##@@BLGQ!
M>K\0/!_B+3]$A,\,/EB&YS^[NI$82,B>H^4+GH2W'K0!:MM-\;:I:"]N?$4>
MDSRJ'2Q@L8Y4A'4*[/\ ,Q]<$=\53G\8ZK%X+\1O<1PV^OZ)F.;8-T;$@%)%
M![,#G!]*I:58?#/4].%T4MK211^_M[J^>*2!AU5E9P1@\9Z4_P#LS1M6^'OB
M>/PCISQI<*\:2G<?M;(H.4+$DC.5'3D4 >B6\AEMHI&QN= QQ[BN*74-6U_P
M_P"+8UOUM9+'4;BVBD6!7_<I&IVD'N=QYJ_I/CSPU/X;M[^36+.W"PKYL4LH
M$D; <J5ZD@\<#GM6/X$F;6- \82Q0R1-=ZM=%(YAM9=T4> P['D<4 6?AUIV
MLQ^&M#NIM=\VP-FA6R^R(NT%>!O!SQ^M6M*\63)H?B+4M2_>KIVJW-K"D2 ,
MZJX6-!ZL20,^]0^ /$6CGPCX=T[^T;?[<]N(%MMX\S>BG<"O48P>OMZUE:59
M75]X:\4BRC\R[M_$T]W#$3CS&BG239^.W'XT ;JZ5XSOH?M4_B6+3+AQN6SM
M[*.6*+_99G^9SZD$>U2I?^+'\,.HTRV&NI<?9BS-BW(R/WXYR4P<XZY!JU:>
M-O#EW9&Y.K6MOL'[V*YD$4D1'561L$$=*YKQ'XOGO_"]E?V$ESIFEW>J+:RZ
MB!\RVW(,JY'R!B,!B./Q% %S4K+QCHFE3:LGB=-1>TC:>6SFL8HHY5499591
MN4X!P<GWIOBN^CU2P\#ZA""(KK6K.= >H5HW8?SK(\3V'@G3_#=V\+_VIJ4M
MLXMP;Y[F61BI^?[QPHZEL8 %2W?_ ")?PS_Z_M._]$-0!LOJ.K:_XNU72+'6
M5TF'3/+4K' DD\Y=0Q;YP0J#( P#GUK8T.W\06=S=6^KWUOJ%J K6UTL8BE.
M<[E=5^7CC!&/IZ86KQ>"/$7B"YLM72*WUBSPHDED-M*RD9#(X(++R?7&#QZM
M\(3-#XIU'2].UNXUC18;9'\Z>43>1.6(\L2_Q#;SCG% '=4444 %%%% !111
M0 4444 %%%% !1110 5C^*O^17U#_KE_4444 ;%97B/_ ) %S_P#_P!"%%%
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(W\S110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img103607317_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img103607317_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +7"T$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKG]:\<^%_#K,FJZY96\J]8O
M,W2#_@"Y;]*X^Z^/W@:W?;%/?7(S]Z*U('_CQ4T >H45Y2G[0G@EG"E=40'^
M)K88'Y-71:1\6? ^M.L=OX@MXI6. ET&@.?3+@ _@: .THIJ.DB*\;*R,,AE
M.013J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[+M^H4445P'N!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116#XE\30:%;[$VRWK
MC]W%V'^TWM_.KITY5)*,5J95Z].A!U*CLD2>(?$=MH-KEB)+IQ^ZASU]SZ"O
M)[Z_N=2NWNKN4R2MW/8>@'84V[NY[ZZDN;F0R2R'+,:@KZ'"X6-"/F?"9EF=
M3&3[16R_5^84445U'EA1110 4444 %%%% &OX7_Y&?3_ /KJ/Y5[)7C?A?\
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M$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%%
M'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__
M ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)W
MX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\
M^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT
M/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8
MP_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\
MQ5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_
M  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?
M@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\
MZ&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q56+;Q;X;O&"VOB'
M29R3@"*]C;G\#7PQ10!]_ AE#*001D$=Z6OAG0_%FO\ AJ59-'U>[M,'.Q),
MH?JARI_$5[U\.OCO!K-Q%I/BE8K2\<A(KU/EBD;H X_@/OT^E 'ME%%% !11
M10 4444 %%%% !7QQ\8/^2KZ_P#]=4_]%I7V/7QQ\8/^2KZ__P!=4_\ 1:4
M</1110 4444 %%%% 'M?[.WB@V7B&\\-SR?N+]#- I/29!SCZIG/^X*^E*^%
M_"NL-H'BO2M6!(%K=1R/CN@/S#\1D?C7W0"" 0<@]"* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ^=_VE_P#D(^'?^N4_\TKPBO=_VE_^0CX=_P"N
M4_\ -*\(H **** "BBB@ KK?AKXI?PCXZT[43)MM7<070SP8G(!)^G#?\!KD
MJ* /O^BN8^'6L'7OAYH>H,VZ1[58Y&/=T^1C^:FNGH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M**\P^B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** *.L:M9Z#H]WJNH2^7:6L9DD;O@=AZDG@#N
M37QEXW\9ZCXX\0RZE?,5B!*VUL&RL$?8#W]3W/X >Q?M&^*'AMM.\,6\F/.'
MVNZ /50<(/ID,?\ @(KYYH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
MK/@;XVE\3^%)--OYC+J.EE8R['+21'[C'U(P5/T!/6O4Z^4?@#J3V7Q.AM0V
M$OK66%E[' \P?^@?SKZNH **** "BBB@ HHHH *^./C!_P E7U__ *ZI_P"B
MTK['KXX^,'_)5]?_ .NJ?^BTH X>BBB@ HHHH **** "ON3P;>MJ7@C0KUCE
MYK"!W/\ M%!G]<U\-U]D_"*4S?"K0&)'$#+Q[.P_I0!VU%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\[_M+_P#(1\._]<I_YI7A%>[_ +2__(1\._\
M7*?^:5X10 4444 %%%% !1110!]2_L\7IN?AS-;L>;6_D0#T4JC?S9J]:KPS
M]FF8MHVOPXX2XB<<^JL/_9:]SH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** "BBB@ HHHH U_"_\ R,^G_P#74?RKV2O&_"__ ",^G_\
M74?RKV2O$S3^(O0^RX;_ -WGZ_H@HHHKS#Z(**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^/?C
M-J+:C\5-9);*6[);H/0*@!_\>W'\:X*NH^(__)2?$?\ V$)O_0C7+T %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /G?]I?\ Y"/AW_KE/_-*\(KW?]I?_D(^'?\ KE/_ #2O
M"* "BBB@ HHHH **** /H']F9V,?B>,GY5-JP'N?-S_(5[]7S_\ LR_\S3_V
MZ?\ M:OH"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445Y_P"+/&._?I^E2_+TEG4]?93_ %K:A0G6ERQ.3&8REA*?/4?HNK)_
M%GC$1"33M,D_>?=EG4_=]0OO[]OY>>T45]%0H0HQY8GP6,QM7%U.>I\EV"BB
MBMCC"BBB@ HHHH **** "BBB@ HHHH **** -?PO_P C/I__ %U'\J]DKQOP
MO_R,^G_]=1_*O9*\3-/XB]#[+AO_ '>?K^B"BBBO,/H@HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#YW_:7_P"0CX=_ZY3_ ,TKPBO=_P!I?_D(^'?^N4_\
MTKPB@ HHHH **** "BBB@#W_ /9E_P"9I_[=/_:U?0%?/_[,O_,T_P#;I_[6
MKZ H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9I_[=/\ VM7T!0!Y/_PSSX+_ .>NJ_\ @0O_ ,11_P ,\^"_^>NJ_P#@0O\
M\17K%% 'D_\ PSSX+_YZZK_X$+_\11_PSSX+_P">NJ_^!"__ !%>L44 >3_\
M,\^"_P#GKJO_ ($+_P#$4?\ #//@O_GKJO\ X$+_ /$5ZQ10!Y/_ ,,\^"_^
M>NJ_^!"__$4?\,\^"_\ GKJO_@0O_P 17K%% 'D__#//@O\ YZZK_P"!"_\
MQ%'_  SSX+_YZZK_ .!"_P#Q%>L44 >3_P##//@O_GKJO_@0O_Q%'_#//@O_
M )ZZK_X$+_\ $5ZQ10!Y/_PSSX+_ .>NJ_\ @0O_ ,11_P ,\^"_^>NJ_P#@
M0O\ \17K%% 'D_\ PSSX+_YZZK_X$+_\11_PSSX+_P">NJ_^!"__ !%>L44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^=_VE_\
MD(^'?^N4_P#-*\(KW?\ :7_Y"/AW_KE/_-*\(H **** "BBB@ HHHH ]_P#V
M9?\ F:?^W3_VM7T!7S_^S+_S-/\ VZ?^UJ^@* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *X3Q9X.\S?J&EQ@-]Z6!1U]U'K[5W=%;4:TZ,N:)RXO!TL53]G47_ /
M!**]&\6>#Q=!]0TR/%Q]Z6%?^6GN/?V[_7KYT058@@@C@@]J^BH5X5H\T3X'
M&X*KA*G)/;H^XE%%%;'&%%%% !1110 4444 =WX3\8[-FGZK+\O2*=CT]F/]
M?SKT"O!*[;PGXP-J8].U*3,'W8IFZI['V]^WTZ>3C<#?]Y37JCZC*,YM:AB'
MIT?Z/_,]%HI 0RAE((/(([TM>.?6!1110 4444 %%%% !1110 4444 %%%%
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M1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'Q1\1_^2D^(_P#L(3?^A&N7KJ/B/_R4GQ'_ -A"
M;_T(UR] !1110 4444 %%%% 'O\ ^S+_ ,S3_P!NG_M:OH"OG_\ 9E_YFG_M
MT_\ :U?0% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QQ\8/^2KZ_\
M]=4_]%I7V/7QQ\8/^2KZ_P#]=4_]%I0!P]%%% !1110 4444 %?7_P $O^20
MZ%_V\?\ I1)7R!7U_P#!+_DD.A?]O'_I1)0!Z!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?._[2_\ R$?#O_7*?^:5X17N_P"TO_R$?#O_ %RG_FE>
M$4 %%%% !1110 4444 >_P#[,O\ S-/_ &Z?^UJ^@*^?_P!F7_F:?^W3_P!K
M5] 4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%% !1110 4444 %?7_P2_Y)#H7_ &\?^E$E?(%?7_P2_P"20Z%_V\?^E$E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%>8?1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Q1\1_^2D^(_\ L(3?^A&N7KJ/B/\ \E)\
M1_\ 80F_]"-<O0 4444 %%%% !1110![_P#LR_\ ,T_]NG_M:OH"OG_]F7_F
M:?\ MT_]K5] 4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?''Q@_P"2
MKZ__ -=4_P#1:5]CU\<?&#_DJ^O_ /75/_1:4 </1110 4444 %%%% !7U_\
M$O\ DD.A?]O'_I1)7R!7U_\ !+_DD.A?]O'_ *424 >@4444 %%%% !1110
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M:I=V39R?(E*AOJ.A_&O4?#?[1'B#3]D.NV=OJD(X,J?N9OKP-I^F!]:\;HH
M^R_"GQ4\)^+BD5EJ M[UN!:7>(Y"?0<X;_@)-=I7P!T->C^#/C1XF\*&.VN9
M3JNFKQY%RYWJ/]B3DCZ'(]J /KBBN5\&_$/P]XXMMVEW6RZ49DLY\+*GOCN/
M<9%=50 4444 ?._[2_\ R$?#O_7*?^:5X17N_P"TO_R$?#O_ %RG_FE>$4 %
M%%% !1110 4444 >_P#[,O\ S-/_ &Z?^UJ^@*^?_P!F7_F:?^W3_P!K5] 4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !115>^O[33+.2\O[F&VMHA
MEY9G"JH]R: +%17-U;V5N]Q=3Q001C+R2N%51ZDG@5XCXQ_:'L[1I+3PI:"\
ME''VVY!6(?[J<%OJ<?0UX;XA\7:]XJNO/UK4Y[H@Y6-FQ&G^Z@X'X"@#Z3\2
M?'KPEHI>'3VFUBY7C%L-L0/O(W\U#5Y/KWQ_\7ZH633OLVDP'IY*>9)CW9L_
MF *\JHH OZIKFK:W-YNJ:E=WKYR#<3,^/ID\50HHH **** "BBB@ HHHH **
M** "BBB@#?T3QMXG\.%1I.N7MM&O2(2;H_\ OALK^E>G>'OVC=7MF6/7]+M[
MV+H9K8^5(/<@Y4_0;:\2HH ^R_#/Q6\(>*BD5IJB6]VW2UO/W3D^@SPQ_P!T
MFNTKX KN?"7Q:\5^$2D,%Z;VQ48^R7A+H!_LG.5_ X]J /L:BO./!?QH\->+
M#%:W$G]E:F_'V>Y8;';T23H?H<'VKT>@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /"/B=\;]2T36[OP_X>MHX9K5O+FO9U#G=C^!>G&>ISGTK
MPW6?%&N^(9"^KZO>7F3G;+*2@^B]!^ K:^*G_)4/$/\ U]G^0KCZ "BBB@#0
MTK7M7T*?SM*U*[LI,Y)@E9,_4#K^->R>"?VA+R":.S\71"X@/'VZ! LB>[(.
M&'T /L:\+HH ^]["_M-4L(;ZQN([BUG7?'+&V5858KY&^$_Q*G\$:TMI>2,^
MAW;@3H<GR6Z>8H_+/J/<"OK>.1)8UDC=71P&5E.00>A!H =1110 4444 %,E
MFCMX7FFD2.) 69W8 */4D]*X/Q[\6M!\$*]KN^WZMCBSA;[GIYC=%^G)]N]?
M-7C#XB>(O&UPQU.\*V@;,=G#\L2>G'\1]SDT >^>+/CYX:T,R6^D*VLW:\;H
MFVP _P"__%_P$$>]>+^)/C)XS\1EXSJ1T^U;_EA89BX]W^\?SQ[5P%% #I)'
MED:21V=V.2S'))IM%% !1110 4444 %%%% !1110!N:#XR\1^&9%;1]8N[55
M.?*5]T9^J'*G\17KGA?]HVYB*0>)],69.ANK+Y6'N4)P?P(^E>#T4 ?<GASQ
M=H/BRU-QHFI0W049>,';(G^\AP1^5;=?!-AJ%YI=Y'>6%U-:W,9RDL+E&7\1
M7NW@+]H$EH]/\8J,'"KJ,*8_[^(/YK^7>@#Z HJ*UNK>]M8KJUGCGMY5#QRQ
ML&5@>X(ZU+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBJFG:C:ZK9I=6DF^-OS4^A'8U;KP6FG9GVL91G%2B[IA1112*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *S]9UFUT2Q:YN6R3Q'&#RY]!_C4>N:[:Z%9^=.=TC<1Q \N?Z#WKR75-
M4NM7O7NKI]SGA5'1!Z#VKNPF#=9\TOA_,\;-,UCA%R0UF_P]?\A^L:Q=:U>F
MYNFZ<)&/NH/05GT45[\8J*Y8['P]2I*I)SF[MA1113("BBB@ HHHH ***U-"
MT*YUV]\F$;8EYEE(X0?U/M4SG&$>:3T-*5*=6:A!7;&:-HUWK=Z+>V7Y1S)(
M1\J#U/\ A7K6D:/::+9"WM4Z\NY^\Y]33]+TNUTBR2UM4VH.68]7/J?>KM>!
MB\7*L[+2)]SE>50P<>:6LWU[>2"BBBN(]<**** "BBB@ KR/QK_R-M]_VS_]
M%K7KE>1^-?\ D;;[_MG_ .BUKT<L_C/T_5'@<1_[K'_$OR9@4445[I\4%%%%
M !1110!K^%_^1GT__KJ/Y5[)7C?A?_D9]/\ ^NH_E7LE>)FG\1>A]EPW_N\_
M7]$%%%%>8?1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'Q1\1_P#DI/B/_L(3?^A&N7KJ/B/_
M ,E)\1_]A";_ -"-<O0 4444 %%%% !1110![_\ LR_\S3_VZ?\ M:OH"OG_
M /9E_P"9I_[=/_:U?0% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QQ
M\8/^2KZ__P!=4_\ 1:5]CU\<?&#_ )*OK_\ UU3_ -%I0!P]%%% !1110 44
M44 %?7_P2_Y)#H7_ &\?^E$E?(%?7_P2_P"20Z%_V\?^E$E 'H%%%% !1110
M 4444 %%%% !1110 4444 %%%% !7'>.?B5H/@2VQ>R_:-0=<Q6,)'F-Z%O[
MJ^Y_ &N'^)WQNAT1IM%\+O'<:BN4FO.&C@/<+V9OT'OT'S?=WESJ%W+=WD\E
MQ<RL6DEE8LSGU)/6@#JO&OQ*\0^.)R+^X\FP#9CL8"1&OH3_ 'C[G\,5Q]%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7:^!OB?K_@
M:=8[6;[5II;,EC,<H?4J>J'W''J#7%44 ?:_@OQ[H?CG3OM&ES[;A //M)<"
M6(^X[CT(X_'BNHKX-TK5K_0]2AU'3+J2UNX6RDL9P1[>X/<'@U]2?##XN67C
M6)--U+R[37$7[F<)<XZE/?N5_+(S@ ].HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BHYYXK:WDGGE2*&-2[R.P"JHY))/05\T?%+XTW'B!IM%\
M-RR6^D\I-<C*R7/J!W5/;J>_'% ';_$;XYV6@M+I?AHQ7VI+\LER?FAA/H/[
M[?H/?D5\XZKJ^H:YJ,NH:I>2W=U*<M+*V3]!Z#V' JE10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!-:7=Q8W4=U:3R07$3;HY8F*LI]
M01TKZ%^&WQVCOFATCQ?)'#<'"Q:C@*DA])!T4_[0X]<=3\Z44 ??P(90RD$$
M9!'>EKYA^$_QAG\.RP:%XAG:71VPD-PV2UKZ#W3V[=N.*^G(I8YHDEB=9(W4
M,CH<A@>00>XH ^>?VE_^0CX=_P"N4_\ -*\(KW?]I?\ Y"/AW_KE/_-*\(H
M**** "BBB@ HHHH ]_\ V9?^9I_[=/\ VM7T!7S_ /LR_P#,T_\ ;I_[6KZ
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M %%%% 'Q1\1_^2D^(_\ L(3?^A&N7KJ/B/\ \E)\1_\ 80F_]"-<O0 4444
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M ']3V ZDT^^OK73;&>]O9T@MH$,DLKG 51U-?)/Q0^)EWX[U4P6[20Z);O\
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#O_A5\1)O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ!9-X:T>?&IW*?Z3,AYMXSV'HS#\ASU(([GXB>-K?P+X5FU%]KWDG[JSA/\
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MS=Q!PN<E&Z,I]P01^%:E> ?LY>*B?[0\+7$G 'VNU!_ 2*/_ !TX_P!ZO?Z
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MHHKS#Z(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^*/B/_P E)\1_]A";_P!"-<O74?$?_DI/
MB/\ ["$W_H1KEZ "BBB@ HHHH **** /<_V<]6TW2_\ A)?[0U"TM/,^R[/M
M$RQ[L>;G&2,XR/SKW3_A+/#?_0P:5_X&Q_XU\,44 ?<__"6>&_\ H8-*_P#
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M_IU]$  &!P***^=KUYUI<TC[W!8*EA*?)3^;[A1116)V!1110 4444 %%%%
M!1110 4444 %<IXJ\6II2-9V3*]\>&;J(OK[^WYU%XK\7C3@UCI[JUT>))!R
M(O8?[7\J\U9F=BS,69CDDG))KU,'@>;]Y4V['S>;YQ[.]##OWNK[>GG^7J.E
ME>:5I979Y'.69CDDTRBBO:/D&[ZL****!!1110 4444 :_A?_D9]/_ZZC^5>
MR5Y3X%M#<^)HI,'; C2'\L#]3^E>K5X69M.JEY'VG#L&L-*3ZO\ 1!1117G'
MT 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\4?$?_ )*3XC_["$W_ *$:Y>NH^(__ "4GQ'_V
M$)O_ $(UR] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'TM^S[XSFU;1KGPW?2EYM.4/:ECDF
M G!7Z*<?@P':O::^1?@=?O9?%;3$!(2Z26!\=P8RP_\ 'E6OKJ@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KXX^,'_)5]?_ .NJ?^BTK['KXX^,'_)5]?\
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M_P 2L,$?D:^'/$FB3^&_$FH:-<9,EG.T6XC&]0?E;Z$8/XT 9=%%% !1110
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MO;M].GLX/'<UJ=3?HSY+-\FY+U\.M.J[>:.)HHHKU3Y@**** "BBB@ HHHH
M569&#*Q5E.00<$&O2O"GB]=0"V.HNJW0XCD/ E]C_M?SKS2@$@Y'!K#$8>%>
M-I';@<=5P=3GAMU7<][HKB?"?C 7/EZ=J3XF^[%.Q^_[-[^_?Z]>VKYVM1G1
MERR/OL)BZ6*IJI3?_ "BBBLCI"BBB@ HHHH **** "BBD9@JEF(  R2>U "D
M@#)X%>>>+/&)FWZ?I<O[KI+.O\?LOM[]_P"</BSQ@U\9-/TY\6O224=9/8?[
M/\_I7&U[.#P-OWE1>B/DLWSGFO0P[TZO]%_F%%%%>J?,!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[(LC_EJ^1D?10W_?0H ^AO#>A6OAGP[8Z-9C]S:1! V,%VZLQ]R23^-:E%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+_ !"\)1>-
M/!UYI3*OVG;YMHY_@F4';SV!Z'V)KJ** /@.:*2":2&9&26-BKHPP5(X(-,K
MUCX^>%!H?C1=7MX]MIJRF4X' F7 ?\\JWU)KR>@ HHHH **** "BBB@#W_\
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MM\/!%"C[+G &.2Q)/YUV- !1110 4444 %%%% !1110 4444 %%%% !1110
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MU]?!X[_EW5?HSY;-\FO>OAUZK]5_D>>44$$'!X-%>N?*!1110 4444 %%%%
M!7?>$_&(Q'IVJ2<_=BG8_HQ_K7 T5C7H0K1Y9'7@\95PE3VE-^J[GO=%<CX&
MUYM1LVL+E]UQ;KE&/5TZ?F.GXBNNKYNK2E2FX2Z'Z#A<3#$TE5ALPHHHK,Z
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MR6;YSS7H8=Z=7^B_S"BBBO5/F HHHH **** "BBB@ H ).!R:559V"JI9F.
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M\*]EKP9',<BNOWE((^M>\UXV:12E&1]=PU4;IU(=FG]__#!1117E'TP4444
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M(44 >W_\-*:Q_P!"_8_]_GH_X:4UC_H7['_O\]>(44 >W_\ #2FL?]"_8_\
M?YZ/^&E-8_Z%^Q_[_/7B%% 'M_\ PTIK'_0OV/\ W^>C_AI36/\ H7['_O\
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M%% !1110 4444 %%%% !1110 4444 >#_M+_ /(/\._]=9_Y)7SQ7T/^TO\
M\@_P[_UUG_DE?/% !1110 4444 %%%% 'O\ ^S+_ ,S3_P!NG_M:OH"OG_\
M9E_YFG_MT_\ :U?0% !1110 4444 %%%% 'Q;\4+TW_Q.\13%L[;QX<_]<_D
M_P#9:Y*M'7[C[9XCU2YSGSKN63/U<FLZ@ HHHH **** "O5OV?-,^V_$@WC+
M\MA9R2@^C-A!^CM^5>4U] _LT60V>(K]EY)@A0^GWRW_ ++0![]1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-XMTS
M^VO!^L::%W/<V<L:#_:*G;^N*^&:^_Z^$O$5E_9GB;5K # M;R:' [;7(_I0
M!FT444 %%%% !1110!]#_LTWN[3_ !#8$_ZN6&91_O!@?_0!7O%?-7[-MT4\
M6ZQ:;N);$2XYYVR*/_9Z^E: "BBB@ HHHH **** /C#XJ?\ )4/$/_7V?Y"N
M/KL/BI_R5#Q#_P!?9_D*X^@ HHHH **** "BBB@#[/\ A7_R2[P]_P!>@_F:
M["N/^%?_ "2[P]_UZ#^9KL* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /@:[18[V=$&%61@!Z#-0U8O_ /D(7/\ UU;^9JO0 4444 %%
M%% !1110![_1110!] 4444 %%%% !1110!QOBSP@M\)-0TY,77WI(ATD]Q_M
M?S^M>;LK(Q5E*LIP01@@U[U7)^*O"*:H'O;(!+T#+)T$O^!]Z]3!X[E_=U-N
MY\UFV3>TO7PZUZKOYKS_ #]3S"BG.CQR-'(I5U.&5A@@^E-KVCY$****!!11
M10 4444 %=EX3\8&Q,>GZB^;7I'*>L?L?]G^7TKC:*SK48U8\LCIPN*J86HJ
ME-Z_F>] AE#*00>01WI:\P\*>+FTLK97S,]F3\K=3%_];VKTU'26-9(V#(PR
MK*<@CUKYW$8>5"5I;=S[W X^GC*?-#?JNPZBBBN<[@HHHH **** "BBB@ HH
MHH **** .8\4^%(]9C-S:A8[Y1UZ"0>A]_0_Y'ETT,EO,\,R,DB':RL,$&O>
M*\W^(T2+JEI(J*'>([F Y.#QFO6R_$RYO92U1\QGV7TU!XJ&CZ^?_!.,HHHK
MV#Y(**** "BBB@ KWNO!*][KR,U^Q\_T/JN&?^7O_;OZA1117D'U04444 %9
MGB/_ )%O4?\ KW?^5:=9GB/_ )%O4?\ KW?^5:4OXD?5&.)_@S]'^1XO1117
MU1^8A1110 4444 %6;"PN=3O$M;6,O*_Y >I]!5:O1_AS&G]EW<FU=YFVEL<
MXVCC]:PQ-9T:;FCNR["+%8A4I.R-OP_X=MM!M2J8DN''[R8CD^P]!6S117S4
MYRG+FD]3]"I4H48*G35D@HHHJ30**** "BBB@ HHHH **** "BBH+N[@L+62
MYN9!'%&,LQII-NR%*2BKO8=<7,-I;O/<2+'$@RSL< 5Y7XF\4S:W,8(2T=BI
M^5.[^[?X5%XD\37&O3[0#%9H?W<6>O\ M-[_ ,JPJ]S!X)4_?GO^1\7FV</$
M-T:+M#OW_P" %%%%>B> %%%% !1110 4444 %2VUM->7*6]O&TDLAPJKU-.L
M[.XO[I+:VB:25S@*/\\"O5_#GAJWT*WW'$EXZXDE]/9?0?SKEQ6*C0CYGI9=
MEM3&3[16[_R\R+PQX7AT2 33!9+YQ\S]0GLO^/>NBHHKYZI4E4ES2>I]Y0H4
MZ%-4Z:LD%%%%0;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q1\1_^2D^
M(_\ L(3?^A&N7KJ/B/\ \E)\1_\ 80F_]"-<O0 4444 %%%% !1110![_P#L
MR_\ ,T_]NG_M:OH"OG_]F7_F:?\ MT_]K5] 4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?''Q@_P"2KZ__ -=4_P#1:5]CU\<?&#_DJ^O_ /75/_1:
M4 </1110 4444 %%%% !7U_\$O\ DD.A?]O'_I1)7R!7U_\ !+_DD.A?]O'_
M *424 >@4444 %%%% !1110 5\5_$R1I?B9XB9@ 1?2+QZ X'\J^U*^(/'?/
MQ#\2_P#85NO_ $:U '/T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5ZQ^S
MS_R4J3_L'R_^A)7D]>L?L\_\E*D_[!\O_H24 ?4]%%% !1110!P/QID:/X1Z
MZRG!(A7\#/&#^AKX^KZY^.C,OPGU, D!I8 ?<>:I_I7R-0 4444 %%%% !11
M10![E^S5"&UO7I^,I;1)TYY8G_V6OHVOGW]F:-3-XFEYW*MJH^A\W_ 5]!4
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M_)4/$/\ U]G^0KCZ "BBB@ HHHH **** /L_X5_\DN\/?]>@_F:["N/^%?\
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MO657O8/!JDN:7Q?D?$YKFTL4_9T](?G_ ,#R"BBBN\\,**** "BBB@ HHHH
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M^PA-_P"A&N7H **** "BBB@ HHHH ]__ &9?^9I_[=/_ &M7T!7S_P#LR_\
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M5-<_\%TW_P 30!S]%=!_P@GC#_H5-<_\%TW_ ,31_P ()XP_Z%37/_!=-_\
M$T <_170?\()XP_Z%37/_!=-_P#$T?\ "">,/^A4US_P73?_ !- '/T5T'_"
M">,/^A4US_P73?\ Q-'_  @GC#_H5-<_\%TW_P 30!S]%=!_P@GC#_H5-<_\
M%TW_ ,31_P ()XP_Z%37/_!=-_\ $T <_170?\()XP_Z%37/_!=-_P#$T?\
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M6NG[Q_P&11_[-7TQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '@_[2_\ R#_#O_76?^25\\5]#_M+_P#(/\._]=9_Y)7S
MQ0 4444 %%%% !1110![_P#LR_\ ,T_]NG_M:OH"OG_]F7_F:?\ MT_]K5]
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M* "BBB@ HHHH **** "BBB@ HHHH ^"+_P#Y"%S_ -=6_F:KU8O_ /D(7/\
MUU;^9JO0 4444 %%%% !1110![_1110!] 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%W)]^>5I6YSRQ)/\Z^Q_BIJXT7X9Z[<[L/);FV3US(=G'T#$_A7QC0 4444
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M%>;5Z3\.?^0/=_\ 7Q_[**XLP_@/Y'LY#_OJ]'^1V5%%%?/'W84444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\4?$?_DI/B/\ ["$W_H1KEZZCXC_\E)\1
M_P#80F_]"-<O0 4444 %%%% !1110![_ /LR_P#,T_\ ;I_[6KZ KY__ &9?
M^9I_[=/_ &M7T!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\<?&#_D
MJ^O_ /75/_1:5]CU\<?&#_DJ^O\ _75/_1:4 </1110 4444 %%%% !7U_\
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M)^\M6^U6P)_Y9L<.![!L'_@=>YT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!X3^TCKPBTW2/#\;C=-(UW,H/(51M3/L2S
M?]\U\[5U_P 3O$P\5^/]3U")]]JC_9[8@Y'EIP"/8G+?\"KD* "BBB@ HHHH
M ***GLK26_O[>S@&Z:XE6*,>K,<#]30!]>?!K2SI?PLT=6&)+A7N6]][$K_X
M[MKO*K:=91:9IEI80#$-M"D,8_V5  _059H **** "BBB@ HHHH ^,/BI_R5
M#Q#_ -?9_D*X^NP^*G_)4/$/_7V?Y"N/H **** "BBB@ HHHH ^S_A7_ ,DN
M\/?]>@_F:["N/^%?_)+O#W_7H/YFNPH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ^"+_ /Y"%S_UU;^9JO5B_P#^0A<_]=6_F:KT %%%
M% !1110 4444 >_T444 ?0%%%% !1110 4444 %%%% !1110 4444 %%%% %
M'5M)M=9LFMKI,KU5Q]Y#Z@UY)K>B76AWI@G&Y#S'*!PX_P ?:O::J:EIMMJM
MD]K=1[HVZ'NI]0>QKLPF+E0=GK$\G,\KAC(\T=)KKW\F>'T5K:]H%SH-WY<O
MSPO_ *N8#AO\#[5DU]!"<9QYHO0^%JTITIN$U9H****HS"BBB@ HHHH *O:3
MJUUHU\MU:M@CAT/1QZ&J-%*45)6>Q<)RIR4X.S1[3HFMVNN60N+<[7'$D1/*
M'_#WK2KP_3=2NM*O$NK20HZ]1V8>A'<5[!HNKP:UIJ7</!^[(AZHW<5X&,PC
MHOFC\)]QE6:K%QY)Z37X^9H4445PGLA1110 5YU\1_\ D(67_7)OYUZ+7G7Q
M'_Y"%E_UR;^==N7_ ,=?,\C/?]RE\OS.)HHHKZ$^""BBB@ HHHH *][KP2O>
MZ\C-?L?/]#ZKAG_E[_V[^H4445Y!]4%%%% !69XC_P"1;U'_ *]W_E6G69XC
M_P"1;U'_ *]W_E6E+^)'U1CB?X,_1_D>+T445]4?F(4444 %%%% !7I/PY_Y
M ]W_ -?'_LHKS:O2?AS_ ,@>[_Z^/_917%F'\!_(]G(?]]7H_P CLJ***^>/
MNPHHHH ***P?%'B)-"L1Y>U[N7(B0]!ZL?8?K5TX2J248[LRKUH4*;J5'9(/
M$OB:#0K?8FV6]<?)%G@?[3>W\Z\IN[N>^NI+FYD,DLARS&F7%Q+=7#SSR-)*
MYRS,>2:CKZ'#86-"/GW/@LQS*IC)ZZ16R_KJ%%%%=1YH4444 %%%% !1110
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M "4GQ'_V$)O_ $(UR] !1110 4444 %%%% 'O_[,O_,T_P#;I_[6KZ KY_\
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MF[\*:;K"+E[&Y,;D=DD'7_OI5'XU[16%XTT(>)O!FK:/@%[FW81Y[2#YD/\
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M5#Q#_P!?9_D*X^NP^*G_ "5#Q#_U]G^0KCZ "BBB@ HHHH **** /L_X5_\
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MS7['S_0^JX9_Y>_]N_J%%%%>0?5!1110 5F>(_\ D6]1_P"O=_Y5IUF>(_\
MD6]1_P"O=_Y5I2_B1]48XG^#/T?Y'B]%%%?5'YB%%%% !1110 5Z3\.?^0/=
M_P#7Q_[**\VKTGX<_P#('N_^OC_V45Q9A_ ?R/9R'_?5Z/\ ([*BBBOGC[L*
M*** #I7B^OZHVKZS<71),>[;$#V0=/\ '\:]9UR5H-!OY5^\MN^#Z'::\3KU
M\KIKWI_(^6XDKM<E%;;_ .7ZA1117KGR@4444 %%%% !1110 5U/A;PG)J[K
M=W8*6*G@=#+[#V]_\B7PIX1?462^OT*V8Y1#P9?_ +'^=>EHB1HJ(JJBC"JH
MP /05YF,QW)^[I[]SZ3*<G]K:O77N]%W]?+\_02*)(8EBB14C0;551@ 4^BB
MO$/L$K:(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]I)^ZNX0?OQD\D?[0ZCZ8[FOLNPOK74["WOK*99K:X0212(>&4C(-?!%>O\
MP9^*7_",7:^']:F_XD]P_P"YE8\6LA/<]D/?T//K0!]044@(90RD$$9!'>EH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1F5%+,0% R2
M3P!7R5\8OB%_PFGB(6EA*3HU@2L&#Q,_1I/IV'MSQDUW/QO^*2K'<>$-#GRY
MRFHW"'H.\0/_ *%^7K7S[0 4444 >B?#_P"+NM^"YHK2X>34-&'#6LC9:,>L
M;'I].GTZU]5Z'KFG>(](M]4TNY6XM)URK#J#W!'8CN*^$*]-^"WCN7PKXKBT
MVZE/]DZG(L4BD\1RGA)!Z<X!]C["@#ZRHHHH **** "BBB@ HHHH ^/?C%X:
M_P"$;^(VH+&FVUOC]L@],.3N'X.&'TQ7!5]2_'[PJ=9\&)K-O'NNM)<NV!R8
M6P'_ ".UO8!J^6J "BBB@ HHHH **** -;PSXAO?"OB&SUFP;$]N^2I/$B]&
M4^Q&17VIX;\06/BG0+36-.DW6]PF<'JC=U;W!XKX5KT7X3_$F7P-K1MKUF?1
M+Q@+A!SY+=!(H]NX[CW H ^NJ*BMKF&\M8KFVE26"9!)'(ARKJ1D$'N"*EH
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M_P JTI?Q(^J,<3_!GZ/\CQ>BBBOJC\Q"BBB@ HHHH *])^'/_('N_P#KX_\
M917FU>D_#G_D#W?_ %\?^RBN+,/X#^1[.0_[ZO1_D=E1117SQ]V%%%% %#7(
MFGT&_B7[S6[X'J=IKQ.O>R 1@\BO%M?TMM(UFXM2"(PVZ(GNAZ?X?A7KY747
MO0^9\MQ)1?N5EMM_E^IFT445ZY\H%%%% !1110 5VGA/P>;S9?ZG&1;]8H6X
M,GN?;^?TZS>$_!WFB/4=3C^3[T4##[WH6]O:O0:\G&XZUZ=-^K/J,HR;FM7Q
M"TZ+]7_D( %4*H  X ':EHHKQSZP**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /BCXC_\E)\1_P#80F_]
M"-<O74?$?_DI/B/_ +"$W_H1KEZ "BBB@ HHHH **** /?\ ]F7_ )FG_MT_
M]K5] 5\R? ?QAH'A/_A(/[<U*.S^T_9_)WHS;]OF[ON@]-P_.O8_^%P^ ?\
MH8X/^_4O_P 30!W%%</_ ,+A\ _]#'!_WZE_^)H_X7#X!_Z&.#_OU+_\30!W
M%%</_P +A\ _]#'!_P!^I?\ XFC_ (7#X!_Z&.#_ +]2_P#Q- '<45P__"X?
M /\ T,<'_?J7_P")H_X7#X!_Z&.#_OU+_P#$T =Q17#_ /"X? /_ $,<'_?J
M7_XFC_A</@'_ *&.#_OU+_\ $T =Q17#_P#"X? /_0QP?]^I?_B:/^%P^ ?^
MAC@_[]2__$T =Q17#_\ "X? /_0QP?\ ?J7_ .)H_P"%P^ ?^AC@_P"_4O\
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MW'3 !]CT5S?A'QUH/C6Q^T:1>*TJC,MK)A98O]Y?3W&1[UTE !1110 4444
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M,.=<E+;N?299D?LI*KB-7T7;U"BBBO+/I HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /BCXC_\
M)2?$?_80F_\ 0C7+UU'Q'_Y*3XC_ .PA-_Z$:Y>@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "NG\*_$'Q)X.N$;2]1D^S@Y:TF)>%_JO;ZC!]ZYBB@#[-^'GQ
M$TWQ_I+30+]GU"  7-HS9*9Z,I[J?7\Z[*OB3P)XHG\'^,+#5HG(B1Q'<J/X
MX6(#C\N1[@5]M*RNH92"I&00>"* %HHHH **** "BBB@ KXX^,'_ "5?7_\
MKJG_ *+2OL>OCCXP?\E7U_\ ZZI_Z+2@#AZ*** "BBB@ HHHH *^O_@E_P D
MAT+_ +>/_2B2OD"OK_X)?\DAT+_MX_\ 2B2@#T"BBB@ HHHH **** "BBB@
MHHHH P_%_A:Q\8^&[G1K\824;HY0,F*0?=<?3]02.]?%_B'0+_PQKMUI&I1>
M7<V[[3Z..S*>X(Y%?=E>>?%?X;0^.M&$]HJ1ZW:*3;R'@2KU,;'T/8]C[$T
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M(Q[="WMQWKZR "J%4  #  [50T31;#P[HUMI6F0"&TMTVHO<^I)[DGDFM"@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*HJ]J^CZAH.IS:=JEI):W<)P\<@_4=B/0C@U1H **** "BBB@ HHHH ****
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MS_LGDI].1]*\"U[PWK'AB_-EK.GS6DPSCS%^5QZJPX8>X)H RJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BNH\)?#[Q'XTG"Z38
M-]FSA[N;*0I_P+N?89/M7T1X&^">@>%3'>:B%U;5%P1),G[J(_["'O[G)],4
M >1_#SX*ZKXJ:+4=8$FFZ.<,"RXEG'^P#T'^T?P!KZ;T70]-\.Z7%INE6D=K
M:1#Y40=3W)/4D]R>:T** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MDO'?P]T?QYIHAOD\F]B'^CWD:_/'['^\OL?PP>:ZVB@#XD\8^!];\$:F;35;
M?]VQ/DW4>3%,/]D^OJ#R*YNOO+5M(T_7=.ET_5+.*[M)1AHY5R/J.X/H1R*^
M=_'GP"U#2S+?^%6DU"S'S&S<YGC_ -W^^/U]CUH \5HI\L4D$KQ31M'(C%61
MQ@J1U!!Z&F4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1178>"/AMK
M_CJY'V&#R+!6Q+?3 B-?4#^\WL/QQUH YG3=,O=8U"&PTZUDN;N9ML<4:Y+'
M_/>OJ3X7?"*T\&1QZKJOEW6NLO!'*6P(Y5?5NH+?@.,YZ3P/\/-#\"6/EZ?%
MYMY(N)[V4#S)/8?W5_V1^.3S76T %%%% 'C'[2-JTG@[2KH D0W^QL=MR-S_
M .._K7S/7VA\3_#K^)_A[JNGPH7N5C\^ #J70[@![D K^-?%_0T %%%% !11
M10 4444 ?2'[-=HR>'-<O#G;+=I$/JB9/_H8KV^N*^$_AR3PS\.M,M)T*74R
MFYG4]0S\@'W"[0?<5VM !1110 4444 %%%% !1110 4444 %%%% !7,>,_ >
MB>.=-^S:I!B= ?(NXP!+"?8]QZ@\'Z\UT]% 'QIXZ^&6O>!;AGNXOM.FLV([
MZ%3L/H&'\#>Q_ FN+K[[G@ANH)(+B*.:&12KQR*&5@>H(/!%>*>./V?K*_,E
M]X3E6RG/)L923$Q_V6ZI]#D?2@#YOHK3USP]J_AN_:QUBPFL[@=%D7AAZJ>C
M#W!(K,H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *<B/
M)(L<:L[L0%51DDGL!7:>#?A7XF\:,DMK:_9-//)O;H%4(_V1U?\ #CU(KZ/\
M#_"GP[X)5)X8OMNI@?->W"@L#WV+T0?3GW- 'E'P\^ UWJ+0ZGXM5[6SX9+
M'$LG^^?X![?>_P!VOHJRL;73;*&SLK>.WMH5VQQ1*%51Z "IZ* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#XZ^,=FUE\5M<1AQ)(DJGU#1J?YDC\*X
M6O<_VC_#KPZMIGB**,^3<1?99F'0.N67/N5)'_ *\,H **** "BBB@ HHK9\
M)Z!-XH\5:;HT(8FZF57(_A0<NWX*"?PH ^P?AY9M8?#KP];L,,+")F'H64,1
M^M=+38HTAB2*-0L:*%51T '04Z@ HHHH **** "BBB@ HHHH **** "BBB@
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M7/\ NL& ^@Q0!\FT5]%R_LTZ<SYA\272+Z/;*Q_,,*C_ .&:+/\ Z&>?_P
MQ_\ %T ?/%/AAEN9T@@B>661@J1HI9F)Z  =37TI9?LW^'8F#7NL:E< 8^6,
M)&"?R;BO0_#7@#PQX2P^D:3#%/C!N'S)*?7YFR1]!@4 <'\&?A7-X74^(-=B
M"ZM,FV" \FV0]2?]L]/8<=R![#110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !534M+L-8LWL]2LH+NV;K'/&'7ZX/?WJW10!XGXJ_9VTJ^+W
M'AJ^?3I3R+:XS)"?8-]Y?_'J\:\1_#+Q=X7+M?Z/,]NN3]IMAYL6/4E?N_\
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ML;?L?AO4"K?=>6+R5/T9\#]:[[1/V<_$5X5?5]2L]/C/5(\S2#\!A?\ QXT
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MTG#Q3('4_@: /@FBOJO5_P!G_P &:C(TEH+[36)SMMYMR9^CAOT(KGI/V:;
MN3'XEN57T:U4G\]PH ^=:*^A_P#AFBS_ .AGG_\  ,?_ !=:5A^SAX;@<-?:
MKJ5UC^%"D2GZ\$_K0!\VV=G<ZA>16EG;RW%S*VV.*)2S,?0 =:^IOA!\+SX*
MLFU75 K:W=QA2HY%M&>=@/=CQD^V!ZGM/#G@KP[X2B*:+I4%LS##2\M(P]W;
M)Q[9Q6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 <G\0_ UKX\\-/ITK+#=Q'S;2X(SY;X[_[)Z'\^H%?(&O\ A[5?#&JR:;J]
MG);7*=F'RN/[RGHP]Q7W76=K.@:3XALOLFKZ?;WL&<A9DSM/JIZ@^XH ^$:*
M^H]4_9W\(WDC26-SJ-@3T1)1(@_[Z!;_ ,>K$;]FBR+';XFN N> ;12<?]]4
M ?.]%?1 _9HLLC/B>?'?%F/_ (NMC3?V=?"EK(LE]>ZE?8ZQF18T/UVC=^M
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M*C@GBNH$G@D62)QE64Y!%25XC5C[%--704444#"BBB@ HHHH **** "BBB@
MHHHH **** "O.OB/_P A"R_ZY-_.O1:\Z^(__(0LO^N3?SKMR_\ CKYGD9[_
M +E+Y?F<31117T)\$%%%% !1110 5[W7@E>]UY&:_8^?Z'U7#/\ R]_[=_4*
M***\@^J"BBB@ K,\1_\ (MZC_P!>[_RK3K,\1_\ (MZC_P!>[_RK2E_$CZHQ
MQ/\ !GZ/\CQ>BBBOJC\Q"BBB@ HHHH *])^'/_('N_\ KX_]E%>;5Z3\.?\
MD#W?_7Q_[**XLP_@/Y'LY#_OJ]'^1V5%%%?/'W84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*K76G65\,7=G;W ])8E?^8JS10!S\_@3PC<Y,WAC1V8]6^Q1@G\0,U1?X7>!
MY'+-X9T\$_W8]H_(5UU% ''_ /"J_ W_ $+-C_WR?\:EB^&?@F$87PQIAYS\
M\ ;^>:ZNB@#&M_"/AJT.;;P[I,)]8[*-?Y+6O'%'"@2)%1!T51@"G44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "O.OB/_ ,A"R_ZY-_.O1:\Z^(__ "$++_KDW\Z[<O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %9^KZ/::U9&WNDZ<HX^\A
M]16A13C)Q=X[D5*<:D7":NF>*ZSHUUHEZ;>Y7Y3S'(!\KCU'^%9U>W:II=KJ
M]D]K=)N0\JPZH?4>]>2Z[H5SH5[Y,PW1-S%*!PX_H?:O?PF,59<LOB_,^'S3
M*981^TAK!_AZ_P"9ET445W'C!1110 4444 %%%% &AH^L76BWHN;9N#P\9^Z
MX]#7K>C:S:ZW8K<VS8(XDC)Y0^A_QKQ2KNEZI=:1>I=6K[6'#*>CCT(]*XL7
MA(UE=:2/7RO-9X.7)+6#Z=O-'MU%9>AZ[:Z[9^= =LB\21,>4/\ 4>]:E>!*
M,H/EDM3[JG4A5@IP=TPHHHJ2PHHHH **** "BBB@ KSKXC_\A"R_ZY-_.O1:
M\Z^(_P#R$++_ *Y-_.NW+_XZ^9Y&>_[E+Y?F<31117T)\$%%%% !1110 5[W
M7@E>]UY&:_8^?Z'U7#/_ "]_[=_4****\@^J"BBB@ K,\1_\BWJ/_7N_\JTZ
MS/$?_(MZC_U[O_*M*7\2/JC'$_P9^C_(\7HHHKZH_,0HHHH **** "O2?AS_
M ,@>[_Z^/_917FU>D_#G_D#W?_7Q_P"RBN+,/X#^1[.0_P"^KT?Y'94445\\
M?=A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5ROQ#\8)X'\(7.K^6LMQN$-M$QX>5LXS[  D_2NJKQ[]HVWFE
M\!V$T8)BAU!3)CME' )_'C\: /#M3^)WC75;IIYO$NHPECD):SM B^P"8KLO
MAO\ &;7['Q%9Z=K]_)?Z9=2+"SS_ #20EC@.&ZD D9!SQG%>058L+:>]U&UM
M;8,;B>5(X@O7<Q &/Q- 'WO1110 4444 %%%% !1110 4444 %%%% !1110
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M]"?!!1110 4444 %>]UX)7O=>1FOV/G^A]5PS_R]_P"W?U"BBBO(/J@HHHH
M*S/$?_(MZC_U[O\ RK3K,\1_\BWJ/_7N_P#*M*7\2/JC'$_P9^C_ "/%Z***
M^J/S$**** "BBB@ KTGX<_\ ('N_^OC_ -E%>;5Z3\.?^0/=_P#7Q_[**XLP
M_@/Y'LY#_OJ]'^1V5%%%?/'W84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Q_Q4_Y)=XA_Z]#_ #%?&%?9_P 5/^27>(?^O0_S
M%?&% 'LO[/.F:?J>O:RFH6-M=HEJA5;B%9 IW=1D'%?07_")^&_^A?TK_P
MH_\ "O!_V:_^1AUS_KT3_P!#KZ0H Q_^$3\-_P#0OZ5_X!1_X4?\(GX;_P"A
M?TK_ , H_P#"MBB@#'_X1/PW_P!"_I7_ (!1_P"%'_")^&_^A?TK_P  H_\
M"MBB@#G+GX?^#KL'S?"^D$G.66S12<^X -<YJ?P-\":BI\O39K%S_':W##]&
M++^E>C44 ?.OB+]G"]@5YO#NL1W('(M[Q=C_ $#C@GZ@5X[KGAW5_#5^;+6=
M/FL[CJ%D'##U5APP]P37W969KOA_2O$NF2:=K%E%=6S_ ,+CE3ZJ>JGW% 'P
MG7J'PO\ B[>^#KB+3-5>2ZT)V P?F>U_VD]5]5_+GK0^)WPOO/ 5\MQ [W6C
M7#D07!'S1GKL?WQT/0^W2O/J /OJUNH+VTBNK69)K>9 \<B'*LIY!!J6OG7X
M ^/GM[P^$-1FS!-E[!G/W'ZM']#R1[@^M?15 !1110!GZ]_R+VI_]>DO_H!K
MX0K[OU[_ )%[4_\ KTE_] -?"% 'K'[//_)2I/\ L'R_^A)7U/7RQ^SS_P E
M*D_[!\O_ *$E?4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\BWJ/_7N_P#*M*7\2/JC'$_P9^C_ "/%Z***^J/S$**** "BBB@ KTGX<_\
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M?\B]J?\ UZ2_^@&OA"@#UC]GG_DI4G_8/E_]"2OJ>OEC]GG_ )*5)_V#Y?\
MT)*^IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *^?_VFO^96_P"WO_VC7T!7S_\ M-?\RM_V
M]_\ M&@#P"OM?X;_ /)-?#G_ &#X?_017Q17VO\ #?\ Y)KX<_[!\/\ Z"*
M.HHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:ZG1#_WSDL/RK6_X9Y\:_P#/72O_  (;_P"(H X&T\8>)K$@VOB'58<=DO)
M/RS77:/\<_'&E,!-?PZC$/\ EG>0@_\ CR[6_,FHM1^"/CS3D,@TE+I!U-M.
MCG_ODD,?P%<+?:?>Z9<M;7]I/:SK]Z*>,HP_ \T ?37A/X_^'M:=+;6H6T>Y
M8X$CMO@)_P!_ *_B,#UKUJ*6.:))8G62-P&5U.0P/0@]Z^ J]"^''Q6U7P-=
M):SM)>:([?O+5FYCSU:,GH?;H?8\T ?7M%4]*U6RUO2K;4M.N%GM+A \<B]Q
M[^A'0CJ#Q5R@ HHHH **** "BH[BX@M+:2XN9HX8(E+R22,%50.I)/05\Z?$
M7X\7=])-I?A%VMK095]0QB63_<_N#WZ_2@#V;Q5\0_#/@Y"NK:D@N<96TA'F
M3-_P$=/JV![UX]KW[2-]*S1^']%AMTZ":]8R,??:N #^)KPR662:5Y97:21R
M69V.2Q/4D]Z(XWFD6.-&=V.%51DD^PH [34OBYX[U0MYOB&YA4_PVH6''T*@
M']:Y^?Q1X@NFW7&NZG,V<YDNY&/ZFM[2?A+XYUE0\'A^YAC/\=V1!^CD$_@*
MZ>#]G;QG*FY[K1X3_=DN)"?_ !U"* /-/[=UC_H*WW_@0_\ C6E9^/O%]@^Z
MW\3:JO\ LM=.Z_\ ?+$BN_F_9Q\6KDQ:EHT@ S@RRJ2?3_5_UK!U/X(^.]-5
MG&E)>1KU:UG5S^"DAC^ H TM$_: \8Z:RKJ!M-4B'!\Z(1OCV9,#\2#7KOA/
MXY>%O$CI;7KMH]ZW&RZ8>4Q]%DZ?]]!:^5K[3[W3+EK:_M)[6=?O13QE&'X'
MFJU 'W^"" 0<@]"**^3/AO\ %_5/!LT5AJ#27VAYVF%CEX!ZQD]O]GIZ8KZH
MTS4[+6=,M]1TZX2XM+A-\4J'AA_0]B.Q&* +=%%% !1110 4444 %%-EECAB
M>65UCC12SNYP% Y))["O ?B'\?&6272_!S# RLFI.N<GOY2G_P!"/X#H: /8
MO$OC/P_X1MA-K6I0VY892+[TC_[J#D_7I7COB#]I$Y:+PYH@QGBXOVZ_]LU/
M_LWX5X-=WES?W4EU>7$MQ<2'<\LKEF8^I)J)$:1U1%+.QPJJ,DGT% '=:I\8
M_'>J,=VNR6R$\):(L0'X@;OS-<W<>*O$5V<W.O:I,<YS)>2-_,UT.B?"+QOK
MJ+)#HDMM"W(DO&$(^N&^8_@*["U_9N\1NF;K6=+A;'W8_,?^:B@#R?\ MW6/
M^@K??^!#_P"-:-GX\\6V#9MO$NK(/[INW9?R)([5ZG)^S3J 7]UXDM6;/1K9
ME&/^^C61?_L[>+K96:TN]+O .BK*R,?P9<?K0!1T?X]^-M-91=7%KJ48_AN8
M IQ_O)M/YYKU'PQ^T'X<U5D@UJVFTB=N/,)\V$G_ '@,C\1@>M> :]X%\4>&
M07U?1+NWB'68+OC'_ UROZUSU 'WS:7=M?VL=U9W$5Q;R#*2Q.&5AZ@C@U-7
MQ)X1\<Z]X*OOM&D7C+$QS+:R9:*7_>7U]Q@^]?4OP^^)>D>/;$B$BUU2)<SV
M3MEA_M(?XE]^W?MD [:BBB@ HHHH **** "J>J:MI^BV+WNIWL%I;)UDF<*/
MISU/M7 ?$CXOZ9X*5]/L0E_K9'^IS^[@]#(1W_V1SZXXKYC\1^*=:\5ZB;W6
M;^6YDYV*3A(P>RKT4?2@#WSQ+^T7H]DSP>'M/EU%QP+B<F*+Z@8W-^(6O,=7
M^./CK5';R]2BL(C_ ,L[.!5_\>;+?K7G-=CH/PK\9^(T66ST2:.W;D371$*D
M>HW8+#Z T 9-WXQ\37Q)NO$.JS9ZA[R0C\LXJI_;NL?]!6^_\"'_ ,:]<LOV
M;==D0&^US3[=B.5A1Y<?F%K1?]F:01Y3Q8I?T.GX'Y^9_2@#R&S\<^++!@;7
MQ)JL8&/E^UN5_(G%=CHWQ\\::8RB\FM=3B'5;B$*V/9DQS]<UJ:C^SEXFMPS
M6&IZ;> =%8M$Q_ @C]:\[\0^"/$OA4YUG1[FVCS@38#QD^F]<KGVS0!]$>%?
MCYX9UR1+;54DT:Y;@&9M\)/_ %T &/\ @0 ]Z]4BFCN(4FAD22)P&5T8$,/4
M$=:^ Z[/P-\3=>\#7*K:S&YTTMF2QF8F,^I7^XWN/Q!H ^S**Y_P?XRTGQMH
MRZCI4Q."%F@?B2%O1A_(]#704 %%%% !1110!\X>//CIXBM?%5_IN@&VM;.S
MF: 2-")'D93AB=V0!D'&!TK:^%'QEUCQ)XIBT#7UMY3=(WV>XBCV,'52Q# <
M$$ ] .?KQX;XL_Y'+7/^PA<?^C&KH/@__P E7T#_ *ZO_P"BWH ^QZ*** "B
MBB@ HHHH **** "BBB@#P7XJ_&;6_#_BNXT#0%@@%H%$UQ)&)&=V4-@ \  $
M#H><UG?#[XY>(+[Q7I^DZ_\ 9[JVOIEMQ*D0C>-V.%/R\$9(!X_'U\[^*G/Q
M1\0_]?9_D*Q_"?\ R.6A_P#80M__ $8M 'W/1110!E>)=>M_#'AN_P!:ND9X
M;2(N43JQZ #ZD@5\_P O[26OF5C#H>F)&3\JNTC$#W((S^0KW#X@:'=>)/ 6
ML:39;?M5Q!^Z#' 9E8,%SVSMQGWKY!G\&>*+:=X9O#NJK(IP1]CD/Z@<T >E
M_P##2/B3_H#:5^4G_P 57&>/_B3J7Q"_L_\ M"SM+;[#YFS[/N^;?MSG)/\
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M[Z*\W^%_Q6L_'5M]AO1':ZY$N7A!^6<#JZ9_5>WN.GI% !1110 4444 <O\
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M/_917%F'\!_(]G(?]]7H_P CLJ***^>/NPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#C_ (J?\DN\0_\ 7H?YBOC"OL_XJ?\
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MB?#R*<&[8=S_ +'H._4]@/)J*]@^#GPH'BB5=?UV%O['B?\ <0MQ]J<'G/\
ML ]?4\=C0!B?#WX0ZSXW*7LY;3]'S_Q\NN6E]HU[_P"\>/KC%?2?A7X?>&O!
ML(&DZ<@N,8:[F^>9O^!'I]!@>U=+%%'#$D42+'&BA41!@*!P !V%.H ****
M"BBB@!" RE6 ((P0>]>8^-O@CX=\31RW.F1II&IG+"2!?W4A_P!I!P,^JX/?
MGI7I]% 'PSXF\+:OX1U=]-UBU,,R\HXY25?[R-W'\NAP:HZ9J=[HVI0:CIUR
M]O=V[[XY4/(/]1V(Z$5]H^-?!FF>-] DTW4$"R %K>X R\#XX8>H]1W'X&OC
M;Q#H%_X8UVZTC4H]ES;OM..C#LR^H(Y% 'UW\-_'EMX]\-K> )%J$!$=Y;J?
MN/V8?[+=1^([5V-?&_PG\62>$O'EE,TA%E=L+6Z4GC8QP&_X"<'Z9'>OLB@
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M /HMZ /L>BBB@ HHHH **** "BBB@ HHHH ^,/BI_P E0\0_]?9_D*Q_"?\
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M&&/;)QC/?'/O$$$5K;Q6\$:QPQ($C1!@*H&  /0"I** "BBB@ HHHH ****
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M )ZK\K<=LD9^A%=+7A7[-FL&72M:T5W_ -1,ES&">S@JV/Q1?SKW6@ HHHH
M^&/%G_(Y:Y_V$+C_ -&-70?!_P#Y*OH'_75__1;US_BS_D<M<_["%Q_Z,:N@
M^#__ "5?0/\ KJ__ *+>@#['HHHH **** "BBB@ HHHH **** /C#XJ?\E0\
M0_\ 7V?Y"L?PG_R.6A_]A"W_ /1BUL?%3_DJ'B'_ *^S_(5C^$_^1RT/_L(6
M_P#Z,6@#[GHHHH **** "OG_ /::_P"96_[>_P#VC7T!7S_^TU_S*W_;W_[1
MH \ K[7^&_\ R37PY_V#X?\ T$5\45]K_#?_ ))KX<_[!\/_ *"* .HHHHH
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M^%/PU_X5_IMVU[+!<:I=R?/-#DJL0^ZHR ?4GCJ0.< UZ'110 4444 %%%%
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M[_R,.I_]?<O_ *&: .S^!TK1_%O1U'219U/T\ES_ $KZ\KY ^"7_ "5[0O\
MMX_])Y*^OZ "BBB@ HHHH **** "BN;UOX@>$_#S,FIZ]9Q2K]Z%'\R0?5%R
MWZ5P>I_M%>%;4LEA8ZC?,.C;%B0_B3G_ ,=H ]@HKYTOOVE=2<D:?X=M8?0W
M%PTOZ +7/7?[0/C>XSY3:=:Y_P">-MG'_?9:@#ZLHKX[N/C+X_N2=WB&1001
MB.WB3'Y+6?)\3/&TK;F\3ZF#C'RSE1^0H ^U**^'V\<^+G4JWBK6RI&"#J$N
M"/\ OJH/^$L\2?\ 0P:K_P"!LG^- %?7?^1AU/\ Z^Y?_0S7<? K_DJ^F_\
M7*?_ -%M7G#NTCL[L6=CEF8Y)/J:]'^!7_)5]-_ZY3_^BVH ^MZ*** "BBB@
M#XX^,'_)5]?_ .NJ?^BTKAZ[CXP?\E7U_P#ZZI_Z+2N3TB 7.M6$!Z2W$:'
MSU8"@#[DT2Q&EZ!IVG@8%K:Q08]-JA?Z5?HHH **** "BBB@ HHHH *^4/C]
M_P E1G_Z](?Y&OJ^OE#X_?\ )49_^O2'^1H \OK[_KX K[_H **** "BBB@
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MDFNOL/BEXUTO3[>PLM>FAM;>,1Q1B*,A5 P!RM 'VA17QQ_PN#Q]_P!#'/\
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MO4 R3;3K)CZX/%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MSKXC_P#(0LO^N3?SKT6O.OB/_P A"R_ZY-_.NW+_ ..OF>1GO^Y2^7YG$T44
M5]"?!!1110 4444 %>]UX)7O=>1FOV/G^A]5PS_R]_[=_4****\@^J"BBB@
MK,\1_P#(MZC_ ->[_P JTZS/$?\ R+>H_P#7N_\ *M*7\2/JC'$_P9^C_(\7
MHHHKZH_,0HHHH **** "O2?AS_R![O\ Z^/_ &45YM7I/PY_Y ]W_P!?'_LH
MKBS#^ _D>SD/^^KT?Y'94445\\?=A1110 4444 %%%% !1110 4444 %%%%
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M_A/_ )'+0_\ L(6__HQ:Z#XP?\E7U_\ ZZI_Z+2N?\)_\CEH?_80M_\ T8M
M'W/1110 4444 %%%% !1110 5\H?'[_DJ,__ %Z0_P C7U?7RA\?O^2HS_\
M7I#_ "- 'E]??]? %??] !1110 4444 %%%% !1110!Y?\?O^27S_P#7W#_,
MU\H5]7_'[_DE\_\ U]P_S-?*% 'T_P#LX_\ )/-0_P"PK)_Z*BKV"O'_ -G'
M_DGFH?\ 85D_]%15[!0 4444 %%%% !1110 4444 ?"&N_\ (PZG_P!?<O\
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MS%+I?ES1K(NZX;.",C/RUY;7W%X+O!J'@;0;L')ET^!F_P![8,C\\T ?.O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/THJJBA5 "@8  X JGH^F6^BZ-9:7:C$%I"D*>X48R?<]:NT %%%% !1110
M4444 %-=UCC9W8*J@DD]@*=7&_%3Q GAOX<ZM=;]L\\1M8.>2\@V\>X&6_X#
M0!\<WMP;N^N+D]9I6D/XG->@_ K_ )*OIO\ URG_ /1;5YO7I'P*_P"2KZ;_
M -<I_P#T6U 'UO1110 4444 ?''Q@_Y*OK__ %U3_P!%I7/^$_\ D<M#_P"P
MA;_^C%KH/C!_R5?7_P#KJG_HM*Y_PG_R.6A_]A"W_P#1BT ?<]%%% !1110
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M@<^,65I)?W]O9PC,MQ*L2?5B /YU]VZ7IUOI&E6FFVB;+>UA6&,?[*C H M
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M_P!%M7 ZG;)9ZK>6L98QPSO&I;K@,0,_E7?? K_DJ^F_]<I__1;4 ?6]%%%
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MNZCXBE0^1:1?9H6(X,CX+8^BC_Q\5](4 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q_Q4_Y)=XA_P"O0_S%
M?&%?:'Q3!/PO\0X&?]$/\Q7Q?0![?^S7_P C#KG_ %Z)_P"AU](5\X?LU_\
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M30!]75R_B;XA^%_"4;_VIJL(N%Z6L)\R8GTVCI]3@>]?*&K_ !'\8ZXA2_\
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M[D\8:3"6MYB/[0C0?ZM^GF?0\9]^>YQ]%4V6*.:)XI462-U*NCC(8'@@CN*
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M +!\W_H)KXHH ]W_ &:/^0CXB_ZY0?S>OHBOGC]FC_D(>(C_ -,H/YO7T/0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;+I79]#UZ&1#]V*]C*$?\#7.?^^17(7?P(\>VS8BTVWNAZPW<8'_ (^5HHH
MRU^$GCA[K[,NB9FW%=OVN#J.O.^MBQ^ GCN[8":TL[('O/=*0/\ OC=110!W
M.A?LVVZ,LFOZX\H[P64>P?\ ?;9_]!'UKUWPYX.\/^$[?R=%TR"V)&'E W2/
M_O.>3],XHHH W**** .,^(/PXTOX@6$,=U(UK>V^?(NXU#%0>JL.-R]\9'L1
MSGS_ ,/?L[#2M=L]1O/$?G):SI,L4-KM+E3D L6..@[&BB@#W.BBB@ HHHH
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H[-FBB@#TN""&U@2"WBCAAC&U(XU"JH] !TJ2BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img104530838_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img104530838_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +7"T$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKG]:\<^%_#K,FJZY96\J]8O
M,W2#_@"Y;]*X^Z^/W@:W?;%/?7(S]Z*U('_CQ4T >H45Y2G[0G@EG"E=40'^
M)K88'Y-71:1\6? ^M.L=OX@MXI6. ET&@.?3+@ _@: .THIJ.DB*\;*R,,AE
M.013J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[+M^H4445P'N!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116#XE\30:%;[$VRWK
MC]W%V'^TWM_.KITY5)*,5J95Z].A!U*CLD2>(?$=MH-KEB)+IQ^ZASU]SZ"O
M)[Z_N=2NWNKN4R2MW/8>@'84V[NY[ZZDN;F0R2R'+,:@KZ'"X6-"/F?"9EF=
M3&3[16R_5^84445U'EA1110 4444 %%%% &OX7_Y&?3_ /KJ/Y5[)7C?A?\
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M$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%%
M'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__
M ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)W
MX/\ ^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\
M^AKT/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT
M/_P8P_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8
MP_\ Q5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\
MQ5'_  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_
M  G?@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?
M@_\ Z&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q5'_  G?@_\
MZ&O0_P#P8P__ !5?$%% 'V__ ,)WX/\ ^AKT/_P8P_\ Q56+;Q;X;O&"VOB'
M29R3@"*]C;G\#7PQ10!]_ AE#*001D$=Z6OAG0_%FO\ AJ59-'U>[M,'.Q),
MH?JARI_$5[U\.OCO!K-Q%I/BE8K2\<A(KU/EBD;H X_@/OT^E 'ME%%% !11
M10 4444 %%%% !7QQ\8/^2KZ_P#]=4_]%I7V/7QQ\8/^2KZ__P!=4_\ 1:4
M</1110 4444 %%%% 'M?[.WB@V7B&\\-SR?N+]#- I/29!SCZIG/^X*^E*^%
M_"NL-H'BO2M6!(%K=1R/CN@/S#\1D?C7W0"" 0<@]"* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ^=_VE_P#D(^'?^N4_\TKPBO=_VE_^0CX=_P"N
M4_\ -*\(H **** "BBB@ KK?AKXI?PCXZT[43)MM7<070SP8G(!)^G#?\!KD
MJ* /O^BN8^'6L'7OAYH>H,VZ1[58Y&/=T^1C^:FNGH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M**\P^B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** *.L:M9Z#H]WJNH2^7:6L9DD;O@=AZDG@#N
M37QEXW\9ZCXX\0RZE?,5B!*VUL&RL$?8#W]3W/X >Q?M&^*'AMM.\,6\F/.'
MVNZ /50<(/ID,?\ @(KYYH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
MK/@;XVE\3^%)--OYC+J.EE8R['+21'[C'U(P5/T!/6O4Z^4?@#J3V7Q.AM0V
M$OK66%E[' \P?^@?SKZNH **** "BBB@ HHHH *^./C!_P E7U__ *ZI_P"B
MTK['KXX^,'_)5]?_ .NJ?^BTH X>BBB@ HHHH **** "ON3P;>MJ7@C0KUCE
MYK"!W/\ M%!G]<U\-U]D_"*4S?"K0&)'$#+Q[.P_I0!VU%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\[_M+_P#(1\._]<I_YI7A%>[_ +2__(1\._\
M7*?^:5X10 4444 %%%% !1110!]2_L\7IN?AS-;L>;6_D0#T4JC?S9J]:KPS
M]FF8MHVOPXX2XB<<^JL/_9:]SH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** "BBB@ HHHH U_"_\ R,^G_P#74?RKV2O&_"__ ",^G_\
M74?RKV2O$S3^(O0^RX;_ -WGZ_H@HHHKS#Z(**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^/?C
M-J+:C\5-9);*6[);H/0*@!_\>W'\:X*NH^(__)2?$?\ V$)O_0C7+T %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /G?]I?\ Y"/AW_KE/_-*\(KW?]I?_D(^'?\ KE/_ #2O
M"* "BBB@ HHHH **** /H']F9V,?B>,GY5-JP'N?-S_(5[]7S_\ LR_\S3_V
MZ?\ M:OH"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!DL4<T312HKQN,,K#((KR_Q3X3DTAVN[0%
M[%CTZF+V/MZ'_)]3IKHDL;1R*&1AAE89!'I71A\3*A*ZV['!C\OIXRGRRT:V
M?;_@'@U%==XK\(OIK/?6"%K,\N@Y,7_V/\JY&OHJ56-6/-$^"Q.&J8:HZ=1:
M_GZ!1116ASA1110 4444 %/BED@E66%VCD0Y5E."#3**!IM.Z/4_"WBR/5XU
MM+ME2^4?02CU'O[?Y'45X,CO'(LD;%74Y5E."#ZUZ9X4\7+J:K97[JEX.$<\
M"7_[+V[UXF,P7)^\I[=C[#*<X56U"N_>Z/OZ^?Y^IUM%%%>8?1A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445Y_P"+/&._?I^E2_+TEG4]?93_ %K:A0G6ERQ.3&8REA*?/4?HNK)_
M%GC$1"33M,D_>?=EG4_=]0OO[]OY>>T45]%0H0HQY8GP6,QM7%U.>I\EV"BB
MBMCC"BBB@ HHHH **** "BBB@ HHHH **** -?PO_P C/I__ %U'\J]DKQOP
MO_R,^G_]=1_*O9*\3-/XB]#[+AO_ '>?K^B"BBBO,/H@HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#YW_:7_P"0CX=_ZY3_ ,TKPBO=_P!I?_D(^'?^N4_\
MTKPB@ HHHH **** "BBB@#W_ /9E_P"9I_[=/_:U?0%?/_[,O_,T_P#;I_[6
MKZ H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9I_[=/\ VM7T!0!Y/_PSSX+_ .>NJ_\ @0O_ ,11_P ,\^"_^>NJ_P#@0O\
M\17K%% 'D_\ PSSX+_YZZK_X$+_\11_PSSX+_P">NJ_^!"__ !%>L44 >3_\
M,\^"_P#GKJO_ ($+_P#$4?\ #//@O_GKJO\ X$+_ /$5ZQ10!Y/_ ,,\^"_^
M>NJ_^!"__$4?\,\^"_\ GKJO_@0O_P 17K%% 'D__#//@O\ YZZK_P"!"_\
MQ%'_  SSX+_YZZK_ .!"_P#Q%>L44 >3_P##//@O_GKJO_@0O_Q%'_#//@O_
M )ZZK_X$+_\ $5ZQ10!Y/_PSSX+_ .>NJ_\ @0O_ ,11_P ,\^"_^>NJ_P#@
M0O\ \17K%% 'D_\ PSSX+_YZZK_X$+_\11_PSSX+_P">NJ_^!"__ !%>L44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^=_VE_\
MD(^'?^N4_P#-*\(KW?\ :7_Y"/AW_KE/_-*\(H **** "BBB@ HHHH ]_P#V
M9?\ F:?^W3_VM7T!7S_^S+_S-/\ VZ?^UJ^@* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *X3Q9X.\S?J&EQ@-]Z6!1U]U'K[5W=%;4:TZ,N:)RXO!TL53]G47_ /
M!**]&\6>#Q=!]0TR/%Q]Z6%?^6GN/?V[_7KYT058@@@C@@]J^BH5X5H\T3X'
M&X*KA*G)/;H^XE%%%;'&%%%% !1110 4444 =WX3\8[-FGZK+\O2*=CT]F/]
M?SKT"O!*[;PGXP-J8].U*3,'W8IFZI['V]^WTZ>3C<#?]Y37JCZC*,YM:AB'
MIT?Z/_,]%HI 0RAE((/(([TM>.?6!1110 4444 %%%% !1110 4444 %%%%
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M1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'Q1\1_^2D^(_P#L(3?^A&N7KJ/B/_R4GQ'_ -A"
M;_T(UR] !1110 4444 %%%% 'O\ ^S+_ ,S3_P!NG_M:OH"OG_\ 9E_YFG_M
MT_\ :U?0% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QQ\8/^2KZ_\
M]=4_]%I7V/7QQ\8/^2KZ_P#]=4_]%I0!P]%%% !1110 4444 %?7_P $O^20
MZ%_V\?\ I1)7R!7U_P#!+_DD.A?]O'_I1)0!Z!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?._[2_\ R$?#O_7*?^:5X17N_P"TO_R$?#O_ %RG_FE>
M$4 %%%% !1110 4444 >_P#[,O\ S-/_ &Z?^UJ^@*^?_P!F7_F:?^W3_P!K
M5] 4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%% !1110 4444 %?7_P2_Y)#H7_ &\?^E$E?(%?7_P2_P"20Z%_V\?^E$E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HKFM7^(7A'0BRZAX@L8W7K&DGFN/JJ9/Z5Q&I?M$>$;0LMG;:E?,.C
M)$L:'\6(/Z4 >N45\]WO[2\Y)%CX9C0=FGNRV?P"C^=8=Q^T;XNDR(=/T>$=
MCY,C']7Q^E 'U!17RB_Q_P#'#.6$NGH#_"MKP/S-)_PO[QS_ ,_%C_X"C_&@
M#ZOHKY;A_:)\9QGY[72)1C&'MW'\G%:]I^TKJB'_ $WP[9S#_IC.T?\ ,-0!
M]&T5XQIW[2'AV? U#2-1M2>\1251^.5/Z5VFD?%CP/K15;?Q!;0R'^"[S <^
MF7 !_ F@#LZ*9%-'/$LL,B21L,JZ,""/8BGT %%%% !1110 4444 ?._[2__
M "$?#O\ URG_ )I7A%>[_M+_ /(1\._]<I_YI7A% !1110 4444 %%%% 'O_
M .S+_P S3_VZ?^UJ^@*^?_V9?^9I_P"W3_VM7T!0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%,EFC@B:6:1(XU&6=V  'N37)
M:I\5/ ^D%EN?$=F[KU6V)G.?3Y : .PHKQ[4/VC/"MN2ME8:G=L.C%$C0_B6
MS^E<W=_M+W!)%EX8C0=FFNRV?P"C^= 'T+17S#<?M'>+'R(--T>($=3%(Q'_
M (_C]*HR_M ^-Y&!5M.C&.BVW7\R: /JRBOE#_A?WCG_ )^+'_P%'^-21?M!
M^-XU(;^S9#GJUL>/R84 ?5=%?,UO^TCXF4_Z3H^DR#TC61/YN:W+/]I=#@7W
MAAAZO!>9_P#'2G]: /?:*\JT[]H/P5>$+=#4; ]"T]ON4?\ ?!8_I79Z3X]\
M)ZX573_$&GRR-TB,P1S_ ,!;!_2@#HJ*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHI"0JEF(  R2>U "T5CW7BSPY9,5N_
M$&E6[ X(EO(T.?Q-,A\9^%KE]D'B71Y7_NQWT3']&H VZ*;'+'-&)(G5T;HR
MG(/XTZ@ HHHH **** "BBB@ HHHH **** "BLG6/$^A>'TW:OJ]G9G&0DTP#
M-]%ZG\!7 ZK^T!X*L"5M&OM1;H#;P;5_-RI_0T >J45\^WW[2[DE=/\ #*@9
MX>XN\Y_X"%_K6#<?M&>+I.(;#1X1_P!<9&/ZOC]* /J"BOE%OC_XY9B1-8*"
M>@M1@?F:3_A?WCG/^OL?_ 4?XT ?5]%?+D/[17C&-OWEGH\H..&@D&/IAZV+
M/]I;44(^V^&[68=_)N6C_F&]J /HNBO&]._:-\,W!"W^F:E9L?XD"2J/QR#^
ME=OH_P 3O!>N%5L_$-F)&X$=PQA8GT <#)^E '6T4BLKJ&4@J1D$'@BEH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF_
M%'A6+6H3<6X6.^4<-T$@]&_H:Z2BKIU)4Y<T7J8XC#T\13=.HKIGA%Q;RVMP
M\$\;1RH<,K#D&HZ];\2^&(-=@,B;8[U!\DG9O]EO;^5>575K/97+V]S$T4J'
M#*PKZ+#8J->/GV/@\QRZI@YV>L7L_P"NI#11172>:%%%% !1110 4444 =+X
M7\52Z+*MO<%I+!CRO4QGU']17J4%Q%=0)/!(LD3C*LIX(KPBN@\->)Y]"F\I
M\RV3MEX^Z^Z^_P#.O.QF"53WZ>_YGT&4YPZ%J-9^YT?;_@'K=%0VMU!>VR7%
MO(LD3C*LM35X;33LS[--25UL%%%%(84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5-1U
M&UTJS>ZNY-D:_FQ] .YINJ:K:Z/9-<W<FU1PJC[SGT KR36]<N]<O#-<-MC7
M/EQ#H@_J?>NS"825=W>D3R<SS2&#CRQUF]E^K)-?\07.NW9>0E+=3^ZA!X4>
MI]3[UD445]!"$81Y8K0^%JU9U9N<W=L****HS"BBB@ HHHH ***O:5I-WK%X
MMM:)ENK,?NH/4FE*2BKO8N$)3DHQ5VQFFZ;<ZK>I:VL>Z1NI[*.Y)["O6= T
M"VT&S\N/#SO_ *V8CECZ>P]JDT30[70[,0VZ[I#_ *R4CYG/^'M6G7@8O&.L
M^6/P_F?;Y5E,<*O:5-9_E_7<****X3V@HHHH *\C\:_\C;??]L__ $6M>N5Y
M'XU_Y&V^_P"V?_HM:]'+/XS]/U1X'$?^ZQ_Q+\F8%%%%>Z?%!1110 4444 :
M_A?_ )&?3_\ KJ/Y5[)7C?A?_D9]/_ZZC^5>R5XF:?Q%Z'V7#?\ N\_7]$%%
M%%>8?1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Q1\1_^2D^(_\ L(3?^A&N7KJ/B/\ \E)\
M1_\ 80F_]"-<O0 4444 %%%% !1110![_P#LR_\ ,T_]NG_M:OH"OG_]F7_F
M:?\ MT_]K5] 4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?''Q@_P"2
MKZ__ -=4_P#1:5]CU\<?&#_DJ^O_ /75/_1:4 </1110 4444 %%%% !7U_\
M$O\ DD.A?]O'_I1)7R!7U_\ !+_DD.A?]O'_ *424 >@4444 %%%% !1110
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M:I=V39R?(E*AOJ.A_&O4?#?[1'B#3]D.NV=OJD(X,J?N9OKP-I^F!]:\;HH
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ML&5@>X(ZU+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBJFG:C:ZK9I=6DF^-OS4^A'8U;KP6FG9GVL91G%2B[IA1112*"BBB@ HHHH
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M,CH<A@>00>XH ^>?VE_^0CX=_P"N4_\ -*\(KW?]I?\ Y"/AW_KE/_-*\(H
M**** "BBB@ HHHH ]_\ V9?^9I_[=/\ VM7T!7S_ /LR_P#,T_\ ;I_[6KZ
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M %%%% 'Q1\1_^2D^(_\ L(3?^A&N7KJ/B/\ \E)\1_\ 80F_]"-<O0 4444
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M ']3V ZDT^^OK73;&>]O9T@MH$,DLKG 51U-?)/Q0^)EWX[U4P6[20Z);O\
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#O_A5\1)O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ!9-X:T>?&IW*?Z3,AYMXSV'HS#\ASU(([GXB>-K?P+X5FU%]KWDG[JSA/\
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MS=Q!PN<E&Z,I]P01^%:E> ?LY>*B?[0\+7$G 'VNU!_ 2*/_ !TX_P!ZO?Z
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MHHKS#Z(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^*/B/_P E)\1_]A";_P!"-<O74?$?_DI/
MB/\ ["$W_H1KEZ "BBB@ HHHH **** /<_V<]6TW2_\ A)?[0U"TM/,^R[/M
M$RQ[L>;G&2,XR/SKW3_A+/#?_0P:5_X&Q_XU\,44 ?<__"6>&_\ H8-*_P#
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M_IU]$  &!P***^=KUYUI<TC[W!8*EA*?)3^;[A1116)V!1110 4444 %%%%
M!1110 4444 %<IXJ\6II2-9V3*]\>&;J(OK[^WYU%XK\7C3@UCI[JUT>))!R
M(O8?[7\J\U9F=BS,69CDDG))KU,'@>;]Y4V['S>;YQ[.]##OWNK[>GG^7J.E
ME>:5I979Y'.69CDDTRBBO:/D&[ZL****!!1110 4444 :_A?_D9]/_ZZC^5>
MR5Y3X%M#<^)HI,'; C2'\L#]3^E>K5X69M.JEY'VG#L&L-*3ZO\ 1!1117G'
MT 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\4?$?_ )*3XC_["$W_ *$:Y>NH^(__ "4GQ'_V
M$)O_ $(UR] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'TM^S[XSFU;1KGPW?2EYM.4/:ECDF
M G!7Z*<?@P':O::^1?@=?O9?%;3$!(2Z26!\=P8RP_\ 'E6OKJ@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KXX^,'_)5]?_ .NJ?^BTK['KXX^,'_)5]?\
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M_P 2L,$?D:^'/$FB3^&_$FH:-<9,EG.T6XC&]0?E;Z$8/XT 9=%%% !1110
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MO;M].GLX/'<UJ=3?HSY+-\FY+U\.M.J[>:.)HHHKU3Y@**** "BBB@ HHHH
M569&#*Q5E.00<$&O2O"GB]=0"V.HNJW0XCD/ E]C_M?SKS2@$@Y'!K#$8>%>
M-I';@<=5P=3GAMU7<][HKB?"?C 7/EZ=J3XF^[%.Q^_[-[^_?Z]>VKYVM1G1
MERR/OL)BZ6*IJI3?_ "BBBLCI"BBB@ HHHH **** "BBD9@JEF(  R2>U "D
M@#)X%>>>+/&)FWZ?I<O[KI+.O\?LOM[]_P"</BSQ@U\9-/TY\6O224=9/8?[
M/\_I7&U[.#P-OWE1>B/DLWSGFO0P[TZO]%_F%%%%>J?,!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[(LC_EJ^1D?10W_?0H ^AO#>A6OAGP[8Z-9C]S:1! V,%VZLQ]R23^-:E%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+_ !"\)1>-
M/!UYI3*OVG;YMHY_@F4';SV!Z'V)KJ** /@.:*2":2&9&26-BKHPP5(X(-,K
MUCX^>%!H?C1=7MX]MIJRF4X' F7 ?\\JWU)KR>@ HHHH **** "BBB@#W_\
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MM\/!%"C[+G &.2Q)/YUV- !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?-/[1F@BS\4Z=K<2 )?P&*0CO)'CD_564?\!KZ6KRS]H#21?\ PV:\
M"Y?3[J.;/?:Q\LC\W!_"@#Y3HHHH **** "BBB@ KJ_AG>FP^)GAV8'&Z]CA
M_"0[/_9JY2KVB7!L]>TZY!P8;J*3CV8'^E 'WC1110 4C*KH590RL,$$9!%+
M10!YKXK\(-8%K[3HV:UZR1CDQ>X_V?Y5QU>]D C!Y%>=>+/!_P!E$FHZ:A,/
MWI8%'W/=?;V[?3I[.#QW-:G4WZ,^2S?)N2]?#K3JNWFCB:***]4^8"BBB@ H
MHHH **** %5F1@RL593D$'!!KTKPIXO&H[;#4&"W8&$D/ E^O^U_.O-* 2#D
M<&L,1AX5XVD=N!QU7!U.>&W5=SWNBN)\)^,!<^7IVI/B?[L4['[_ * ^_OW^
MO7MJ^=K49T9<LC[["8NEBJ:J4W_P HHHK(Z0HHHH **** "BBB@ HHHH ***
M* .!\6^#CF34=,CX^]+ H_,K_A7!5[W7#^+/!WG[]0TN("7K+ O\?NOO[=_K
MU]?!X[_EW5?HSY;-\FO>OAUZK]5_D>>44$$'!X-%>N?*!1110 4444 %%%%
M!7?>$_&(Q'IVJ2<_=BG8_HQ_K7 T5C7H0K1Y9'7@\95PE3VE-^J[GO=%<CX&
MUYM1LVL+E]UQ;KE&/5TZ?F.GXBNNKYNK2E2FX2Z'Z#A<3#$TE5ALPHHHK,Z
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MR6;YSS7H8=Z=7^B_S"BBBO5/F HHHH **** "BBB@ H ).!R:559V"JI9F.
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M\*]EKP9',<BNOWE((^M>\UXV:12E&1]=PU4;IU(=FG]__#!1117E'TP4444
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M(44 >W_\-*:Q_P!"_8_]_GH_X:4UC_H7['_O\]>(44 >W_\ #2FL?]"_8_\
M?YZ/^&E-8_Z%^Q_[_/7B%% 'M_\ PTIK'_0OV/\ W^>C_AI36/\ H7['_O\
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M%% !1110 4444 %%%% !1110 4444 >#_M+_ /(/\._]=9_Y)7SQ7T/^TO\
M\@_P[_UUG_DE?/% !1110 4444 %%%% 'O\ ^S+_ ,S3_P!NG_M:OH"OG_\
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M10![E^S5"&UO7I^,I;1)TYY8G_V6OHVOGW]F:-3-XFEYW*MJH^A\W_ 5]!4
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M_)4/$/\ U]G^0KCZ "BBB@ HHHH **** /L_X5_\DN\/?]>@_F:["N/^%?\
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MO657O8/!JDN:7Q?D?$YKFTL4_9T](?G_ ,#R"BBBN\\,**** "BBB@ HHHH
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M^PA-_P"A&N7H **** "BBB@ HHHH ]__ &9?^9I_[=/_ &M7T!7S_P#LR_\
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M5-<_\%TW_P 30!S]%=!_P@GC#_H5-<_\%TW_ ,31_P ()XP_Z%37/_!=-_\
M$T <_170?\()XP_Z%37/_!=-_P#$T?\ "">,/^A4US_P73?_ !- '/T5T'_"
M">,/^A4US_P73?\ Q-'_  @GC#_H5-<_\%TW_P 30!S]%=!_P@GC#_H5-<_\
M%TW_ ,31_P ()XP_Z%37/_!=-_\ $T <_170?\()XP_Z%37/_!=-_P#$T?\
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M6NG[Q_P&11_[-7TQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '@_[2_\ R#_#O_76?^25\\5]#_M+_P#(/\._]=9_Y)7S
MQ0 4444 %%%% !1110![_P#LR_\ ,T_]NG_M:OH"OG_]F7_F:?\ MT_]K5]
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M* "BBB@ HHHH **** "BBB@ HHHH ^"+_P#Y"%S_ -=6_F:KU8O_ /D(7/\
MUU;^9JO0 4444 %%%% !1110![_1110!] 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%W)]^>5I6YSRQ)/\Z^Q_BIJXT7X9Z[<[L/);FV3US(=G'T#$_A7QC0 4444
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M%>;5Z3\.?^0/=_\ 7Q_[**XLP_@/Y'LY#_OJ]'^1V5%%%?/'W84444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\4?$?_DI/B/\ ["$W_H1KEZZCXC_\E)\1
M_P#80F_]"-<O0 4444 %%%% !1110![_ /LR_P#,T_\ ;I_[6KZ KY__ &9?
M^9I_[=/_ &M7T!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\<?&#_D
MJ^O_ /75/_1:5]CU\<?&#_DJ^O\ _75/_1:4 </1110 4444 %%%% !7U_\
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M)^\M6^U6P)_Y9L<.![!L'_@=>YT %%%% !1110 4444 %%%% !1110 4444
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MYRS,>2:CKZ'#86-"/GW/@LQS*IC)ZZ16R_KJ%%%%=1YH4444 %%%% !1110
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M "4GQ'_V$)O_ $(UR] !1110 4444 %%%% 'O_[,O_,T_P#;I_[6KZ KY_\
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MF[\*:;K"+E[&Y,;D=DD'7_OI5'XU[16%XTT(>)O!FK:/@%[FW81Y[2#YD/\
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M5#Q#_P!?9_D*X^NP^*G_ "5#Q#_U]G^0KCZ "BBB@ HHHH **** /L_X5_\
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MS7['S_0^JX9_Y>_]N_J%%%%>0?5!1110 5F>(_\ D6]1_P"O=_Y5IUF>(_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ^*/B/_R4GQ'_ -A";_T(UR]=1\1_^2D^(_\ L(3?^A&N
M7H **** "BBB@ HHHH ]_P#V9?\ F:?^W3_VM7T!7S_^S+_S-/\ VZ?^UJ^@
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OCCXP?\E7U_\ ZZI_Z+2O
ML>OCCXP?\E7U_P#ZZI_Z+2@#AZ*** "BBB@ HHHH *^O_@E_R2'0O^WC_P!*
M)*^0*^O_ ()?\DAT+_MX_P#2B2@#T"BBB@ HHHH **** "BBB@#SGXV>%SXC
M^'MS-"FZ[TP_:X\#DJ =X_[YR?JHKY&K[^95="CJ&5A@@C((KXL^(_A1O!OC
M>_TQ486C-YUH3WB;E?KCE?JIH Y2BBB@ HHHH **** .L^'?C6X\#>*H-23<
M]I)^ZNX0?OQD\D?[0ZCZ8[FOLNPOK74["WOK*99K:X0212(>&4C(-?!%>O\
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M+Q@+A!SY+=!(H]NX[CW H ^NJ*BMKF&\M8KFVE26"9!)'(ARKJ1D$'N"*EH
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M_P JTI?Q(^J,<3_!GZ/\CQ>BBBOJC\Q"BBB@ HHHH *])^'/_('N_P#KX_\
M917FU>D_#G_D#W?_ %\?^RBN+,/X#^1[.0_[ZO1_D=E1117SQ]V%%%% %#7(
MFGT&_B7[S6[X'J=IKQ.O>R 1@\BO%M?TMM(UFXM2"(PVZ(GNAZ?X?A7KY747
MO0^9\MQ)1?N5EMM_E^IFT445ZY\H%%%% !1110 5VGA/P>;S9?ZG&1;]8H6X
M,GN?;^?TZS>$_!WFB/4=3C^3[T4##[WH6]O:O0:\G&XZUZ=-^K/J,HR;FM7Q
M"TZ+]7_D( %4*H  X ':EHHKQSZP**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /BCXC_\E)\1_P#80F_]
M"-<O74?$?_DI/B/_ +"$W_H1KEZ "BBB@ HHHH **** /?\ ]F7_ )FG_MT_
M]K5] 5\R? ?QAH'A/_A(/[<U*.S^T_9_)WHS;]OF[ON@]-P_.O8_^%P^ ?\
MH8X/^_4O_P 30!W%%</_ ,+A\ _]#'!_WZE_^)H_X7#X!_Z&.#_OU+_\30!W
M%%</_P +A\ _]#'!_P!^I?\ XFC_ (7#X!_Z&.#_ +]2_P#Q- '<45P__"X?
M /\ T,<'_?J7_P")H_X7#X!_Z&.#_OU+_P#$T =Q17#_ /"X? /_ $,<'_?J
M7_XFC_A</@'_ *&.#_OU+_\ $T =Q17#_P#"X? /_0QP?]^I?_B:/^%P^ ?^
MAC@_[]2__$T =Q17#_\ "X? /_0QP?\ ?J7_ .)H_P"%P^ ?^AC@_P"_4O\
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MW'3 !]CT5S?A'QUH/C6Q^T:1>*TJC,MK)A98O]Y?3W&1[UTE !1110 4444
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M,.=<E+;N?299D?LI*KB-7T7;U"BBBO+/I HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /BCXC_\
M)2?$?_80F_\ 0C7+UU'Q'_Y*3XC_ .PA-_Z$:Y>@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "NG\*_$'Q)X.N$;2]1D^S@Y:TF)>%_JO;ZC!]ZYBB@#[-^'GQ
M$TWQ_I+30+]GU"  7-HS9*9Z,I[J?7\Z[*OB3P)XHG\'^,+#5HG(B1Q'<J/X
MX6(#C\N1[@5]M*RNH92"I&00>"* %HHHH **** "BBB@ KXX^,'_ "5?7_\
MKJG_ *+2OL>OCCXP?\E7U_\ ZZI_Z+2@#AZ*** "BBB@ HHHH *^O_@E_P D
MAT+_ +>/_2B2OD"OK_X)?\DAT+_MX_\ 2B2@#T"BBB@ HHHH **** "BBB@
MHHHH P_%_A:Q\8^&[G1K\824;HY0,F*0?=<?3]02.]?%_B'0+_PQKMUI&I1>
M7<V[[3Z..S*>X(Y%?=E>>?%?X;0^.M&$]HJ1ZW:*3;R'@2KU,;'T/8]C[$T
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M(Q[="WMQWKZR "J%4  #  [50T31;#P[HUMI6F0"&TMTVHO<^I)[DGDFM"@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*HJ]J^CZAH.IS:=JEI):W<)P\<@_4=B/0C@U1H **** "BBB@ HHHH ****
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MS_LGDI].1]*\"U[PWK'AB_-EK.GS6DPSCS%^5QZJPX8>X)H RJ*** "BBB@
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M#_"GP[X)5)X8OMNI@?->W"@L#WV+T0?3GW- 'E'P\^ UWJ+0ZGXM5[6SX9+
M'$LG^^?X![?>_P!VOHJRL;73;*&SLK>.WMH5VQQ1*%51Z "IZ* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#XZ^,=FUE\5M<1AQ)(DJGU#1J?YDC\*X
M6O<_VC_#KPZMIGB**,^3<1?99F'0.N67/N5)'_ *\,H **** "BBB@ HHK9\
M)Z!-XH\5:;HT(8FZF57(_A0<NWX*"?PH ^P?AY9M8?#KP];L,,+")F'H64,1
M^M=+38HTAB2*-0L:*%51T '04Z@ HHHH **** "BBB@ HHHH **** "BBB@
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M7/\ NL& ^@Q0!\FT5]%R_LTZ<SYA\272+Z/;*Q_,,*C_ .&:+/\ Z&>?_P
MQ_\ %T ?/%/AAEN9T@@B>661@J1HI9F)Z  =37TI9?LW^'8F#7NL:E< 8^6,
M)&"?R;BO0_#7@#PQX2P^D:3#%/C!N'S)*?7YFR1]!@4 <'\&?A7-X74^(-=B
M"ZM,FV" \FV0]2?]L]/8<=R![#110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !534M+L-8LWL]2LH+NV;K'/&'7ZX/?WJW10!XGXJ_9VTJ^+W
M'AJ^?3I3R+:XS)"?8-]Y?_'J\:\1_#+Q=X7+M?Z/,]NN3]IMAYL6/4E?N_\
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ML;?L?AO4"K?=>6+R5/T9\#]:[[1/V<_$5X5?5]2L]/C/5(\S2#\!A?\ QXT
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MTG#Q3('4_@: /@FBOJO5_P!G_P &:C(TEH+[36)SMMYMR9^CAOT(KGI/V:;
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M ?.]%?1 _9HLLC/B>?'?%F/_ (NMC3?V=?"EK(LE]>ZE?8ZQF18T/UVC=^M
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M*C@GBNH$G@D62)QE64Y!%25XC5C[%--704444#"BBB@ HHHH **** "BBB@
MHHHH **** "O.OB/_P A"R_ZY-_.O1:\Z^(__(0LO^N3?SKMR_\ CKYGD9[_
M +E+Y?F<31117T)\$%%%% !1110 5[W7@E>]UY&:_8^?Z'U7#/\ R]_[=_4*
M***\@^J"BBB@ K,\1_\ (MZC_P!>[_RK3K,\1_\ (MZC_P!>[_RK2E_$CZHQ
MQ/\ !GZ/\CQ>BBBOJC\Q"BBB@ HHHH *])^'/_('N_\ KX_]E%>;5Z3\.?\
MD#W?_7Q_[**XLP_@/Y'LY#_OJ]'^1V5%%%?/'W84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*K76G65\,7=G;W ])8E?^8JS10!S\_@3PC<Y,WAC1V8]6^Q1@G\0,U1?X7>!
MY'+-X9T\$_W8]H_(5UU% ''_ /"J_ W_ $+-C_WR?\:EB^&?@F$87PQIAYS\
M\ ;^>:ZNB@#&M_"/AJT.;;P[I,)]8[*-?Y+6O'%'"@2)%1!T51@"G44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_XE\,0
M:[ 9$VQWJ#Y).S?[+>W\JZ"BKIU)4Y<T7J95Z%.O!TZBNF>%75K/97+V]S$T
M4J'#*PJ&O8/$7ANWUZV&<1W2#]W+C]#ZC^5>3WME<:==R6MU&8Y4."#_ #'J
M*^APN*C7CYGP>99;4P<^\7L_T?F5Z***ZCS HHHH **** "BBB@#H/#7B>?0
MIO*DS+9.?GC[K[K[^W>O5;6Z@O+9+BWD62)QE67O7A5;?ASQ)<:#<]Y+1S^\
MBS^H]#_.O/QF"57WX?%^9[V4YN\.U2K:P_+_ (![!15>RO;?4;2.ZM9!)$XR
M"/Y'T-6*\)IIV9]K&2DE*+NF%%%%(84444 %%%% !1110 4444 %%%% !7G7
MQ'_Y"%E_UR;^=>BUYU\1_P#D(67_ %R;^==N7_QU\SR,]_W*7R_,XFBBBOH3
MX(**** "BBB@ KWNO!*][KR,U^Q\_P!#ZKAG_E[_ -N_J%%%%>0?5!1110 5
MF>(_^1;U'_KW?^5:=9GB/_D6]1_Z]W_E6E+^)'U1CB?X,_1_D>+T445]4?F(
M4444 %%%% !7I/PY_P"0/=_]?'_LHKS:O2?AS_R![O\ Z^/_ &45Q9A_ ?R/
M9R'_ 'U>C_([*BBBOGC[L**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "O.OB/_ ,A"R_ZY-_.O1:\Z^(__ "$++_KDW\Z[<O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5ROQ#\8)X'\(7.K^6LMQN$-M$QX>5LXS[  D_2NJKQ[]HVWFE
M\!V$T8)BAU!3)CME' )_'C\: /#M3^)WC75;IIYO$NHPECD):SM B^P"8KLO
MAO\ &;7['Q%9Z=K]_)?Z9=2+"SS_ #20EC@.&ZD D9!SQG%>058L+:>]U&UM
M;8,;B>5(X@O7<Q &/Q- 'WO1110 4444 %%%% !1110 4444 %%%% !1110
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M]"?!!1110 4444 %>]UX)7O=>1FOV/G^A]5PS_R]_P"W?U"BBBO(/J@HHHH
M*S/$?_(MZC_U[O\ RK3K,\1_\BWJ/_7N_P#*M*7\2/JC'$_P9^C_ "/%Z***
M^J/S$**** "BBB@ KTGX<_\ ('N_^OC_ -E%>;5Z3\.?^0/=_P#7Q_[**XLP
M_@/Y'LY#_OJ]'^1V5%%%?/'W84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Q_Q4_Y)=XA_Z]#_ #%?&%?9_P 5/^27>(?^O0_S
M%?&% 'LO[/.F:?J>O:RFH6-M=HEJA5;B%9 IW=1D'%?07_")^&_^A?TK_P
MH_\ "O!_V:_^1AUS_KT3_P!#KZ0H Q_^$3\-_P#0OZ5_X!1_X4?\(GX;_P"A
M?TK_ , H_P#"MBB@#'_X1/PW_P!"_I7_ (!1_P"%'_")^&_^A?TK_P  H_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<GX_\>6'@#0DU"[A>YFF?R[>
MV1MID;&3D\X '4X/45UE> ?M-,0OA=<G:3=$C/&?W/\ B: $L_VEB;M!>^&0
MML3AVAN]SJ/4 J ?ID?6O>;*\@U&PMKZUD$EO<Q+-$X_B1@"#^1%? ]?:_PW
M_P"2:^'/^P?#_P"@B@#J**** "BBB@ HHHH *HZQH]CK^D7.EZE;K/9W*;)(
MSW[@@]B#@@]B*O44 >!:A^S3&URS:;XE:. DX2XM=S*/]X, ?R%=AX$^"FB^
M#=2CU2>[EU348L^3))&(XXCTR$R>>O))]L'FO3:* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#E_B1_R37Q'_V#YO\ T$U\45]K_$C_ ))KXC_[
M!\W_ *":^** /=_V:/\ D(^(O^N4'\WKZ(KYW_9H_P"0CXB_ZY0?S>OHB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "@@$8/(HHH \Z\6>#_LPDU'34)A^]+"
M!]SW7V]NWTZ<37O=<#XM\'?ZS4=,C_VI;=1^97_"O8P>.O\ NZK]&?*9ODUK
MU\.O5?JO\C@J***]8^6"BBB@ HHHH *=&[1R+(OWE((^HIM6=.MC>:E;6P&3
M+*J?F:3:2NRH)RDDMSW*BBBODC]2"BBB@ KSKXC_ /(0LO\ KDW\Z]%KSKXC
M_P#(0LO^N3?SKMR_^.OF>1GO^Y2^7YG$T445]"?!!1110 4444 %>]UX)7O=
M>1FOV/G^A]5PS_R]_P"W?U"BBBO(/J@HHHH *S/$?_(MZC_U[O\ RK3K,\1_
M\BWJ/_7N_P#*M*7\2/JC'$_P9^C_ "/%Z***^J/S$**** "BBB@ KTGX<_\
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M?\B]J?\ UZ2_^@&OA"@#UC]GG_DI4G_8/E_]"2OJ>OEC]GG_ )*5)_V#Y?\
MT)*^IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *^?_VFO^96_P"WO_VC7T!7S_\ M-?\RM_V
M]_\ M&@#P"OM?X;_ /)-?#G_ &#X?_017Q17VO\ #?\ Y)KX<_[!\/\ Z"*
M.HHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:ZG1#_WSDL/RK6_X9Y\:_P#/72O_  (;_P"(H X&T\8>)K$@VOB'58<=DO)
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M_P##2/B3_H#:5^4G_P 57&>/_B3J7Q"_L_\ M"SM+;[#YFS[/N^;?MSG)/\
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M[Z*\W^%_Q6L_'5M]AO1':ZY$N7A!^6<#JZ9_5>WN.GI% !1110 4444 <O\
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M/_917%F'\!_(]G(?]]7H_P CLJ***^>/NPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#C_ (J?\DN\0_\ 7H?YBOC"OL_XJ?\
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MB?#R*<&[8=S_ +'H._4]@/)J*]@^#GPH'BB5=?UV%O['B?\ <0MQ]J<'G/\
ML ]?4\=C0!B?#WX0ZSXW*7LY;3]'S_Q\NN6E]HU[_P"\>/KC%?2?A7X?>&O!
ML(&DZ<@N,8:[F^>9O^!'I]!@>U=+%%'#$D42+'&BA41!@*!P !V%.H ****
M"BBB@!" RE6 ((P0>]>8^-O@CX=\31RW.F1II&IG+"2!?W4A_P!I!P,^JX/?
MGI7I]% 'PSXF\+:OX1U=]-UBU,,R\HXY25?[R-W'\NAP:HZ9J=[HVI0:CIUR
M]O=V[[XY4/(/]1V(Z$5]H^-?!FF>-] DTW4$"R %K>X R\#XX8>H]1W'X&OC
M;Q#H%_X8UVZTC4H]ES;OM..C#LR^H(Y% 'UW\-_'EMX]\-K> )%J$!$=Y;J?
MN/V8?[+=1^([5V-?&_PG\62>$O'EE,TA%E=L+6Z4GC8QP&_X"<'Z9'>OLB@
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M /HMZ /L>BBB@ HHHH **** "BBB@ HHHH ^,/BI_P E0\0_]?9_D*Q_"?\
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M&&/;)QC/?'/O$$$5K;Q6\$:QPQ($C1!@*H&  /0"I** "BBB@ HHHH ****
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M )ZK\K<=LD9^A%=+7A7[-FL&72M:T5W_ -1,ES&">S@JV/Q1?SKW6@ HHHH
M^&/%G_(Y:Y_V$+C_ -&-70?!_P#Y*OH'_75__1;US_BS_D<M<_["%Q_Z,:N@
M^#__ "5?0/\ KJ__ *+>@#['HHHH **** "BBB@ HHHH **** /C#XJ?\E0\
M0_\ 7V?Y"L?PG_R.6A_]A"W_ /1BUL?%3_DJ'B'_ *^S_(5C^$_^1RT/_L(6
M_P#Z,6@#[GHHHH **** "OG_ /::_P"96_[>_P#VC7T!7S_^TU_S*W_;W_[1
MH \ K[7^&_\ R37PY_V#X?\ T$5\45]K_#?_ ))KX<_[!\/_ *"* .HHHHH
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M^%/PU_X5_IMVU[+!<:I=R?/-#DJL0^ZHR ?4GCJ0.< UZ'110 4444 %%%%
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M[_R,.I_]?<O_ *&: .S^!TK1_%O1U'219U/T\ES_ $KZ\KY ^"7_ "5[0O\
MMX_])Y*^OZ "BBB@ HHHH **** "BN;UOX@>$_#S,FIZ]9Q2K]Z%'\R0?5%R
MWZ5P>I_M%>%;4LEA8ZC?,.C;%B0_B3G_ ,=H ]@HKYTOOVE=2<D:?X=M8?0W
M%PTOZ +7/7?[0/C>XSY3:=:Y_P">-MG'_?9:@#ZLHKX[N/C+X_N2=WB&1001
MB.WB3'Y+6?)\3/&TK;F\3ZF#C'RSE1^0H ^U**^'V\<^+G4JWBK6RI&"#J$N
M"/\ OJH/^$L\2?\ 0P:K_P"!LG^- %?7?^1AU/\ Z^Y?_0S7<? K_DJ^F_\
M7*?_ -%M7G#NTCL[L6=CEF8Y)/J:]'^!7_)5]-_ZY3_^BVH ^MZ*** "BBB@
M#XX^,'_)5]?_ .NJ?^BTKAZ[CXP?\E7U_P#ZZI_Z+2N3TB 7.M6$!Z2W$:'
MSU8"@#[DT2Q&EZ!IVG@8%K:Q08]-JA?Z5?HHH **** "BBB@ HHHH *^4/C]
M_P E1G_Z](?Y&OJ^OE#X_?\ )49_^O2'^1H \OK[_KX K[_H **** "BBB@
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MDFNOL/BEXUTO3[>PLM>FAM;>,1Q1B*,A5 P!RM 'VA17QQ_PN#Q]_P!#'/\
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MO4 R3;3K)CZX/%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MSKXC_P#(0LO^N3?SKT6O.OB/_P A"R_ZY-_.NW+_ ..OF>1GO^Y2^7YG$T44
M5]"?!!1110 4444 %>]UX)7O=>1FOV/G^A]5PS_R]_[=_4****\@^J"BBB@
MK,\1_P#(MZC_ ->[_P JTZS/$?\ R+>H_P#7N_\ *M*7\2/JC'$_P9^C_(\7
MHHHKZH_,0HHHH **** "O2?AS_R![O\ Z^/_ &45YM7I/PY_Y ]W_P!?'_LH
MKBS#^ _D>SD/^^KT?Y'94445\\?=A1110 4444 %%%% !1110 4444 %%%%
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M_A/_ )'+0_\ L(6__HQ:Z#XP?\E7U_\ ZZI_Z+2N?\)_\CEH?_80M_\ T8M
M'W/1110 4444 %%%% !1110 5\H?'[_DJ,__ %Z0_P C7U?7RA\?O^2HS_\
M7I#_ "- 'E]??]? %??] !1110 4444 %%%% !1110!Y?\?O^27S_P#7W#_,
MU\H5]7_'[_DE\_\ U]P_S-?*% 'T_P#LX_\ )/-0_P"PK)_Z*BKV"O'_ -G'
M_DGFH?\ 85D_]%15[!0 4444 %%%% !1110 4444 ?"&N_\ (PZG_P!?<O\
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MS%+I?ES1K(NZX;.",C/RUY;7W%X+O!J'@;0;L')ET^!F_P![8,C\\T ?.O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/THJJBA5 "@8  X JGH^F6^BZ-9:7:C$%I"D*>X48R?<]:NT %%%% !1110
M4444 %-=UCC9W8*J@DD]@*=7&_%3Q GAOX<ZM=;]L\\1M8.>2\@V\>X&6_X#
M0!\<WMP;N^N+D]9I6D/XG->@_ K_ )*OIO\ URG_ /1;5YO7I'P*_P"2KZ;_
M -<I_P#T6U 'UO1110 4444 ?''Q@_Y*OK__ %U3_P!%I7/^$_\ D<M#_P"P
MA;_^C%KH/C!_R5?7_P#KJG_HM*Y_PG_R.6A_]A"W_P#1BT ?<]%%% !1110
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M@<^,65I)?W]O9PC,MQ*L2?5B /YU]VZ7IUOI&E6FFVB;+>UA6&,?[*C H M
M!5"J  !@ =J6BB@ HHHH **** "BBB@!DLJ00O+(P6-%+,Q[ <DU\#SR^?<2
MRXV[W+8SG&3FOL;XLZ^OAWX;ZM<!L3W,?V2$9P2TGRG'N%W-^%?&M 'J'P!_
MY*C!_P!>DW\A7U?7RA\ ?^2HP?\ 7I-_(5]7T %%%% 'RU^T+I)LOB%%?JF(
M[^T1RWJZ90C\@GYUY,"58,I((Y!':OJ/]H+PZ=5\#1:M#'NGTJ;>Q Y\I\*W
MZ[#] :^6Z /N?PGK2>(O">E:NC!C=6R.^.SXPP_!@1^%;%>&?LZ^*UN-+O/"
MUQ)^^MF-S:@GK&Q^=1]&Y_X&?2O<Z "BBB@ HHHH **** "BBB@ HHJEK&JV
MVAZ->:I>-MM[2%II".I &<#W/0>] %VBO,O"/QP\->*=4CTR2*XTV[F;;"+C
M!21CT4,#P3Z$#TSGBO3: "O'OVB]*-WX'LM11<M97@#'T1U(/_CP2O8:PO&>
M@CQ-X-U;1R 7N;=A'GH)!\R'\&"F@#X=KZR^ ^LC5/AG;VS-F73IY+9L]<9W
MJ?IA\?A7R>Z-'(R.I5U)#*1@@CM7K/P!\5+HWC*31[B3;;:L@1,G@3+DI^8+
M#ZD4 ?4E%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\/^.(/LOC[
MQ##@X34K@#/7'F-C]*N_#&Z%G\3?#LI.-UZD7_?9V?\ LU:7QHTXZ=\5=8&W
M"7!CN$/KN09_\>W5Q-A>2:?J-M>Q?ZRWE65,^JD$?RH ^]Z*@LKN+4+"VO;=
MMT-Q$LL9]58 C]#4] !1110 4444 %%%% !112,RHI9B H&22> * /C'XJ?\
ME0\0_P#7V?Y"L?PG_P CEH?_ &$+?_T8M6?'6K6VN^.M:U.S)-M<73M$Q_B4
M< _CC/XU6\)_\CEH?_80M_\ T8M 'W/1110 4444 %?/_P"TU_S*W_;W_P"T
M:^@*^?\ ]IK_ )E;_M[_ /:- '@%?:_PW_Y)KX<_[!\/_H(KXHK[7^&__)-?
M#G_8/A_]!% '44444 %%%% !1110 5GZ]_R+VI_]>DO_ * :T*S]>_Y%[4_^
MO27_ - - 'PA7L'[./\ R4/4/^P5)_Z-BKQ^O8/V<?\ DH>H?]@J3_T;%0!]
M/T444 %>*_M(:2USX6TK547)L[IHFP.BR+U^F44?C7M5<]XZ\/CQ1X)U;2 H
M,L\!,.?^>J_,G_CP% 'Q#7U;\ M;74_APEBS9FTVX>$@GG:QWJ?I\Q'_  &O
ME-E9'*.I5E."",$&O4/@5XL7P]XX&GW,FVSU91;G)X$H/[LG\25_X'0!]744
M44 %%%% !1110 4444 %%%% !117E,GQ]\+V_B:YTFY@NX[>&9H?MR /&2#@
MM@<[>O(S]* /5J*CM[B&[MHKFWE26"5 \<B'*LI&00?3%24 5=3U"WTC2KO4
MKIMMO:PO-(1UVJ"3_*OA_P 2Z_=^)_$5]K-ZQ,UU(7VYR$7HJCV P/PKZB^.
MNHM8?"R^C1MK7<T5OD>A;<?T4BODB@#6\->'K[Q5X@M-&T],SW#XW'[J*.68
M^P&37V-X,\%Z5X(T1-.TV(%R ;BY8#S)W]6/IZ#H/SKR7]FS0X_)UG7W3,FY
M;.)L?=& [_GE/RKWV@ HHHH **** "BBB@ HHHH ^>_VF+M6N?#EF&^9$N)6
M7/9B@!_\=:O!*]$^-OB!->^)5ZL+[H-/1;)"#P2N2_\ X^S#\*\[H ^S_A7_
M ,DN\/?]>@_F:["N/^%?_)+O#W_7H/YFNPH **** .7^)'_)-?$?_8/F_P#0
M37Q17VO\2/\ DFOB/_L'S?\ H)KXHH ]W_9H_P"0CXB_ZY0?S>OHBOG?]FC_
M )"/B+_KE!_-Z^B* "BBB@ HHHH **** "BBB@ HHHH *IZII.GZU8O9:G90
M7=L_6.9 P^O/0^]7** /EWXL?!X^$8FUS0S)+HY8"6%SN>U)X'/=,\9/(XSG
MK7D5?>]_96^I:?<6-W&);:XC:*5#T96&"*^%M:TU]'UW4-,D.Y[.YDMV/J48
MKG]* /<_V=/%DCB^\*7,F5C4W=H#_",XD7\RK ?[U>_5\=?!R]>R^*VALIXE
MD>%AZAHV'\\'\*^Q: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YSQKIIU#P_
M(\:YEMCYJ@=2!]X?ES^%='1UJZ<W3FIKH8XBC&O2E2ELT>"45T_BWPR^DW37
M=JA-C(<C _U1/\)]O3\JYBOJ*52-2*E$_.,1AZF'J.G46J"BBBK, HHJ>SL[
MB_NDMK6)I)7. J_S]A0VDKLJ,7)V6YN>"M,:_P#$$4I7]S:_O6.._P#"/KGG
M\#7K%97A_1(M"TU;="'E;YI9/[S?X"M6OF\97]M4NMEL??Y5@GA,.HR^)ZO_
M ""BBBN4],**** "D(# @@$'@@TM% 'B>M::^DZO<6; [4;*'U4\@_E5"O5_
M%WAS^VK,3VX'VV$?)VWK_=_P_P#KUY4\;Q2-'(K(ZG#*PP0:^DPF(5:G?JMS
M\]S/ RPE9JWNO;_+Y#:***ZCS0HHHH 5$:1U1%+,QP .I->U:'I_]E:+:V9Q
MNC3Y\?WCR?U)KD/!/AA_,35KZ,J%YMXV')/]\^WI^?I7?UXF8XA3DJ<=E^9]
MED&!E2@Z]16<MO3_ ((4445YA]$%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 <?\5/^27>(?\ KT/\Q7QA7V?\5/\ DEWB'_KT
M/\Q7QA0![?\ LU_\C#KG_7HG_H=?2%?-_P"S7_R,.N?]>B?^AU](4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% &?KW_ "+VI_\ 7I+_ .@&OA"ON_7O
M^1>U/_KTE_\ 0#7PA0!ZQ^SS_P E*D_[!\O_ *$E?4]?+'[//_)2I/\ L'R_
M^A)7U/0 4444 %%%% !1110 4444 %?"&N_\C#J?_7W+_P"AFON^OA#7?^1A
MU/\ Z^Y?_0S0!V'P2_Y*]H7_ &\?^D\E?7]?('P2_P"2O:%_V\?^D\E?7] !
M1110!\8_%567XH^(0P(/VHGD=B!BL/PQ*D/BS1I9#A$OH&8^@$BYKOOC]HKZ
M=\1WO@F(=2MXYE(Z;E&QA]?E!_X%7E@)!!!P1T- 'W_17,?#_P 50^,?!MAJ
MJ.K3[!%=*#RDR@!@?KU'L173T %%%% !1110 4444 %?+'QT\=)XE\1IHUA,
M'TW3&(9E.1+/T8^X7[H_X%ZUV_Q?^,$-A!<>&_#5R)+UP8[N\B;B ="B$=7]
M3V^O3PKPGX:O/%WB6ST:R!WSO\\F,B)!]YS[ ?GP.] &+7I'P*_Y*OIO_7*?
M_P!%M7 ZG;)9ZK>6L98QPSO&I;K@,0,_E7?? K_DJ^F_]<I__1;4 ?6]%%%
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MNZCXBE0^1:1?9H6(X,CX+8^BC_Q\5](4 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q_Q4_Y)=XA_P"O0_S%
M?&%?:'Q3!/PO\0X&?]$/\Q7Q?0![?^S7_P C#KG_ %Z)_P"AU](5\X?LU_\
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M30!]75R_B;XA^%_"4;_VIJL(N%Z6L)\R8GTVCI]3@>]?*&K_ !'\8ZXA2_\
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M[D\8:3"6MYB/[0C0?ZM^GF?0\9]^>YQ]%4V6*.:)XI462-U*NCC(8'@@CN*
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M +!\W_H)KXHH ]W_ &:/^0CXB_ZY0?S>OHBOGC]FC_D(>(C_ -,H/YO7T/0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;+I79]#UZ&1#]V*]C*$?\#7.?^^17(7?P(\>VS8BTVWNAZPW<8'_ (^5HHH
MRU^$GCA[K[,NB9FW%=OVN#J.O.^MBQ^ GCN[8":TL[('O/=*0/\ OC=110!W
M.A?LVVZ,LFOZX\H[P64>P?\ ?;9_]!'UKUWPYX.\/^$[?R=%TR"V)&'E W2/
M_O.>3],XHHH W**** .,^(/PXTOX@6$,=U(UK>V^?(NXU#%0>JL.-R]\9'L1
MSGS_ ,/?L[#2M=L]1O/$?G):SI,L4-KM+E3D L6..@[&BB@#W.BBB@ HHHH
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H[-FBB@#TN""&U@2"WBCAAC&U(XU"JH] !TJ2BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>eldn-20230426.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-01T06:13:06.4566+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.eledon.com/20230426" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:eldn="http://www.eledon.com/20230426" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eldn-20230426_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eldn-20230426_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>eldn-20230426_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-01T06:13:06.4843+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>eldn-20230426_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-01T06:13:06.4804+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="eldn-20230426.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139677217963616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 26,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Eledon Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001404281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-36620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1000967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">19900 MacArthur Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">238-8090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELDN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>eldn-20230426_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="eldn-20230426.xsd" xlink:type="simple"/>
    <context id="C_48c1f781-f488-4629-9efd-dada7ef92a5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_c3d98b99-4c6d-4180-85a5-22485eeb6d4c">0001404281</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_14222ccc-4b59-4d6d-bca3-2237a06d498a">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_985d01b5-0e17-430f-a8bb-89af571b2bf7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_9cb388a8-980b-4cb9-baad-df0e37f66f02">2023-04-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_52dba78f-6695-4df4-aecf-49b5f9a03b81">Eledon Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_13ae3907-20c6-4e2d-ab2e-0e0d537beb1a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_4f43e3de-57eb-4a0a-b3f0-261a1bc02066">001-36620</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_262126fc-7ed8-4859-8f05-77ea69ac2485">20-1000967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_c9ab9090-9363-4113-a3ff-e71ffeb2ab90">19900 MacArthur Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_b6719140-4a8b-4848-993f-6ba05ac7e05a">Suite 550</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_e45863ee-617f-4b83-ba91-32accd4e6b4e">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_332f937d-8380-4028-a20e-ffe51bee6587">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_e0b053b4-9b9e-4ecc-a829-e1cf8bf2dcb9">92612</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_8aaa76e6-a0dd-45d2-b42b-aabfc90c206b">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_fe3c26c3-3f36-4b0e-afa9-815f1c11ee1b">238-8090</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_e7bf27af-73d3-4fdd-b821-ad253da1d3ae">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_b9ff66e4-4d8a-4d36-a801-ee86d87cb65d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_60c04ceb-545e-47ab-bd0e-da3487134096">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_580e676e-c4d0-4abe-a07b-ffcc72bf7bf6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_a4fba383-3bb7-4160-884e-43c6471043a9">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_7456d117-5dda-48d9-9290-88a304938875">ELDN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_59842e74-253f-4345-b787-c6af976bb194">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_48c1f781-f488-4629-9efd-dada7ef92a5a"
      id="F_a0db72f0-f574-4199-8199-eb0fe490448b">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M"^#WI5+V?>!>N:M_3,;_ 5!+ P04    " !Z.Z%6GZ ;\+$"  #B#   #0
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ >CNA5@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !Z
M.Z%6RRXK'N\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " !Z.Z%6F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( 'H[H598YZR.
M= 0  #T1   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " !Z.Z%6GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"   9%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="eldn-20230426.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="eldn-20230426.htm">eldn-20230426.htm</File>
    <File>eldn-20230426.xsd</File>
    <File>eldn-20230426_lab.xml</File>
    <File>eldn-20230426_pre.xml</File>
    <File>eldn-ex10_1.htm</File>
    <File>eldn-ex10_2.htm</File>
    <File>eldn-ex10_3.htm</File>
    <File>eldn-ex10_4.htm</File>
    <File>eldn-ex4_1.htm</File>
    <File>eldn-ex4_2.htm</File>
    <File>eldn-ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "eldn-20230426.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "eldn-20230426.htm"
     ]
    },
    "labelLink": {
     "local": [
      "eldn-20230426_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eldn-20230426_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "eldn-20230426.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "eldn",
   "nsuri": "http://www.eledon.com/20230426",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "eldn-20230426.htm",
      "contextRef": "C_48c1f781-f488-4629-9efd-dada7ef92a5a",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "eldn-20230426.htm",
      "contextRef": "C_48c1f781-f488-4629-9efd-dada7ef92a5a",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.eledon.com/20230426/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0000950170-23-016017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-016017-xbrl.zip
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MSRCQ!J;OTM$XT(9#9Z#9?F!KE'F!9CON('"H;KECXZD23\;TS]@E3S$-DIW
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M4>("J\;XX[:%-1:#;U>!ND!C/L>)2A K$$;B8+!; =H8JSZ)98!>\BM\P8)
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M:>CETCU";%%1@")EL]RT+Y$08_BS1!,6PJ15Y"43$!>"5#%E[26/5ALVU>D
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M><'"D0^[;NPO/OWIP^XTFX6?_A]02P,$%     @ >CNA5O(UK? , P  G@D
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MZ ;<A!P!II2G)7\][I'605AC](-JMC7:6=?&T%KJVE(_8B[^ %!+ P04
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M2!#UO4<G,GR5BU^VH^C6^?FY&5U-0P.L"N2R+?/;_=T@RM/@(Q3RNX8:5R<
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M'Z@97S&X2"P;^D&P0&PH%L7L<3Q60NYL4C7T3^%6"CI [H+Q9ZYECX9B(Z+
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M"ESSG;&*I>?':4O,&P-K&_OEUJEQ.CAZ@1[!.^9-"W#RY2?'Z>(4=G OZHH
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MCZ=UWO<79-_DG8[]?U9U\J8K=/+X^)MD!?NH*Q9D++9XO-,2I[0YQ/9)<MW
MIFIP#YJFZ33MS$87!7Y"-H33D(%=$7S6Z$M=JP+.#?RVK-KD767*MEBGX;VM
M(>+WM@P ;^#>BFQ<.S;8J,L*[)-YA[>'NV6UF?&6[XM35'6WOZ]^??5[FKQ%
M???3JS<OP&_X-7GVZM?SE\]?O#E[^_+5K_9E+;NV4P4HI$M=J@W5U']/O(-
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M8-&%@YNFKDE(LW%\]LP4K !KC)L!!3?UPF3,,:1L0'*%!QK/9=.TR.$.J//
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M9$\VUS"<($1<U.9+<Z[-JI(SM[M<3XC75-JLVHU.W6[/FG+0MC2OBD+5;/G
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M5S^94I58XF*_HB*&**M15EE6IR.L;\@#8BL_><,U-C=#QD18YK1D9>+$R#>
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M\,/WZQPS3&@M%!J%O>]'!H021 -R[BDYAHWM/H3SE(Y&G.NCFTL?I<(&5CU
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MLA==:0Y[EL*N<W['61P\MPJ!C]=C0#D>UH?E$I"5D9Q-S^!- PLQ=2>I8'S
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M]2R707K:4@))-!<^#>WX:!#IU X8@@.P0)X*B&3PI"!]C2!J"RV@P"YC3GH
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MS^LLH0HNSV]X]A2^1BX Q&Y_G&/"7E=^:1I;NVE:-E>X?C-1KG-A":\238K
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MXT,F,(:_G9R"1!\?)X,=ACB$(&/>J$*R(MBPI"O(9IBC&/2V8XW-S"@>3!"
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M=6E*FI\;BJ*0G<C=XIEC)B<&WJ <T9$/5 6B5FK,YH*5V!B^C0NL@[$Y(Z<
M/UU5!BW9%9JM!WTB@[#_J2WU=NR^-@QUZ,$XEHP&$\$/6OMJJ2RPZ8>)MA3^
M4"<AKCH,C4G2R9;^!N;54@96L"F'MKTQ-1R6'()0WP]O9!L/$/R(^Z1QN-^O
MX6C:6-D^/ILANZ&A.^^*.2RE^$JF#@!#]%S]0=>9:?SWLIY^;481.&$QOF7M
M(<HC,;<WQ[BQQ"[#O9G8MI,82?9CYX:ZN3"KS9_%XVSRQ]F?$S_.GKL2A_TY
MM00L/ :I] U;MC33_72(8;\^G2AY\1&DL2T7MVD=-5L/_8GWPA@/E]@)HA(#
M-5*1GH=LPX'NYH,#=#"A3>VQ4#:Z\$P#85&N#?%(R(=F!Y+3=BV#/I>43O$?
MNO4BCJ,'JPZ.@BR\X\!&H/V*%#6Y6]M@%0:#ISA3C5')R@>:%A4N1!^@180T
M7)^#AT[X=I!6;EMJ!H%ACOLXK.41CB)^GT,0ZVX$%G(<URZ.N*L4);6GXSCU
MOYQ7V[<:8[O"4Y.\/C\+"_,6C[!/<8[5ZG4G#86J&@VU[:04 \H&U_.GAQ&S
M!,9=23=V= (,[W4W179F6E,D(\!6!63'X _[EW@;,;0)EV!RT4 "M@+?Q<>4
M+K);T$:U!:2F!AG$;8<40VR'N%#M.KG">BJ\2\I-CTP#;C"NJ&Q>W&K4I8[;
MY<!&:;2EJA] \O*NMF^BO=(%5D%MC2]O$,];"QDMG:N+"DPU:</T^<L[N&!0
M>T\7Y78-\><W7_U;67A/$[GC-3AARESB0L@8< &M(JV\--)X7>A=GK/> '=B
M6L1C.S\.9\]"&.:HP7!MM".JH&JV;7!1R3!$(W/R1J92$[<R?ZV(*VI1DU2]
M0B T"/[^6)Q?#H"^2?:;>I.20P>>V--_-6IG.NO1&YR6/-#V=K!_I5Z_$HR=
M^5E4H9L!0H9^UU1@)IK6F:WT SR+NG7OVE3.C/XY$K1VL*@>C'C(IAEQ_OF4
M,WZ#D9)?U08/2OG9!KH>$XFKKL:FAC0'XG7:Q/_P<<:CD6-U-$/N*!L#<W0;
MJ(A2]43O1.>=#]U0R(M9&IF"Z))Y,#GZY)9Z6V(Z\!&VXY4PJ.8SU P@P$6+
MQ]3DCZG9;.+'U'D%)GV9[1&(_\> GH+\>M#,N>IWG7(!D U5,4K8EPJR?V&H
MRXY%M=C>W@SW'Q;8"@D5=P4/6G1=5Z>4.KT\5X9/'-*4KKO1:*!8&-XB9.-N
M(!L/(V0C0C8B9,.^0>3*1J5&MC]U$1$35D@'!M&8E3*DD;EWF@U%;%-ECK4R
MU[,V[%P*%O[,MI4.LIX8.RD%GT<,&,%UAPE#,RD6U]7:<HSN4*$^0F4CPET9
ML/LT2XPH9FIE6FZ"GH$3LW9Q;)NN)<3AU:#LB:/;85/QL/+)S@?O8^]?\C*K
M]]R/!$D)F *4#Q?8HR;K*,4J/QACU URR/9I_<,J[9^3PO?TCDNT1N],05;Y
M0ETJ4UA*TC9DX&7>5#J'!>"3J>8BF1>P,D.Z^+9::'K+#@;JCL[P6+5N"0%8
M4XZW<5RP,# ^"D-*^S_3VG=JS^^Q=21V8-@ZF5G1Y+N 6@5'F\HC,:C89\Y5
M:_ZQ=-$9V]\XA'#7^KXQKO=./2HM@P"A"TL3EI0N)+)X$9&97E<2CW?O@0?(
MC)4L1SU!2 ZV;:K6+"UVU4UMSB_.CH\91;9-&!\WY%3<W=FP&OK#[-QAL%1>
M[BA@%YD8I:5"52]4*>2YW&F0-T,?P8 T)'6W:C/I9=S[E84BX+#>@576Y,;#
MPS!F7&KJMNHMN0&G,V5>NI9R003=1N-.Q D35/S7RQ+71^<AZ=K6PAIRF^=5
M/=)P:;S=$1'!M)*<&^>E-KM+CF B/PDX(XP5#+,MD^$^#=_7GCA)KA86RX7A
M*/W 49E04>&>XS8CL$FXDPAN.*L/KGCK!"TS'A\?4\N,L"L+]R@7W=(XO>':
M7,CFJS"[B!L8KL/6J' [>V(=PGF]/B0UN^B4Q I3)/FMI(-&:!\$)D (X!EH
MJ('\T4^Q'/N"CQ],%572;%8AS(CIE)H+>PK4>E[HL%AY$Q<5'J8S51" I[G0
MNB54%/X&'J$ET]16AZX7K9\DGM#!-'&DI5Y4K9$E;-J:<_#TJG)&QG(RG%N?
MLQZT"*QA!OF:=7_*Q_>?AW(04^ VZ*^+NX6ZC;DF,N.[ 4F-6/U*IG%PU(D)
M0<35(]SI2-%^\W9OAD:1Z[E"1-48F5,HRS'X-_G@7Y9-//CW5GU(SENP!_?E
M9.O3)H*EVU(:QF=7;MC/^_H.[H+;I,8;6YI[;W;OV*"6I9)R#/>Y=#Z1_"'!
M.)YYOY644<)7A&>RSK%K1.H )GE25!GUQ1+^"_X58HI 7X0?S[&?QP7V_VKA
ME<.9T]78;\-V(.!&"%DA730"-3U;;]K#,'LV1PWA<H500SQK0G"ANX\C@8?I
M\(!>(+:XQ ,#W49$!36!.WD!"E$'/;\=P ,7F2R/%(_AJY*S.%PEZ;LM=.21
M2+WD=1/TWNF%D&6J!MN@6#>^JMXW 0@ZV ?PDO[ I@:.TR4H6.EAC7CR<^[O
MQDT7X-7#C[7G"K#?N"4='S[--QS]:E4(!U;-%@KX5EU)Z\Z/%6B-&XP$:8C-
ML+=D$@B 7Y'3QTU(VO68(^3K<WUGP0W_17X7',OH\Y'Y4B%SM.$E<;E#&E$\
MBR=_%N?YQ,_B7ZODW](6Z)RQ!/3D_3F8=UGQ&UB-<7#JA1)0!&?RP<GJH83[
MO(*">*"&6+;A4A.L+-[!?J[PX&ZIPF,D<&4?.7C&7/ @W/III 8%#S6AIN;S
MSP9-P,^!^QGV(9%LJK) F:UT7MCO*'E\?+(581%UZ.1UJ-83UZ$_B>7[K*HQ
MS)N\QHZ^V(1U&EHTC!N7W(<>+]O6HG<LW$R>BJ619Z6U&NKFB#&X&XS!HX@Q
MB!B#B#&P;W#<!!S166BB80QE&XRW:P25.^^P2 O-MJXLU-6\DPX\4BT-#O?"
MS%O*+[1LM_7;P+M?N18<M>:B"="T-NJ"OGH%TX5S)UE5F$[)J!%K:RYM+]%#
MCRQVM[11A"UW\I$3=KX-MNVL? -P1C97UNC=,1+"#$C7" 5K"E<*.,T676M>
M*-OV=*XH'@4WMVE#K)<NUKYRW5:;VR8)N].4!Q29XRNIW=Z.>D!X^9N93VS]
M?J5J?6C#4!3NN#15X:#)L*B".+X\E&\DPQ &16QV@)O^V5@/_/RG9Z_/HCT]
M>7MZ/I^X/2T]SM4^<A<.>!9@+5>:]ER?R)"J?X,VVEC;BQKG__WE_T$W8P8Z
MY1^@1I\Z[?3SSYBR?#LTO3$80""6X8F6"AYH\ @\T P31%PW&M6/U^.]>PR%
M$NL^E*8X<'A1]2>5PZQ,.=85A]#'8WVT;=T)8M5V9,#/RK*#'S*DQ+>P@O,#
M/B40#?%G)\]UII<S.%H?GJ3)Z?'I:=2ZD]>ZB\7DM:Y5&V3OO7'U]R-5=?8C
M5"H^'KB7RGIWE?06<FY4H6Q8-E6!O NBL3(%LW)YKD352Z^\"ETNL)C.%5V/
M:<=1/HP;<!RTO08VGH"H)@^C-\7-ZF\_&ZJH'VW1-C=YEY&A/?"<#CC339DW
MR\LDJW!X%U/D5X3O#0:7:2R>T:4U^OV<?"%G.R2/"$M&+]EE$=*/+8W2/G?$
ML+Y+7?,VR4S.>>J-P+X3OE4@?/V _);7ZR;4.#YYOQ!#DER_(4'[L&N"/T+7
ME$&[ ZH%EYRE1XTOA2/LY1Z^(A.5[;'K;2#?U/=ZAAA9O('C9_$.@Y<8#_C)
M'_ 7%_& O^: ][)O"Y_/)("T/T?[6;G&1.?"=<7TJHP(KQM]Q6W!F<)%U##W
M;JN)5AWUOD/;'V@/_!+^@ 8)! [T(>FB1[ 5!0)_F IT2;B;JDK*<_SINT&#
M@]KY24)N68F5 )NFAM.MJGD_\ON*S974$<;WCT'Z,D\IS*8;\/@X)B='C+"A
M-YI("M.DJ+A"XY^,3*X1&;6M_)T"83;S#//%EHB@B7U#I"!K;DMG@\^0@7!S
M.AQMQ+K]L:PXV1C,%X.GJZZ73]D#7:F&WJYPJE<KXL?ADGX;9>T=-$-S(>WS
MT+BBJ72$8#%-SG%IDG/F;-BY".%#4WB-&$,E>X/KAG#C2;&'K87PLUA)ETG?
M"+=_-VSP6B*P$!Z(8X85E'XL,G6X0;:]LI>]_F+]@.#T>?!NGDJ$=K!"3(#5
MH:'PP$9[37G3V7LLFL-H]0U0BB"OM[-FR'%?K&GBA*14[N&T6=US";0N;&<R
M=T>&;RO(+@^'AA*',:1S6HXJ(W=-'LCR$#(09QIRXV)B6"5R4^:$V+3XPT5;
M6UOY9LNVQ> ;DL-MVO=8WD#ZI$Z6N.<"A8++!P/#UL\PE@OX$5G^?! 0 RA"
M\FM3=0T6;2&/E^?J8F2A-RI#XE#<VKY.*;U.BC;N&G#;]8K2?V<Z%Q [> 2:
MK06L5DT%"T/_8C"<F>9Z3XOI3%W] 6W D;D?,+_NH7#"UAJ\'KTY)%=+VN">
M8IX1;\!CU(S>-,;7&O8K8G;[;K+;CV-V.V:W8W;;OL&>J\S.N[<U4)M['3NF
M^9W.="7=NX)E="M.,Z!A@S8*:'9RW3=NO5G^KA+<01Q>"]"6L>G\O=I2]\:]
M!XMTVN[]&]=%//F%Y)%[1.V/Y[Y9V&][MPV[L)45&;?;N)Z%Z@@Y8K?[$ZS-
MAKW?A">OJOO%6"U3N6(=LR<#@+F955?TPIG.Y^H3^6V0(<]5AC71Z-^UCKR)
MHM1"XS2*/Q>8#P+4P9LT.7K%J8L7Y^B2IU(F12":)>*)>'QS3R:(:V9_TTA#
MZ-&',;<>^=<FYS Y1A,L"83@@BS(_IHGVG9A^&,;X/;LW;O"#*[R._5I%HZ.
M9X4B7@UA )3:J[0_#BY?DFB[\Z7/"(VZ)>#O7>[8Z.#>Z(A[<Q*]>S?QD^BG
MYV?[<^J<^:39JJZX^7SM_IEA,(-H3H(&[Z@1>J6KHB5^.SH_2GZR8=_G=;=(
MSG)XM*<W/9@,O\G^[!$;ESL,:J1^XIII>MDIOVE\Y<^J9JD1%\MM9\&A6A(@
MR9>XULZ($YH.ON>4]L6S_=L8MI<4_+1#ZBED9$)#+'NO%OBO0LUT06D8C73!
MJ>^FA7^P.2=I%X[=CV9& F+J7K7_ 2DO\L-%;:5!:'SO=]3K"P5/SG3'0/37
MO 3[ML<$SSD^6=Q['+?Y]!UXW0;<TI@XX-SN,?FQ7D-I)]UGH4'(AI8F-35;
MP<]#?4A5#Y02J'JDX*E4LPKS$DP;C'Y*"$FBBYIQXK!@GN!^E0TQ,E:U'1RW
M11,6\#19X GM%XK<(5O1)]_"<N$&QI:@PZ\RV,Q<\>"_L-:"-&A.J5TU^J&T
M[/1)4 I,C;*K.D_>:[VRG'B86^(TH+ S./(F3E>W3-Q;8&;0HF5[+\3RD-C4
MV!;V$$?O0+VR$P3FT)#H5IJYS%-KY&PD#9T+CB0DM89'<%:%S:!!RT!\UYU!
M953/C'N7R**G%S N?#^!=62946@_\,(33R./CD@\9)38^3IE=S[8%N  +A02
M6-U0;?*9'";=;Z!J+P@4/>C"COON2M544@U+V#+ZS'*'+9==:?>@H_@#Z\@]
M9I/"!..HF KE?"G&,D@A--Q$YMJ-WY>=*B# IP;U<(?..O[X1Z^SH_VP+QYH
M$),JX2W*E^" PK\E<I'Z'HR\]RWOY[(*&?['%9D$.%"[Y#42)Q+W9#A\5#)N
M)>!5@ Y"U=B@OV_GVVCS)^$ >##^;@1ES)F[1[O/Z<ZA@/J.#&[8RC.P]!15
M>MUD$&^_9+I#Y74'(1QLT,1^V-O.-S__4\EFE^\JV/Y6%Y'*:RT9)I-WWGB?
MPRWICJVTIQ!VV6: %%04SL<P"1SXM29!6FE8B9)C*^^Z<A!8N<FC,>IT"<M&
M@G&%Y$+PCC6#<]?]>BRK9>R)XA6(17E\C"X@<0.U*PWFKF5S8I5[$W5+"ZAK
MCJIY+E\D,(*/;7>E(2D%]CDCX \F<38S,]N[D(U0W@V.ZEW'L(P#5-1X3)8'
MQ9WKO)F &LVEEO /HE*%>5^8F0EA*:3/4;JLSB*]CT%76>$^.Y6\97O"#GB.
M<WVI"UC#W)[!S."QS8:Q&"D[1JE9T39>"LM54ULQW-RD=40;N';?<W=W>\K9
MD5FL@0PH$)N-P0Z&=13! 7<$#O@F@@.^7G! C)-_Y7'R]^^G'B='FJCS!P^3
M%[#!##.H[TE<8F :@#.I:8[<-=T6EXJ1OJ4US=PG/.5 #,IWRL2M'AKA7;%@
M&OU(4W7/]L*]43=%,7%U\XKH,XEH0J@ZSKCUR+.*4,K[HWINR-Q=WC"41:TP
M"!B"/Q 6TI2+ E/'A<*X?6D(>2U_#*I$Z4Z"W5U\\A OHT1AHTJ!QMLPF Y*
M[:][F;V<XULDDNW@H<\U@LP)N3"=E-*KG\Z>[<G>=N'^>)Y-_CQ;+B=^GI%J
M>Z,YH(KALW7RGZJ@],(SX93:*R;;@4&-H3:,S5'836.!$4<#6>77FAO:\KI<
MR+ID?EVV$+[:'LC???^M/4*PGW1=$J_*I2X['$1.)\_)]]]],PYCL,/DFJFF
M(D):V.9)MX)[C]2;2M@^JK7)J[6RG+A:^U&5[P-%QH)TMC>(A6O,\[&L*GSE
M.ZT'O1^L[;YMQ5A'/>[IJ.0 ?S$9V_?'_^PAG$HP_SXI99VB'RM5Y_C6_TWI
M\LJWBK" O#<:'G*ID_,UN%/+B6V&P2+LV[[X;,U2795-4+7=;"\.F2,<!4RK
MC#SIQW\_=(74LM]Z#1FY+EDRE5FAN%O99=6Z=HW&<J.V5W#']8/^_4]''M!6
MA 3A2F*\-769M'$&1H@XW.%07_Y'4%>C0C38)9^]JOH#S,,(P(%7MF#^C7G1
M:<Q 4W6\H$K4PG%QK*@X1%;NSJ87+<ZI6YQ5-7&+\Q=JM/FSHB>!:.[)P2 N
M\W8(S6AO-$32L%MM\35!,VWNV\RL%V. 5X^@\21Y#.9\$((Y&<*)?XWUS7Y&
M8>&,QV>CNV]#KI0W[O?.ROWV>.")^Z%P']7"O5XB5NU:RV88 '1'\3YA&8+M
M\HF,,HSJFXSQ-!02^.?5OC!>!BAR!KT2[Q=7L;YV,%L\0;$_+[,4,2*JJ^FH
M[G?86^#N3<.N;MC5-W=9$(OW98AN55Q:GI?MV9(QHLC1-X+V@("60Z3RQS0C
M\<CE:!Q,WCA8K29N'/Q:)<]-\T<'^VMN<>HO+O5><;/_/J)= OP(PS-M.S8J
M5T%\MC\7J=6W& )()"8Q]$<'ZO#@]) ]/RJ>D79JWVS%J:1C%0=IZ&G!$L'[
MUTU3U4UZ$Q67]MC)$!>,U'KU,*T-;EK6<9F%37!SZ8'\.52<1/&6F14CW6UO
M;UPC_-NM#3]F!MJ4VX>@D\TW.SW^^]"IW4C"AVZT^,OB\C8!#T&FBJQC4ECA
ME.6.G][)7E57.!3KM#)L'PT:94G%-//KYS#,DK'3]*X>'3_>^JX.+3< 7+^!
M8!<:-T?X+,AGHMB!<1&JB0KS<(&F8T6]I+T'JW1)LL3<$'NB2!Q!'VQ8E,J%
M1OE))_YR]^68\.'G?L0IX$:Q+_I'E:-^J&JW(_+!"8J*ILEJ,PM4#1P+!_GA
MP<DAD=-46.2"U4';M _HKNGLK'$+9-]VEBOI)#+;+687'#J7%@@6[IM3"A'C
MOQX>CA3FV"AL[IN*(T\.5XLZ!DPL)J5#'W\V*L[#W;]EE",CX&")D TS228N
M0!" 2&.ARQT5NGP;"UV^WD*7R()YV_) UCHZ4]):D(J!9X64UEIR J==M<3%
M4(O-N[HTS87VE&%!YVW0<:NU3?3Y>S?<YB^W+3_H]C&V-/G8TA]_3#RV](IL
MC?WT%\ ">N68"<?(!=-^O$  G5>J=OR.TJ+TP#,<;K?+A&3(=8,@7H.BP, 5
M$1P>C$,9#L$<7':E9,A"3D971+\*VEJ-TR&&G)21"?&OWWSW1L'5]<05W*]$
M_X*RL?<Q]-#=(\V#U#?S]8:-) CQ$:;5J]HP^\.J-DRP2\1ESZ0#RG,IJSJ0
MUB-;W..0)6J[%^N:DQ*<B'Y(^I,X.]* Z54UC9*0.BQ,ZKUG#&I31^ZLM0P.
MX.'J[7[[C09&%+8T;<MA*\VF6]=_^@9Z-50 HN:B$OT*E.CIT2/4FP^/3J>M
M-M\$S?NH !*D5;J\! S07JOLCQ9]T>LYE))!!HZJ+N;, @=_(KDY&83!9=(+
M,6CT2(1%O&0- H-DS8BJEMN1,?J'OB&%$P"!>BJW7R"+OYA715%=-<E!5Q9$
M5"003=LCBY_2<@<UTFBLQ$BEP<>V+FB&%.U@+N+5? _B,,1?'SZ)UN.$%-^H
M]:@F;CR^JA>JE'X"3Y,SBZ;:'V5WOM'E38#FJ@SHU1BB93'?><?]]Z20D8FT
MF&HLQ1Y<)H?O7?LM0GB63,SI@ 0^HU80Z=]\E+#;$%%:6# I#PHZO,T[T&(U
MKE;J2BN1>10V-[C4S859I=S2#(99&,4,+Y0($>B9I3TE? (K9 >:&W#I,9X=
M"?6ZY=+VA=C>'5?0[MM;$WOZ/.IJ46/GYJZE:8>A4 ]R$<O=AB_9XA?4B%C4
MTGIM=Z\>YGO4-:TE(F9F&_W^KNW]NW-V'KE+FT56]$_^&?7P(_P,P@H_ZZ7Q
M@QEV&^2P!(*"]W-'FIN:/>+'1NY;((JUSRT/?4R'IL,KSI/IW]NR%.*5_"+&
MKAIC_V.ZSGK9B&F0L@<7-&/"*TBZZ!E$T(H>D!&@I=LPFS-.81?#J\XT61:6
M@]6T8^/ S4?CL)E0:7T*"V#?",P'_$6JX" D$-T5',8R,RN+7@XL&:P:J;M5
MBWA4>'!57#(V%689:-<444B(1S7=T@N'4P_V@3VZ8*)O)$ 23\^V \E@U0W<
MRK?[(P71V+L@<)H]S]ZDZ%FABTADDI<*=MK,L7,Z RL0G]01:5+K\L+HN:>7
M]4N$&//<R ()[RBLQQSW<4,]N)>E]UBYEV?I>5\I@=&0(&)_2+#<@K'WB2-C
MW&_REMMLXI;;;Z[_*@@SU\.A)\:E;7ODK6X:<"K#>A:+YP_;K3962X,B%:\6
ML:!T!G1E0&51"2@U3%0DRJ\?T<'V%YB+;QQ9-N=-"+?K:>R%_%=:GH\06_.Y
M%0SY@!HNU[U81.A7$[LWZT&JJNDM1D!M@2\#QX)MM(?+LNKJIE.E0QV_";BY
MF>+63MG;:]<4'DE](\&4J8%84&&*I\SAQ[VX'LJ9,+ZX@FP\=37'**F]FM 6
M;]X][$;L*(!_=[$)"0@/NOAB&LS"V[!);FTHSNKG$J(MV>1SW,.67G ''Z K
M1?$+-[98[$"$JS/<)!O[.D*8[@;"]%V$,$4(4X0PV3<(1Q.%?9,M1RDJ0SX:
MDDL#MX;SA>,7P;''W.5XNG%%_E"WV6H)]&1;"1K#(="CV/]DU9K:TUZ.5VJ'
M7MK;]@8I$.OA\&YM*/?0]KB]N>VM%3-F1M]'24VVF031(9Z,0YQ-W"'VS@!J
M@VZ/7."SH*YO$&B]HIPF%XWV%6:*\<\K)7UEQK.S% /F"RJ!A-#75>F#Q &U
M#IP$UJ7BNPOXCS,J-H[J*PW!5J! )14@85^AH%I);=9!/CX^P6+6D\,TX:)6
M_N]#^>^W7'P"__IN1\42]XL^#)H/"DZ&'L2A9NZE-.O6>N=X3AX].H/'1;[W
M>R<5]T;GYA/7N2\^@"UJF&!K/HC)[(_^/1\FFR2#7% 9?>W*<'V"*32%+U$7
MH^5/JCN@?&^JU07FD(-\B/;K"5JHUZ7+D_TL54M-T9I*VD3---6 SQ@AK2]5
MT4F*AWAW:R,AL-HT[]TYL*HKXB+ E YKYZ5@)(?GB/5<X'ER;SELQFY-D_3W
M&X\#2HN.F5:L5V'+EM729'0;1GGO'!-7/TN4S_IVC)T,;J_F<^QPJ5Q?R:2H
MFM%!1D4^=46N)Z[(!U#I?=7=%L0(4[%Z6-+YBUIK21U0;?P8?+PA. 8&,*I"
M%P135,G*7:4LR'RL?L6!6%*/8!F"5*Y%M-@"'AX%/KYDZQ1A[1*G*X- D6<&
M"7Z,T0Z"1G(N@Q$8=:=SGL_<Y%U&?%A4J#,X^D9HK<*8%'XF(*H[6@<!-HR]
M']L;<JERIM>S)0+PR7LF$QN$J+" 22)4J2M+EX:,M)BVFEP*C]Z;DK!@V H8
M!F;A,/;!K@*38F;Y)95EU$3.MT3./'[H72X,K QY<<.E<2O!G4)I)9H5O'CI
M"+;!?7:P/AQ9L":UZV5#MR@VO#]IU5&T?%&9WPSL0O'VO)O)2\/?X$8$(*(>
MQ@0J$HXX!Q3B>1\,)^Z'?VCCT=P.]D_>=-8F2]&\4 ;YD;QEABR.1EH>.T;(
M-.B\*ATYI4>JW-H+$5MVM@GH@+$N%5C-Y8W?L4>68534XZ>"'MDX?83D46Q6
M<$IS:E&\L27HCF! $1M2H0PBJ'*U!*V'R^_A?"ERXZF";<=W7;Z0-X2%)3GV
M(Y=1,:U2U7";<>R=S.L#I^X,D[Z\K6"H2%4Y"D6[L3(Z]-+-&[!%\462B+H?
M,2;>B.%CN$XHV-<T>WX[<!XNT.1/F9^+%TMVZN=NZFB63MXLG4_<+/VWH"+/
M@WKAO;5-Q4"36NAQ?)-")=,5K;5(;,=XTI:@8Y$O#P'"I12%6I F6B!=:4,-
M_3QA+\D&>IR8)\2.+/45+-$*U2!H>O6GX8B'A2<CWE,1]6I=J3Q332M$Z[K0
MC.5,(ESESN J0TQ%A*M$N,J$X2JURDW%%C:Y+$*FCBW"]!+AA%N93#=K'*PE
M:6'Y?<(*_WE/_T:#;?(&VV+B!MM9AF5/*&0O2U?(MK<6V\XP8AETM!GZZI8D
M^&S8RW<LIN7"2L/<OT6%&;_4Y =SY&F,SCXP]7 (IK&ID+$;^!(V],IU8\ -
M'W3JN7Y>. $*#2$-LWHO,((A5*P95H!+.(=R]^W_W]ZW-;>-).D^S_D5%7MB
M3T@1M-J6W3?WQ$10$F6S1Y:THMS>V8EY ,FBA#8)< %0,N?7G\K,N@*@I&Z;
M-@CD//3() @4JK*R\O+EE^L:=-HFC@]<A6 $4$M$(1$$6$O +2;/T-*=!&]>
M-V&6;03A$*4%T*N=2#DUP51'PI:*&+)?P_J %_!C^P& D F\?!X]190T1-YK
MB@13'U%/$0KLFC 5K&].01X7[:T\ED^SSI]FMQT_S8Z5;1?%I<8XH&&.TT3M
M' @NHGYJSP'GT<G9,G 3)]A<*NTQ\9=4I$Z-$"T^*B2EJ@P_$J6QH&V:O(WF
M,U!A8+U[0%^X.L!"DP8MZ\=ZWCE7QHRQ6WTYQIB!30XP;#8./KJ%4/"(/M8Z
MV>^:%_8EF*YL%1/@-=*IH S/1*?E3&TY /;0%BC-RBQ6+P1Y(1G?P?"H-4!^
M*V4A]B"75Q"[GI+T^;Z89>EB<ZQ;3Z8]4<M];G)9X&?JG--G#U3V9W .4#GV
MHX7P87F^[GL3+S#V4T >U')I!5%O#3($BR$M8-GL&L)ET-_G)D4J+@WO,&14
MD3=1IOM>)!:K>1$_H^9]4Q\<<B=O(>0% 7Y,[>9R&2';"[2OFBFW+=4M_[)<
M_Q%>8IIV;0*E1[F:06=OU-Q5%X896'^E1X8W6*6];(4SI<LVW!/_P-U!"8TG
M#Y2R(B7[2GVAUS\:IVJPE/]-DSE!^^M;'^EGXI+0')C9WS1L6BY\LPWO#?<V
M&[%L]WB<XUA.T#>YQ1++91H(?JX)#'#0_J]TVF9CK4$9H65U0:\V*8;U+]2E
MQ/;LQ.XHAM-!)QR]TGYM9D%Z2VVE="T13'5CL_G.5*M5FPMU\L#IH\%6D_#(
MP651B^@S -/,IYKXH&IVJNGQ=KF?!J2-"P6-8).BK#O=$/YL__$-/=/6>W27
MQE-CY4[3U1C/ >@(?X,:AEZ.*)RT3'IT$-&#V7H*\\#X*=>I-5>O(LKS=!*9
M,J1QFF7IO=<O-8:[(KHW%1+9%OR3P(]T!^I1:ZS9JEAMYLJKC<96F/(^/QZK
M;8 6VL'_\;=KGQ3L(6>[JO1R3\1PO908FZ9)+P\./0S,(IVJV>I17T,\7$D2
M'BU3RN#PTU0LE;9"Y=%XY5"D[<J#"S17#?;BP3LX>Z"6]26P&*;>IS%B?_!?
MGK6$?:0<O\LF91+J6M)1VF1T%64/VQ7C-:N33>ID^1#E9BFM\P3/6N>]4$4\
M4]MZD;\>*\%&!^HQC?*G<F;X>WQ1B+&\7BVAV;1ZXI_3-.-T/FV1O_WJX/N7
M+\')[E/*5@Q_.VB2L[TMC?[7<?:WB^NW@RO1?W,U&+P;G%^/Q,6I4!^)R_[5
M]7 PXG3Q5F;^Y7-.%S<X7<Q\RKNIR#6?\JN#%TU2WU\_5HIVYPQ:VF@FG;A%
M?38X%=*A';T#1,';]+>]D!RD3C%*.$8VD64*O?V(H*7,JT$$&EBHJ&DU2F0:
M];E0\+4*HSF@A-2+N;N87Y@2T*X5<5%Z)""Y3P)B*KA[=9EEO$N0>_>#SO5E
M"E#I@U'=J.3&QEXSYH,7>^/]$)@.<YA)S#P[?UB]+3FU6(8/05'*&U>(T)5#
MN8P3[4X#\XYRV( >A3I"Z$"L=TNLQ73M(Z(),)R:@LB@F$ [V<1%FJ_&X'U/
MO&X0YKF61MV[;:XF/)]%$ %=5V^L\P#D_[KTAUWF:2H)Z6JF)5A%$^$VET,
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M0<[T*STV"D^N'AO(QH[>-;/ UE,'K*<73;*>MF5%_/-J,!I<_38X^1>S['9
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M=Q>-<Z]8JF?<ESLZ_2'CT#-56NBFX"]S74UG$[.Y(U>H'[NNW,/J!Z]=D#:
M*@UJ-J\!^$!'^Z;2UDV!]_+^:X<OZJ'RQI+*9Z!]*!# I6I@LU4!R5>TY_[T
M(-&:LJUWT@DEF/7/J,Z$,HVV^K(0\@[M)ZI/GJ])6.R_L&;140M:QHQ2389>
M@ 6E ,UZE(TW="#1MLFUZ,(;H(E8WC6HE'IA/"%(C4%Q =0G8&H,!PA7F_E
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MP.=*;]HA&NI)K:'=4#WR;*A%,?7X9.?< /"6!E&B0RNYA=0S\"8M8G1\S6V
MUV5=::R'5&KHS*HYEE/?\S6V6@%"'5)BY$0.I%XK+Q-H:H*+>ZKDPS?*5E#!
MDU=N02D80FE.9$:I5[@O[(ME;6,)DTT&IO7<\2=DXBXU<.]1$.ZP_0[Y$.K
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M*0N9.4MDSG45N09%H1PET(Q>/XW"^QL]E5Q"(2[6,$%B)G(U7'!)\&1@],R
M$2(S#EVO\G0\@^BQ><_+,9G1>OR&Q!2$;MU"9L1C9.XP=3-8/U^L+]NO+SO.
MC:SKH=JC)OO&%J.J4RKV,G0KP/>[2C3A/'ZNS:<XH+7Q\SX$"S(A 2^RY;?@
M 4UEB%OMYU/0<5-QH^Y/7+'2=A#2X2X9J<6E OC7 M/SEHP3]"\H^T6<4R>Z
M6%=M:K,R+;T,8MFLJ7D71] J*8\7R*M H0GW0;):C"F^I[$%1:&<#.+SK 59
M^TPM>NPAQ"#7]] S!"6P!;&<ZD3\]Z]?/A?+@\6!V(,U_4>:?13'0"\$;[L/
M-XW\\$P/TX?D5'PJ@L!-B;5TYR<*7WT:&<9<BD,&DP'/I^Y6V$G]"5.I]D X
MF9-]0U"8(LPBF>X_$@S#Y"QRD-"48@GS6KP_&!T(BGUA!C53=[Q)U$Y6VT9-
M:8+A+^5KJAT%_2^S.[T&>]-]XGQ0U@NT!,$6E<O"LMN92-G];;H(UB_V-B;M
M1=Q0VB R$X^.G/L5G>.,S]L./J\,(F-\7I/P>0S&VZ;PERP(U][KCVM^4&%5
MP(T'L+%&1[F)0IT;Z'?)Z9E6L-!DL&=!-KU-*)M,WD29I8GU2&HQH.21U-:A
MIWW,C6%R\A6X]4FA:RP=TN$+B6.$&Q;B2@+)*<P>\D#]].SO[("UWP'K.!=I
M'UAQ, KQB_B O;M:Y(R=I^6.8W48!&0",LQ ,?R5KY;+.5Y#[AA2!\FI8?Q!
MA)Y)]U.0'N\'"A=^7F:W3N@&1*Q3$[?WR--NT[EI[T+@XN^?'[SX3X%-7)46
MU6QE6$1)Y)?4YUQK? ,K )TYR6)B<^LO(/7B@R+V@+TMP"B7\ B]RA##"A0
M6-:0>%/OMUYH5)M6LVA9:^(CTXO/MIFE)? 6"QJ;IRLE)3UW#)&#0K_R)C3L
M,Y>9#G2PA[-4\UI3HS7TRZ<@XO"O6+T=-0AWD!-(@5.;LZ!3X+ZAV*9&=[99
M>O41=%,Y?<(]#4DKM++S6%1);$T;/7K;J9Q%ZI"K!"(#*B>/ZA2F0=_/3'5)
M],M1 G)M(MW ?84=B6@(>I5U[W+8#*7! :05B/20^9O&67.5!AH\8;"&*#'D
ML54^,WFBJ3G$RR 'F_ER38B=R.L>)AI6"ZL49]KVT;_RQ1%_K8,YN,*PQZS(
M>4*&(ED5 V?S5*0NTFWI+5A#Y]X\Y%&9CA H]R.,V]CD[ )RF\"EN/D6=3@E
MRQ")LZWIQV(7ZJY(>'G<OF";8)>=%FDNJ27D]9K>JD/7"> XIH@_>N?E0C?U
M6J 128Q\"DX-Q-(JBNVT]MMI'2?H?2LQ7-8BXPSB9[?ZK5!3@]K("*BF+KR3
M24Q%8 DHU&F*@4FOEB-"U;^A2YZC?0S..(1CX/%$D#F/X-'C8:03B)5*^Y5*
MQTE@1ZL)0([2C$[4?@X>3*M43+W1&]@<V&LY >-6FU=CF<A97)0Q"-KFB#'2
M[T^;2]9%-($EY!BXF9A4P6_+VDJ'N;0A!P9N+9#= ,H>M-E*YM.>1G1!UF:\
M)@!"MJ_M-K_!XMJ,S<3=J)TV !+TN&@0U7:/84MPESWQ;#B:$T3S:]!<7D**
ME7T\0CGKBZ4T=.U>HI/<E3'(8Q6>@;DY_>N,.(OL@XQK&I#N/H"&Q) H=DW2
M-S:$'!ZJS9 [\'G1^O.B\^RU5,W^[!*=[B-4E!.*S;?IU)#B<A[I,!4!?.W1
M@<H%*_HI\#"V<V MR;!-+9T1NE5M??-4XQ>_/'AA/=NGW21L?>3N<U@]_.(<
M0X@8QS0T QM..@.AL >>5JX0@GCL[*/CE% $U<=05 </G("%7 /VQM)$" &N
MW/,"1W3&]$P$-LKI\WOL@>0CVUTE^$_Z!8+ PT]LU;=?2__<;2W]AI PRDPZ
MB^[;HY;[2@%COQ;3%WJBW]*$YDVM1$_<J<TTC0NH7O$2#F3H%S)3+U!$A<T)
M;3+^K,Z_P0DU):I3\S!-&F,UUH8^9/A(;#7G-;3!WC78(D]#J%S)"&7#;6/.
M#,I<EG/2^= -=AY#_%C]0]W/0)VAYL?5Z?CMU.$5J,<=-AN4%&XIS5XX*WEU
MVJ9R!J4XMI'#'^G0K0M32(_7S_3>_2T!R,<9)GULTBC2;V2P:M2WUCN.&&.U
ME>WVZCECK!ACU5&,532;Q?.8>HM1@^<4ZCQ2]?$$*SYR2+U37@IB%VHN$_QK
M(0&N"^I3J<-T+0GZ'8$#8=.]8TS?+20V$U?6['R5(_.X[>%=4"<B9:1+=7^E
MMP'-"J>1,K-!7^OKCG5O5'-^A"> ;HP=9YF\2R?8"RY?C1>Q*_"TCQ:_K[(X
MG\83_T#\LZ/HB:,453A\^"Y*;@%SEEA'()K^OIK:5+W.;2OQ6>GJ=\W9D)6*
M#>$K/$Y376*$+<V]DR0X@O2[IP@!F*SR7'^F[NDJ-&N#1C7HA(<,A'TJ6*V9
M:\P.Z\YT^C#6_=JAN796F'1T?V(2X.YP)J]G,H_BA48\6%3V$IT@3"J;XB<]
M\O(:VDPV+EO/"ZO5/1)]PP7DL/7L@Q<'Y;4F"P,MUQ/-(4#A/?O;1^6.YL*.
MW8&R9Z;BU=I4I@#9?#Z6U! WN]/6E7FKVI> ""<AQDL]%Q%EKZRJ."^DKJ^8
M )T%8'WP)QAUM>AQ6]&ZAS+B]Q(T7^W;*C!M<!5:O D-KH:J*49FU$X7(>'J
M)VHI:P.IGIRXE3(3I4EB7>+K)C7-Q%:@DG!]-LRJX2*Q5N)Y"OR+-P:=Z;9&
M#2"$DF5ZWN^UST[ "NSVI9;%/DQ?149>A;Q,+8TR5LN-RLR+D38$D:M=5X!V
MZ'YI0=#@X= M$;4A2,ET>[:4+%6@A G&T.IX,82>-L+EG18M4WK^@"!Z/9GC
MQ7@%U8<F[HP V/+-9M:LU8T[H1)$G3F)7.>&W\95VYM*HKPH5=_;*GG/\[@#
M=^FF6A)/L9LLS75=O 5\U+T0ATS:'S)Q38R:8-E]BTRHTI]WT;P]X9+KQX/(
M&PZ!'.>"0MV&H,J$I7VZA^+6[PG,6J(#6J+CQ'P#PR/3)C51!XDGPAS=F>(>
M V\+8*!#%A^9@=T"[@W!!(@ X1YY<:./\%_#!^&YO$FNS&BTOA-IM0ERWT8U
MP*VQ6E7UE:M8QKO[3_>(%0AVCPT3O!@H1BU-G:WIH>#1G?7 &B</0Q- @%EM
M28=-+BQ1-A Z7QJ[H0?M#07,6EU/?1>44;GZJZ#F5XW35?CZM</(]*=>XAGZ
M) &QCH4='"RG,]LAG2JH-'.XNEM/.P[VN=K"5H8EXN4P+(XS8P PSA3V<X!K
M0Y@$C.II1D3JRE94TZ5N."L_)<ZMO.P[XQ.GR9CMIO@<$G>F0-I-@M<%/GB_
M$HW\O9H^\!)2Y8/$X$H6#-3KS,G3<;*Z$?! 1F/E-A;K]AP^.AP A):]L#9$
M:=*(P'%0\Y3YT<DRJN%6SC6Y&0:[*$VV6$JL:0T"8X0:4UXQZ$&E_^>8&.N)
MNS3&J- JT8$&\,%[&H:AE'&B"Q P]04]S+W!YFZT9%][X_5K<@,+F^X*A^ML
MI?Y9U9+V((R!3Q:#+U">HPLL>KJ A6)9^GTB_,*<K"4H!]T,VPPAH .#+MDD
MUAP*-N[@=7.?Q8G.;V(P&ZO8YIC)Q -Y(=7!A1%-:F#M=#[&"&M9[M740'50
MI*-<Y<2A)3=]BBR ].CEQY"C4B;+%=V*CO[)/'*<#2;)F92/NMB$W-0':]TO
M "T+:P$Y*<!@U!]:?I/2=6%G'5.F5X7G:H,+WH*81>S(GRBG?/IUX/3K.*O>
ME<PGVD:&/?9!;:MI%MTK$_ *!M:> _$\+4!G6!H\I2XH7E^B9?5"-Y#6\@G.
M,6IO5 T:V%$6!LWW_<S6 [",'GI=R(\>UB.:FDFHG<5\0$_(N9P8@M4%AJG5
MB4GUQQ13C^I9(TJ%?&*:FER9FD%U=FB&5AT?)_WNQ^]U/RE4YVIRTZDF&52?
M.1IMR 248>F@=S,0*QKKO18I3!C P_)4'8>00%3G)XQXEJ4+1IML"6WR@M$F
MC#;I*-H$6>1 O</_8T%2?2,)UP8#LK!*W]Z!44S7^%K7:&(LE[E-*;P"ZA"*
M)<TAH5X4D1B2LM*Y*>\WF#ZT9+'R9W,[@@K]0^9.:6*]"&KKQ0=*/)!?!34U
M\01]#J>3O<2I8UQ3^G>5Z=P_45ZHNP&7CWK,J$@G'WTLA*O@)]6.&)N0$!N@
MCT3X ^ $$ZW23ZGT%S''9'1S [C,PB,,6&9(DA3%T](2.9B$'K##].>%-IJL
M$U#3R<2FV*,)U>G[]_*IBS;=0,]T0$BN%F9E>,YAJ9:VP$$GA PF8H(O2: '
MS&;KZ50CEUHHN#M$%WR.CC/37GE;)""?:(^WH<-O_L;'L\(2&GEJH,3M'^=B
ML2KB.46=YFE>0#\!==HDQ&JK;I&NM>U=(FP#342\J%[?:_P0G1GY2:FSY$9J
MA-.84$]H@J?$"(*'Y 24V5SW0C1 K[W2F:2'J"[9[^EC<![+E;#<X-[=\1XS
MX#6*1**F<N.L],1X55!C*1R)H1*%^EN#%;,A-?72ZOGY+ (0Z;I\4)A#0,T?
M 99FA9V^E0ES7;OC,B%$V2,#U!X7X?_B3'E:X$\"!,UC'%H:/)<+_F%9VS-*
M !&^R,-+3I3R4,*5 ?9)&1M)7*SW <V83F)TRASHR#MH]-GA-A+#!3IUA'2<
M6^\*D)3M.C%"-"6ESR&J7LQUEMV2<$&:@[@# O+R& ^(&[ X+3"TYP7(@=#9
MI+VGT0*(2W4/HFK):SEXA,W0QC(8$ "\04L&O7X,"'<#=E0K74O\ -DF':U/
M$UF $M1#L]P.D)V9*J\%E#%FGY(\\@ZM-:KXH)$1*5X#UM9=V=2__.A6$.7;
M7*CFH=#U6#6!G,$ ;T2>HZ=2-T,^AMP#"1 $C&K!".< N1$Y10@TU*-1!L6;
M#=;S'=#S'>?FNHS6VKHI1!]P3NU1^!M:LCMJFX^8!5CJ&< .DFO;22Y,&SR)
M1AK-6R_50(E.+*1R:0>/F*:P=4,];=,C!*PZ'%V"M"18>V[-TZ#H)_-B5IDM
M5;#^183!&$-WB45;7NZ]E'.>9=$*VOCH<2CG0D+4"8FP 1<0@:3TS($'K Q9
MNH"*L_PFQ4Y!5,0$SRQU(%"W@C>>PH\Q_F0:C" =@HW55 *'0CD(>2'IH9+8
M.;,*R8))V"1X-C^IJ]TX2CYFJV4QT<<YE8^I>YOJ,?QT0D$[N"E,M'JE OT.
M\@-A>B?:5<.$31&(7D#/Z<71PH(.H5N8VA4S6#%<*\U^09-(?AF4 'EAQSND
MH=7U2$"$2D?O!I2&P[(9@;N-IJZ/[T*=@<*$ DMBI@0@G<WL]>F$# ,^+3MP
M6G:<=&ZHGK"4./GBG."= 3&R+7FZ\"QAV':8ZV^1,W5=K44K$;@Y35R?/(?C
M"(&!<VOI_Y[&2>&B,36\PB52X)[^:7T>)E\"<ANTM%<':,IY X<AH^*V<D?5
MIPSAD?=\J&PQS<+2P[K?VS?4GQ-(O=)NWIHGCFRB,/T*:ZHCO8+,LEN::]X*
MJ J_C9<]Q,[I4!F=F7J9 "]N6+7M*WQ$2,*,O-@U]=(P"&XHYUDMEOKDT\:8
M_^@L6"AX82K6)L(/,J]@>$1(7MO8,%BO["E\'YO=Z$$HSW8:?0\]=OI@CN6=
MA8% FK)/S]Q[Q!@I/%;M+*9>NJLZCEBPF%;%DT P2!M3A(RRB82J5P@$S$(+
MRKXJ&1FPS,B-A2*@(R?1W%61H@BZTE&;.53""*SCU2E4_R7K@K$HV\&B'#(6
MA;$H'<6BV'I1TNR@=]/[1/T(Z\:E)I+27=T-4@Z\)O48/&-=!_8'B_-+!+F@
MTQ"V0@>"CA=C"-D[V\+*(@1BXT/K8Z+&1@F8Q,-B?V,RC25YH#%@(<(^G/"W
M<C9I7%-U0*;&;JA$HRT@77Z"281>5%Y=F65XT"5F5*EF^0]+@=X*.42<^/5K
MM<9@#.="<0]'0_DE(]_: V#C?-WSWK[^1R7+0HGKG&KQYNO*;_$ARK>_*<\)
MN[/M=V<[SHE[%BMU@1% <4))H79YJ%HG.'29[Q\4#DB V3((];GY,$DRV_\X
MTJVHJ-?K(UDXI"'R&Q)5BU5]?>7L<S@:8FC$HYY00'=<*'U*,%#ZP" =MXH9
MI:LPQM\F)6P^# !P'<X1\R 8&.)#K,,ZB'M3K;2E#GKJA(%?-UU1]%%-.(9-
MZ87=( D1PS'$3BC=CE/<CB!N.%4>0D^,U-/PC[<I9&+@+UE,VJ.#AZ3JYM ,
M$&(-RR6$CE!9N$A<$7U$#:F;XUD2)TJ@+&,'.G8<7KZ=:_ 8096JP36(HU6N
M%C//J9FWJZ;1S]$EC!16,P$,>H:CD\"DFFU4B%W5D4J<XA[^$UA_M5]_'7:<
M;NK8HZMNCZK: )KRT%L+L&"^(\44]A4P006T9RBDH#.QD",%UH\E=%A< ?"4
MRD+N8BIGWPR*ZEE0KZ[FIRD0V6HN-9NV706;;J;<KB5QB1;C^&:ENPYFTF;@
ME1N-J6)-5(W J"R:%8[6+U"BFA'6 KG^" ^YCC#;1HNYR4N$@#P-D\/ .2+H
M-.* BGRP?(1J5G)C+]<5T^B8=&V(P8;O_8J;*>Q\_'J& 1-L&$G4L6EV#TSF
M.57I+.<QA-/I7VK; U1Z:C^8I&JB$R_;1P:P*6 -,A#.^G?CQ@7#-+J@.GI<
M$4VR'D94^(#IP '3<::RTU6&^Z>?YZL,P?_M.6:& 3FT:R];XM-5JNH/]"G0
MVI,HIZ!4(V@\8,AY4\,+XO.+F5:Y-KLW#9"Y+BJ@$<NIK6HO_Y#Z4>?&;'99
M1C+\LU3I;U!I, X\IP!AVU.>?P;7K.C%S<TU.ULM:8V!.-&3\PU--(D,TO1B
MT_/(VK,#VK,9;%OC=#[]!KKS0W_XV^!*7)R*7]]?_4-<7PW[9Z!VSD7__!^B
M?WP]O#COB='[X75/7%R)RZN+X\'@9'C^QERB?C8<G0SQ0G%T=?'^S=MK<?0/
M_.ZR?W6M_GK3'YZ/KO&3B^NWZFGX>4^HO_'/X6 D!OWCM^+OYQ<?U*W/X-<G
MZ@'7@W.X;?_L#*Z^P!^\N1KTKP?J=H/_AJ_%Y>#JW?#Z>G""#[V\/!L>]X_.
M!N*L_Z$GU,,&\/'1Z.+L_?4 ;O/^_/CB_&3H[CN\NAK\=@$_HL<._OOR:C :
MJ7_AW(S$Z86Z0(T:YP:> C/UM4X8%(NMG2_?4+T]9^WV5;1;Q]F4!I\FJ_DR
M<#Q+[0[;8RN6>E,X4V[FHJ,9]9H(6B':"<EU TA"@>7"-8?1=&^.8?M.<\F]
M_B/0K,-O R7:O#1;6(?_]W]?_/#\EQ+XQ]M[>OPPSD#GZ2GZ\>#%JY=L0NZ$
MD@7>B,.??OS^^Q?/#W_X^8>?0./N1?M-4KC;DO)S8+:NUZ>]LNK 2%FH.?;B
M?01"(0O:BIJ\ALW O6[>!=(QF\I-Z@A4IAHE:#0\6"8WT0T-9RZ+0G<3]S/H
MOZC'QUZ+*C5,2#$;<*MM#F3J7+"T94._0P:F;@>8^I*!J0T&ICYRAC%6]4OO
MAS@A^GNP8BW#@"Y'\+6:4FNZ2A793OR&*$C\2.Q75&=A]*^M>P&^;<S\V+YY
MKK5L!,F&:++&=K/$:*-T_4K-+F:R=:[=&V;/IVQ![6X"A32:H$4 T>YKPOT2
MW,D'%%7K&AY,),75V*F'9MT<+S7T @0,A;]_@=OMQ7?54V.OOV]/#K_DIH<-
MRTP+MM3U!G,C6,  L;_9+**Q37TNG;&:(7EG2SBCE3H',R5:EL)39]<\WDXX
M::D@!$I#TWO"LB9J&# .)/"!/A"5MK7IYGHD%)6](_N25)I$R"[_52"*.TWI
MK)]E0/B-)*+3U-7D/!3$?G $N@^ZP04CX9$K'@%_QP/LW2=0[Y-#,XL;I2(@
M)=A#LHS9:BX6:J[29+J:X!/'D9[Z)\1!V&QOM]D^[H39?OT$<[W.TZ^M90,C
M/@.$/%7&>[7ENJ[-M E'G !HGUZ9@JT74(T9?D]MMP?%9E./,\&"38.>-[XV
M>OA,Z9$#4"X('/UVY+.^G9T=]ZB% E* 8?5\>.223J37PT+#TM1Z;5[#4\R[
MZ<0[U/-2&P52\'%6X],0A#;*J?5LIO3@BQ]ZXO#YX4M<"3(%RB]XGL*)=1PM
MXR*:P\\^2@ I#)/)P4Z]Z8_TIINT]M?Q%?3&W&7OBWX/PWP-$A%/-NJ-O9'M
M3G2)H.W3=#Y/[_>;X:7MW,1O='M?-6-"V>UU;F^#EN#;Q[%K)Z.2%OS\Z7CY
M0WD^VF+P_L??AN?BP_#Z?# :B0^0G[XX[04=>G3J!K&A6*LY)6?),TU,T:'G
M0)&3.%W-UZZ;#YWA(?34<R,-_$?[_-I&0ACA+,YR<+BP?ST<O^/TSF.W^YK*
MJ7K.?D51V&KV?7 V.+DX%Y=O^U?O^L>#]]?#X_[92-ECY\<'+4E*_N4O7_E%
MOGZ"N3^=8DX5+.1S=&!:LG:OFV&+;-CM#3T+>3X:,A\[N.&.UJ^%:+V^_"[_
M3IQ$=_'T67\N/T6)TI[B^$"\R=*\)]X=G!P(\[^6Z-&__.4T^K11F?IQY5<'
M+WY\64JE\?YY.B8A6LC7#\O67_XR@'[3C5F--OLYUQ H?BV.;V,Y$[J9O')
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M,.BA>8O"H >6@\Z"'GX]N3H5UR].-,B!JS09XK E2>O";O(@#J/B0%S*@E.
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M^!F&L3-KQ#",)EL*[4G&,@R#81@,P^CBSF<81N/6A&$8+ >=Y9+H3Z.%^/5
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M?"UZ#)B$-S*16307EU%6)-PIA]$9G$C?&=%B= 8+%:,S..?"IRRC,W8NN=S
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MOM %_J#3"BX)^&&9%7J[V*B_KL@2DM$_*EWHS67;)GT@QH0I"[:F.^$.)H^
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M94!1AK +8Y'_@*(,1.UNC]'4A:)LO:'49^R(UZ_OA;TSX',6<)0K<)3MEZZ
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M0L<Q#->>"N\X-$=U[Y?\7_^:Y2#;,@<AS+//*@?'H"&MI*D:O]"^\/.71*Q
MED&%9(F.=%F(I86BB]J6AD4T_QTD+$C8B"1LFN#%2O?B1NFYU'C!EW!4ER5>
M^W3AMV]8^+]S>*P XYUNOV56:)1+DE.P'\A(@-_F]$MS#_((X+NU)0#/-]<Y
MW<_SAM0'H1W2"0I">P=":V^P0H =+5N2VI D(WCP!_SHNEC/T!2&.U%&$:Q
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M]2J1I:XV&,)UUJ4N-RM+0P[W#YMYG\EHX722FC'O)Z.:% -K\+"WML2"T+:
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M14X?OX)6PE3X^"HX5E7?;QEZ#6=SKV,T-4F,3F#JG6!Q2J0M>!O0E_%YK7F
M6% CI 5<BKVY5;NUKMP]SL^E,$0LS;3#IH!>*I/V<KO_;;_R9W!W,[B&4*3U
M!9O [OA!X >T#&O&[:BZN,366Z2K59)/7%D]EX'R/ E3R,8'I#>+WK>>FE&R
M^XK,826,VAEL+2<3Z\.J7=;9F7^XCB)38?E48BI8C8^ =IYML7^F:L:>#8C2
M_()U;!I,LCY9QWXO&\=VNIO%A%_00?8:1+!NB@BVBC@?BV/-4P$(IGP"KAIB
MPZ#:"C159!1150"%A6E $&KWQ:#[_.4>BU+E),"^G,D,&BQ'(^%I:M7,W8A+
MLXJ*50%O_N&ZJ6(=3Z):KB@?7(6MY=-]6-5>OQ?R&;O4*HW@49H.C/T#_.*P
MO)SAA#(!70;>5/N7B@)*E21((2@R&'6]VV+Z4IB/&"G/N&-(W\O* Z6IVZN8
M6F>G9R>,XEW<1UGA_^S@[$M_<'9[]>QWV41/!?2QBZ)2,I(9%Y@7F5(R.X_W
MMOM]ZG<17OVX69+;8IO8%%YC9/#Q,^V9A];WI5O[7#[G *"#5%&>N)QS/X9\
M6-2'!Y2I:4A(MH7GZ^>[7[<UW"I+7+=<%T[9U"9%.JN2,58KX=.W0_B8.E%)
MSVS121T^JVUY(3'C#]:LSL>P.PY;+';G\P0M%EK=P)!%XZUW<^U5:[P?<FSE
MQ!/]CX) *&'6B3NY$%_)*02[&86 W.9Z#H',2BN47&D+YFWIDN1;$UIH)/5X
M\BU@?2C'N W"_C=:AV!?D<C;+0X6H[%URN/DP0X#>^TF9+QY/@U0=@FN=0;;
M%X]P9*<S^)0;@+,V'?X&@R-O"@35&W);OMZM%OM1^6/,)08WT"2\0IPP'')U
MB"M.#\[QH^^\@:X_@301<2^-<1S9 =>J")(RSIX->%XH!#\P5&)$A"=QJ^]B
M754B-S;1/*7_V)P4:]X0/FG=9BY>!3Y5YAIUR.N=I97D 1>&"7"QE6NIA)<W
M<.V7UN[2HJ406!9&PWH(;F'\:UD%=>)[5IP6N'+^>'8*"UXM!?*.MC B0'"8
MF G>M5T]V(SBZ!=#YSO?)3\;T%0BO?DN8GW7=[+D8'^G8<6P#HP; 6W]L9ZM
M,@I"-')W75\)*>-Q8N)%%E/DE_4-4I-1)$($MVI66ES?U_NPR;>D@LX=LZ[N
M)'3X\#I"6O,6Y:;:E>9N4T,1Z$BP4:I Z?.*LC@>0%#AYA:: A.@&GRZX"9_
M8!7S[<'[ ^M/-MQIAJ ;Q_QIR88MV?"+*^$7ET1+-ES_V?[,"8L[B0Q_K+S_
M._A?\R#OIJ+V7S!DAH@;<?M(8E8'MH'A\]Z  4*/O2^:$:3 XR<?CZ["4NH6
M-[+ DP$EV G)\ZLR+T.'^Q-7FV.F!RKAN5K>9VU^N9L?=$0IG,9H._$&@0^4
MO>F6%PW291A5=[;B?:-CC?GUZG#+JPAB\!:L<,Y?!$?N+L4!\NOG:K-J4*4<
M>?\XUDR5Y\@'?3;$_#<>'L\8"Q)'X/L9"@6-FEDE >7I-D0%FFNV<NL=?)I.
M!-UI %71:.;\]F(JEP:3QS2*2A>O"\&\5G;:E6;3<U)\MJWTX/%*,Z=!$$<H
M *PP%(&T-3<JY'&<B(<B+Z-HR0-VO]IT3)/3,<=H0)0J(I6+-H(]X5%R0+4>
M801A3:P\+,9?LMR(OXS,J=E<EJ0P<+&/G-3*IBY(]^V-5R&>QDQ)D>8/+=3J
MFUNX!*:N8\ABHXN)-,8CV=AP;['F]QO<K3+. A]#'\;X;'%E4GF?1TS!U:"2
MH_>W>MV<\<=+8GPD*92*+F8<<BLMZU0H37@S*1BU.(:J%F]?NJW@*N34D336
MS=\C1ZD7;.,W;3#<E55T#E()T,"RG[A!"=%V<)::8(*1M\43N6>@BG]/*8*>
M/]]E$Z&*L)S"\!BTC?R(3"QHSXO*LPX2PRVGP7F**J7AKD#$$H-RF\6:SL3#
M3K+QKXD1*6G3\^0BFOWS"K^QFM'QNDLID\U2@@\N#6<DBG^D)@1<O8Z\Y<S@
M6F;E59X:+%-M/E$69[<H>B.;H-"QA!>LW;<[_5UV(<-8S#Q-%AT/Y[=HAVX9
M-L ON50\2RC/W6P$$IXBY*QW1VY_I=->Y;*0Q3LR=Q:(Q9NERG7.U+II<H:0
MKH,@J_S*G#2]:/91Q6JM0'X;*^WH=M6-L MG1;"VC..)I8.='JVW7$EOG9#_
MM#QNYM;6#K^ 5[>BHOH- 1<@CCX'+DNR0Y%A0:T NT7Q/;-7ZZ?[SUUPDCO&
M]?@2>:3^BMB<0YJK))U)"'-T:WDD<H@)#X,7CU,&^@#EM\;F+3NS#0<T/1SP
M&:CUN1%!% 'FC\*A&0LG,^VU=L!_A<F?N&SHKLGMM;W\/ SWNJ8WD.;>O"79
MVJ>';9].K@*1N%M]%<WRX?95&W]FE/(OO2F_\Z; 5?XK2Z[!#F3]9 Q>2*)-
M%O1:=<I^&[!CS:_S6^,\4<Q#&PS, 9**-$8J,;D@#'Y+E.TRP<&'A Y5K^2G
MPZ-0%PH%7I.@#USY^WB)TIT_[?38)T2*<5N ]REYIR74)$@EH<BD#PL=/6!X
MU)+5'BQ9K2%,H<8Q1UJR6DM6^^)*^,4ET9+5UG^V6W_C(7X10'/%]0#=L_,)
MCR^*@#F%WC.O"H,M]"T ^/6-=/YJ/G'58(I3$P7=JNV=)J?!<Q=&J%GM^;DF
M]KC!\]]N>:TP6F&LHYE\BXEZ=K3-WG)W(>/FRK95M%88:\+0/OGYY/@_YZ<_
MGK"CX[?O__73]R>OWYR\.WE_?F=(Y5Z[WV"<\@ -\&EY-JG,2F&^IG(;1DE]
M\5\,1KP>_Y:_1Z,N]43)-+N02[,W,V6:-ZNMM6N%T0KC2QJ_ST_(?6J?LM?\
M4H:](R6NP(@9P=X8O2ZDW*\88[_6__GJJXU4L?N2=)T2H?2SZZEW_?74S1#Y
M^F?4OVV&H!N7WKI=1OWPZ5"'LU=?'SZ=N$B]^C]02P,$%     @ >CNA5E6*
M)2+@!P  BE    \   !E;&1N+65X,3!?-"YH=&WM7&MSVS86_>S^BKMI-R//
M4+(DYV%+JF>\MJ;CW33U--ZVWS(@>2FB!@$6 /7(K]\+4)3\D+-))DXIF;8S
MH4@\+@X.+@XN0(U2FXF3[V"4(HOI?QA9;@6>C/]H][JC@_(#/3Y8/A^%*EZ
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M*OGLRF)E 8,OR.^5):=(A91$C :,M2>88R+%XEBOEJD9N*!2PT[<&U0 O<
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M=Z)69!QJ(TQFP6F.BVXKV86HH B'CAD$$=I"T,3+P>5&7[\D6"6(]\*2!$-
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M! QJX$SA,0HZ5H O[0/P3),8,]R0;;FU%KBSBS^N\_>V?5II"1.1!,+V!(Z
M+!>Z.8BI4@+1UH!I!@&%OI?.EXX"]AF$9\?)J194BF^O!&$XB<'MR#^M.,N*
M\$RD[@>7:A9I@B;T5F-EXG((2IY+YT.8FVPWG>[2!9FS:<A[$A1:(TR.$C7,
MYN*^]-D2;K3_]&G9Z4/-(E_A-)E- PL&W.';L\T/JCW:'.BX:B!?KI,F#-G%
M7;51CVF']]G>C^UYY%YM=%UM;#M=RYDJA;M*H:3N:(\+QY245^1F'B8'DE)W
M4YD+CLG9NA[B[V0*3T,_7 WS#!O81?6-KR,LDY ^L6X$JQK2J=,[,U<\!O3
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M_*QE..[OK/>9BB^8C#Y3<?\R%3__,$G#U2__\?,/E\4\_N7_ U!+ P04
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M"EF,K J8/ACF&RW2)O-"*1)[NZ4SFQ/0DQWEV-(8?HF#"6BM-'CT(T?A0;6
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M& MP5Y5$-O>'%$;/4QC3>Y7"^.R)"G()1"@[KF<#Y^"%KC?5N/SQ\?[!P:T
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M,'F"Y-Y]S;731=TQ=XT6"S7&,\X4+1:+GN+=>ICVR$SS?6K@:Y,D9K').A/
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MZJ:>*#>VKBGU4+'O'R$*^+)@].@I5:9>?'7TE/]?U/X%4$L! A0#%     @
M>CNA5D\.HMHL(@  /D4! !$              ( !     &5L9&XM,C R,S T
M,C8N:'1M4$L! A0#%     @ >CNA5O(UK? , P  G@D  !$
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M97@Q,%\R+FAT;5!+ 0(4 Q0    ( 'H[H5:94!QZO@\  )B?   /
M      "  4)F 0!E;&1N+65X,3!?,RYH=&U02P$"% ,4    " !Z.Z%658HE
M(N '  "*4   #P              @ $M=@$ 96QD;BUE>#$P7S0N:'1M4$L!
M A0#%     @ >CNA5FEX[$K>0@  W$D"  X              ( !.GX! &5L
M9&XM97@T7S$N:'1M4$L! A0#%     @ >CNA5N6, OQ\0P  CD8"  X
M         ( !1,$! &5L9&XM97@T7S(N:'1M4$L! A0#%     @ >CNA5L3I
M"*$^#@  3$T   \              ( ![ 0" &5L9&XM97@Y.5\Q+FAT;5!+
4!08     "P + *T"  !7$P(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
